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ABSTRACT 
 
 
The Role of Fluorescence and Human Factors  
in Quantitative Transdermal Blood and Tissue Analysis  
 Using NIR Raman Spectroscopy 
 
Bin Deng 
Syracuse University, August 2012 
 
This research is part of an ongoing project aimed at the application of combined near 
infrared (NIR) Raman and fluorescence spectroscopy to noninvasive in vivo blood 
analysis including but not limited to glucose monitoring. Coping with practicalities of 
human factors and exploring ways to obtain and use knowledge gained about 
autofluorescence to improve algorithms for blood and tissue analysis are the general 
goals of this research. Firstly, the study investigated the various sources of human factors 
pertinent to our concerns, such as fingerprints, turgor, skin hydration and pigmentation. 
We then introduced specialized in vivo apparatus including means for precise and 
reproducible placement of the tissues relative to the optical aperture, i.e., the position 
detector pressure monitor (PDPM). Based on solid instrumental performances, 
appropriate methodology is now provided for applying and maintaining pressure to keep 
surface tissues immobile during experiments while obtaining the desired blood content 
and flow. Secondly, in vivo human fingertip skin autofluorescence photobleaching under 
200 mW 830 nm NIR irradiation is observed and it is characterized that: i) the majority of 
the photobleached fluorescence originates from static tissue not blood, ii) the bleaching 
(1/e point) occurs in 10
1
-10
2
 sec timescale, and also iii) a photobleached region remains 
bleached for at least 45 min but recovers completely within several hours. A 
corresponding extensive but not exhaustive in vitro systematic study narrowed down the 
major contributors of such fluorescence and bleaching to collagen, melanin, plasma and 
hemoglobin: two major static tissue constituents and two major blood proteins. Thirdly, 
we established that measuring the inelastic and elastic emissions simultaneously leads to 
a sensitive probe for volume changes of both red blood cells and plasma. An algorithm 
based on measurements obtained while performing research needed for this thesis, as 
well as some empirical calibration approaches, was presented. The calibrated algorithm 
showed real potential to track hematocrit variations in cardiac pulses, centrifugal loading, 
blood vessel blockage using tourniquet, and even during as subtle an occurrence as in a 
Valsalva maneuver. Finally, NIR fluorescence and photochemistry of pentosidine, a 
representative of the advanced glycation endproducts (AGEs) which accumulate with age 
and hyperglycemia, was studied. The results indicate that oxygen plays a pivotal role in 
its photobleaching process. We hypothesized and offered proofs showing that pentosidine 
is a 
1
O2 sensitizer that is also subject to attack by the 
1
O2 resulting in the photobleaching 
that is observed when probing tissue using NIR. The photobleaching reaction is 
kinetically first order in pentosidine and ground state oxygen, and in vivo effectively first 
order with NIR irradiation also.  
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1. INTRODUCTION 
 
1.1 Motivation for Noninvasive Blood Analytes Monitoring 
Today the physical principles behind the most common “state-of-the-art” medical 
instruments can be traced back decades with the main differences between the “old” and 
“new” devices entailing differences in the degree of automation involved. Such 
differences mostly affect the degree to which operating the devices are physical labor 
intensive, produce measurements that can be interpreted by less highly trained medical 
practitioners, e.g., medical assistants, or can be networked in order to interface with 
existing or planned patient telemetry systems. Essentially the current paradigms of 
medical practice conventional laboratorial tests provide sufficient accuracy and 
specificity to facilitate clinical diagnosis and treatment. But there are always increasingly 
challenging demands for new and improved medical products.  
For example in these times, in acknowledgment of the benefits of earlier diagnosis 
and more prompt treatment, doctors and scientists are looking forward to subsequent 
rounds of innovation. Minimal or noninvasive approaches to decrease stress and 
discomfort, continuous monitoring to facilitate better disease control and therapy 
management, and transportable or portable test kits to support point-of-care testing 
(POCT) are a few examples of newly posed challenges in the medical device research 
and development (R&D) community. Triggered by these, we set out seeking 
spectroscopic applications in noninvasive continuous monitoring medical devices, 
especially those offering blood analyte information.  
2 
 
As a specialized transportation vehicle between cells and tissues, blood contains 
enormous critical health related information. Usually, blood is sampled through arterial 
puncture, indwelling arterial catheters, venous blood draw or fingerpricks, and then sent 
for lab test. These procedures suffer from drawbacks such as being clumsy during surgery, 
having insufficient monitoring capability, as well as providing delayed feedback. 
Therefore, such conventional laboratory techniques should certainly be improved in cases 
where blood analytes information could indicate life-threatening conditions.  
For example, in neurotrauma intensive care unit (NICU) the cardiopulmonary 
monitoring of blood pH and bicarbonate concentration is particularly vital to high 
intracranial pressure (ICP) patients as an indicator of airway, breathing and oxygenation 
(1). Blood bicarbonate is also a critical diagnostic parameter for acute respiratory failure 
(ARF) among chronic obstructive pulmonary disease (COPD) patients (2). In another 
extreme scenario, internal hemorrhage after traumatic injuries, such as in the case of car 
accidents and battlefield wounds, is well documented to be one of the most avoidable 
common causes of death for all people between 18 and 45 years old (3, 4). However, as 
research has shown, the delay in pre-hospital and in-hospital hemorrhage control is the 
primary contributor to potential preventability (5, 6).  A timely screening showing the 
existence and location of any hidden internal bleeding before the patient is transported to 
ICU will undoubtedly favor the rescuing of a life.  
As examples speak for themselves, a noninvasive continuous fast in-situ blood 
analytes monitoring system is in immediate need. Having drawn the attention of many 
scientists, optical and spectroscopic methods are perhaps the most promising to achieve 
such a goal. By solving the so-called “inverse problem” for the radiation transfer equation 
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(RTE), Tuchin et al. (7-9) from Saratov State University modeled the propagation of light 
in turbid media, i.e., human tissue, thereby modeling the production of elastic emission 
(EE, including Rayleigh/Mie) that can be detected experimentally. The reasonable 
agreement between experiment and theoretical calculation suggests that such a treatment 
accurately and precisely describes the average propagation and production of externally 
observable, e.g., EE and fluorescence and Raman scattered light. Further, Chaiken and 
Goodisman (10) exploited this in order to calculate the EE in their unique probing 
geometry. This will be revisited in Section 3.3 of Chapter 3 in the context of testing the 
new algorithm for measuring hematocrit (Hct) in blood.  
As shown in Figure 1-1, human tissue is relatively “transparent” in the near infrared 
(NIR) spectral range which gives us several “optical windows” (11-14) allowing NIR 
light to penetrate up to several hundred microns into the skin. However, chance or false 
correlations due to confounding factors and broad overlapping bands of NIR absorption 
spectra have largely limited its use in noninvasive in vivo monitoring. To address this 
obstacle, Arnold’s group (15, 16) from the University of Iowa started in early 1990s 
using multivariate chemometrics, e.g., partial least square (PLS) and net analyte signal 
(NAS), to eliminate such influence.  
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Figure 1-1: Principal light-absorbing molecules in the skin. Redrawn from Anderson 
(14). The most penetrating wavelengths are from 600 to 1300 nm, the so-called “optical 
window” of the skin. 
 
Meanwhile, varieties of optical and spectroscopic approaches have been adopted to 
study wide range of medical applications. Puppels et al. from Erasmus Medical College 
Netherlands has applied Raman spectroscopy and microscopy in rapid identification of 
pathogenic microorganisms (17), determination of atherosclerotic plaque composition (18, 
19), and discrimination of healthy (20, 21) and cancerous tissues (22). The Feld group 
from MIT has used endoscopic and optical tomography to image and diagnose cancer in 
addition to noninvasive blood analysis, e.g., glucose (23-25). The Michael Morris group 
from University of Michigan – Ann Arbor has done instrumentation (26) to analyze 
mineral composition and related progressive bone diseases (27, 28). The biomedical 
photonics lab from Vanderbilt University led by Prof. Anita Mahadevan-Jansen has 
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explored the optical imaging and diagnosis of cervical cancer (29), as well as optical 
stimulation of neural tissues (30, 31).  
Most importantly, the aforementioned researches in biomedical optics and 
spectroscopy are largely depended on the advances in semiconductor, laser, high 
precision opto-mechanical industries. Major innovations over the past 20 to 25 years 
involving enabling technologies broke the old technical limits and significantly 
broadened the applicability of fundamental optical and spectroscopic principles to 
progressively more complicated problems. Recent advancement of NIR lasers, charge-
coupled device (CCD) detectors, compact spectrographs and effective laser rejection 
filters have increased the instrumental sensitivity by factors as large as 10
5
 plus decreased 
both interferences and noise (32). A revolution of biomedical optics and spectroscopy is 
on the nearest horizon. 
Despite the fact that these various novel techniques have potential to be applied in 
sensing many physiologically valuable blood analytes, such as bicarbonate, urea, 
cholesterol and total protein, this project concentrates on noninvasive blood glucose 
monitoring. Glucose is the most important carbohydrate in biology: a ubiquitous source 
of energy and especially the only source of energy for the brain and nervous system. 
Because of such importance, whenever the blood glucose is not properly regulated 
various symptoms can occur. Metabolic homeostasis tightly controls the normal blood 
glucose level between about 3.6 and 5.8 mM (64.8 and 104.4 mg/dl). Sudden 
hypoglycemia (low blood sugar) hits the nervous system first and triggers drowsiness or 
impaired cognitive function. In severe glucose deficiency, temporary memory loss, and 
even fatal condition like coma could happen. In the short term, it is far more dangerous to 
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have too little glucose than too much. However in some diseases, diabetes mellitus for 
example, hyperglycemia (high blood sugar) can be chronic. Diabetes itself is not 
immediately lethal, but most diabetic patients actually die from the complications caused 
by this continuous elevated blood sugar such as cardiovascular disease, chronic renal 
failure, retinal damage, and neuropathy.  
So far, diabetes is a serious disease that strikes 25.8 million, or 8.3% of the 
population in the United States, according to the American Diabetes Association (ADA) 
(33). Meticulous regulation of insulin intake based on intensive self-monitoring of the 
blood glucose concentration is still the first recommended tactic for management of 
diabetes mellitus by ADA. By far, the most widely adopted blood glucose self-
monitoring technique is the U.S. Food and Drug Administration (FDA) approved finger 
stick capillary blood sampling method. However, few patients can comply with the 
recommended 5 to 6 measurements per day consistently using this painful and infection-
risky approach. Even healthy people who might want to take some tests for prevention’s 
sake are deterred. Sadly the truth is that early diagnosis has unfortunately been 
consistently overlooked and it plays a critical part in successful treatment and delaying or 
preventing some of the complications of diabetes. People’s reluctance to endure extra 
pain and handle blood contributes to the failure of early diagnosis, leaving 27% of 
diabetes undiagnosed until it is too late. 
Under the industry’s current standard for point-of-care meters, readings may error up 
to 20% from standardized concentrations of 75 mg/dL or less. That means a meter 
reading of normoglycemia may actually be a failure to diagnose hypoglycemia, which as 
mentioned earlier is a very severe and dangerous situation, and serious consequences may 
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occur. Although those meters are considered home-use or over the counter in vitro 
diagnostic devices, some have been used professionally as a substitute for standardized 
plasma glucose measurements in clinical settings. Therefore, FDA is not satisfied with 
the performance of current commercial glucose meters and is recently considering 
tightening the standards. It is a challenge for the conventional finger stick meters, and 
also a chance for new technologies to step in. 
The aforementioned opportunities and challenges comprise the motivations for the 
current project of utilizing combined Raman and fluorescence spectroscopy in the 
development of a noninvasive in vivo glucose monitoring system to assist in diabetes 
therapy. 
 
1.2 Contemporary Technologies 
The commercial opportunity, as well as the advancement in bio-optical technologies, 
drives the development of noninvasive blood glucose monitoring devices (34, 35). Table 
1-1 lists the most popular contemporary technologies that have been adopted in pursuit 
this ultimate goal. However, in order to get FDA approval as a substitute for finger stick 
meters, noninvasive devices must provide straightforward glucose information from 
blood, rather than any other indirect information, e.g., interstitial fluid (ISF) glucose 
concentration. Therefore, products based on micro needle fluid harvesting, ocular 
spectroscopy and iontophoresis, which do not obtain a glucose measurement directly  
from blood, will have to face the public doubt concerning  use of ISF or tear glucose as a 
substitute for blood glucose (36, 37). For other electrical signal based technologies, such 
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as electromagnetic sensing and impedance spectroscopy, their measuring precision can 
easily be influenced by minor temperature fluctuation (35). Similarly, thermal 
spectroscopy cannot work under physiological or pathological conditions which would 
also induce temperature variations (38).  
Table 1-1: Contemporary noninvasive or minimal invasive blood glucose monitoring 
techniques – their underline principles and limitations. 
TECHNIQUE PRINCIPLE LIMITATIONS 
NIR 750 – 2500 nm absorption Strong water absorption 
MIR 2500 – 10000 nm absorption Poor penetration 
OCT Interferometric signal Motion sensitive 
Raman Laser induced Confounding factors 
Polarization change Chiral molecule Scattering depolarization 
Ultrasound Photoacoustic Sensitive to environment 
Fluorescence Fluorescence intensity Ultraviolet excitation 
Thermal Different approaches Pathological temp change 
Ocular Chemical bond Glucose in tears 
Impedance CNa
+
 & CK
+
 change Various hydration status 
Electromagnetic Dielectric parameters Temperature sensitive 
Fluid harvesting Microscopic holes Glucose in ISF 
Iontophoresis Glucose transportation Skin irritation, sweating 
 
Major technological and scientific innovations over the past several decades have 
significantly broadened the applicability of spectroscopy in exploring this challenging 
project. Among all the optical and spectroscopic approaches, Raman spectroscopy is one 
of the most intensively explored technique (20, 23, 39, 40). As stated earlier in Section 
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1.1, in NIR spectral range, human tissue is relatively “transparent” which gives us several 
“spectral windows” (11, 12) to allow more light to penetrate into the tissue. For example, 
the penetration depth of the in-house LighTouch
TM
 device is about 600 µm, which is deep 
enough to shed light on the epidermis and superficial part of dermis layer where the 
blood perfusion is acceptable (3 to 5%) particularly in fingertips (41-43). Furthermore, 
fundamental vibrations observed by Raman are sharper and have less overlap with other 
bands from the same and other molecules compared with NIR absorption or “diffuse 
reflectance” bands that predominantly involve overtones and combinations. Water, 
protein and lipids all have badly overlapping absorption bands in the NIR absorption 
spectra. But water, comprising 60% of body weight and 95% of blood (44), has a very 
small Raman cross section.  
Nevertheless, major challenges for Raman spectroscopy include the presence of a 
strong background fluorescence signal and inherently low signal-to-noise ratios (SNR) 
(32). In general, the quantitative detection limit for spontaneous Raman scattering 
technology is roughly 10
-3
 M. However, the physiological glucose concentration, even for 
the hypoglycemic patient, is rarely less than about 2.3 mM. Our lab, from 1998 to recent 
years, published a sequence of papers (45-51) on the development of a novel tissue 
modulated NIR Raman spectrometer and in those cases demonstrated a detection limit of 
about 4.45 mM with a precision of 1.22 mM in vivo (50). These specifications are 
comparable to existing finger stick technology but better performance is possible. 
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1.3 Tissue Modulated Raman Spectroscopy 
Transdermal in vivo spectroscopic analysis or imaging of tissue analysis involving 
NIR excitation always produces some broadband NIR fluorescence that, depending on 
what spectroscopy is being employed, can degrade SNR and dynamic range. Hardware 
and software have been devised to perform wavelength shifting, time gating, frequency 
domain first- and second- order derivatives, and simple or modified polynomial curve 
fitting (52, 53) for the purpose of fluorescence suppression. However, their 
implementation either relies on spurious assumptions, laborious spectroscopic system 
modification or user intervention, which makes them less reliable, time consuming and 
less commercially viable.  
Tissue modulation as a methodology attempts to obtain more information in a 
measurement cycle and the measurement cycle is designed specifically for differentiating 
blood information from that of static tissue in vivo. Properly executed modulated spectra 
can reduce the fluorescence contribution to closer to that of the Raman contribution and 
also provide information bearing on the physiology of the probed tissue. As shown in 
Figure 1-2, tissue modulation is the use of spatiotemporally localized mechanical, 
thermal, chemical and/or other external influences to manipulate the mobile components, 
i.e., blood of the probed volume, relative to the static components. Thus, the resulting 
difference spectra could be used to isolate the spectral features of blood components from 
those of static tissues. The idea behind this approach is analogous to the difference 
spectroscopy which is widely adopted in infrared absorption spectroscopy to eliminate 
background interference and extract a signal of interest. 
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Figure 1-2: Schematic drawing of tissue modulation. Analogous to background 
subtraction widely used in NIR absorption spectroscopy, the purpose of tissue modulation 
is to separate the spectrum of blood from that of the surrounding static tissue. (Black 
arrows indicate the direction of applied pressure; red arrows indicate the direction of 
excitation/observation.) 
 
Three tissue modulation schemes are shown in Figure 1-2. Top two panels illustrate 
the pressure modulation, while the bottom panel shows the temperature modulation. 
Temperature modulation is a slow process (38) since body temperature simply cannot be 
varied within seconds. And longer experimental time makes the measurement more prone 
to the influence of human factors. Therefore, this study is based on the pressure 
modulation scheme shown in the middle panel. In vivo the incident light probes the volar 
side of fingertips and the backward remitted light is collected. When pressure is applied 
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adjacent to the probed volume as suggested by the black arrow in the middle panel of 
Figure 1-2, blood travels from the venous side to outside the probed volume creating an 
effect analogous to an “empty cuvette”. Therefore, by subtracting spectra with pressure 
from the corresponding ones at lower pressure, i.e., a “full cuvette”, one can get 
differential spectra that manifest the effect of blood on the spectroscopy and tissue optics 
of the whole probed volume. 
To achieve a successful modulation, the ideal scenario is that in the unpressed part of 
the measurement cycle the applied force is well below threshold so that sufficient blood 
perfusion is guaranteed and the capillaries can maintain mechanical stability. While in the 
pressed part of the tissue modulation cycle the force is only slightly above the threshold 
of capillary collapse so that blood is modulated, i.e., moved, but limited deformation is 
introduced to static tissue. The difference spectrum will thus contain a minimum 
contribution from static tissue and be mostly composed of blood borne Raman and 
fluorescence features. This additional contribution to the difference spectrum is due to 
different light propagation, i.e., turbidity, because of the modulated blood. This 
contribution is calculated using the same algorithm as for hematocrit to be described later 
in Section 3.3 of Chapter 3. 
 
1.4 Terminology 
In the tissue modulated Raman spectroscopy, there are several terms that will be 
frequently repeated in the following context. Therefore, it would be beneficial to make 
the terminology clear first before we go in-depth justification and discussion in the 
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subsequent chapters. Figure 1-3 shows a typical 20 ms frame spectrum of a human volar 
side of fingertip under 200 mW 830 nm laser exposure. By scrupulously adjusting the 
laser line rejecting filter to make sure no signal saturation occurs at the Rayleigh line, two 
piece of separate information could be obtained simultaneously:  
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Figure 1-3: Raw typical single 20 ms frame of Andor CCD output for the volar side of 
human fingertip under 200 mW 830 nm exposure. Shaded areas show the integrals for IE 
(500 to 1750 cm
-1
) and EE (-30 to +10 cm
-1
) respectively. Insert: the same frame on an 
expanded scale to show the sections of emission integrated to obtain combined 
fluorescence and Raman emission, i.e., IE. 
 
i) The elastically scattered light, or elastic emission (EE), contains only reflected 
or scattered light that no wavelength shift has occurred. The EE integral covers 
the Raman shift from -30 to +10 cm
-1
 on a spectrum and the overwhelmingly 
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majority of it is Rayleigh and Mie scattering light. EE, a probe based on 
physical optics, provides information relating to the presence and disposition of 
red blood cells (RBCs) in the probed volume.  
ii) The inelastically scattered light, or inelastic emission (IE), is the spectral region 
that is chosen to exclude as much as possible of the Rayleigh line and off-axis 
reflected light from the outermost stratum corneum. Based on the current 
system setup, the Raman shift range from 500 to 1750 cm
-1
 which is comprised 
of undifferentiated Raman scattering and fluorescence is chosen to represent the 
IE integral. As a feature of vibronic spectroscopy, IE provides chemically 
specific and quantitative information concerning molecules in complex mixtures 
such as blood in vivo. 
All of the in vivo data are exclusively collected using custom LighTouch
TM
 software 
programmed by Critical Link (Critical Link, LLC, Syracuse, NY, USA). A typical tissue 
modulated experiment takes 200 sec, however 20, 50 and 100 sec experiments are also 
performed based on the purpose of a study. The single frame exposure is maintained 
constant at 20 ms. Thus, for a typical 200 sec experiment ten thousand frames of such 20 
ms spectrum like the one shown in Figure 1-3 are collected. Toward the end of each 
experiment the IE and EE integrals for each frame are calculated and plotted against 
frame numbers, which are basically the time axis. An example of such IE vs. frame 
numbers curve is shown in Figure 1-4.  
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Figure 1-4: Screenshot of a BV vs. Time curve generated within the custom LighTouch
TM
 
software. The panel below shows a close-up look of only eleven IE integrals from the 
curve. Each blue dot indicates an individual IE integral calculation based on a 20 ms 
single frame spectrum. 
 
In earlier work with noninvasive glucose monitoring (54), using IE was proposed as 
a measure of probed volume or blood volume (BV) in a modulated approach. Despite the 
very low volume fraction (41-44) of RBCs, the optical constants of plasma, RBCs, and 
other skin constituent materials are such that the net propagation of light is mostly 
determined by the RBCs. Empirically, this is especially true for EE. Therefore, the IE vs. 
frame numbers and EE vs. frame numbers curves are thereinafter mentioned 
interchangeably as BV vs. Time and RBC vs. Time curves respectively. Detailed 
discussion will be continued in Chapter 3. 
 
1.5 Previous Work and Limitations 
Since 1998, most previous work (45-51, 54) has been done in the following aspects:  
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i) The earliest research was conducted to collect in vitro evidence for 
demonstrating the feasibility of the noninvasive spectroscopic approach to 
quantitative glucose level determination. Raman spectra of various chemicals 
presented in blood, such as glucose, hemoglobin (Hb), albumin, urea, tyrosine, 
bicarbonate and glutathione have been investigated in either crystalline, 
solution, or gelatin tissue phantom forms. (54) This comprehensive work led to 
the selection of 373-686 cm
-1
 Raman shift range as an indicator of glucose 
concentration. Since this range corresponds to two very strong Raman of 
glucose skeletal modes at 423 cm
-1
 and 547 cm
-1
 and has little interference with 
prominent protein peaks, quantitative measurements using these features 
reached the resolution of ±1.5 mM in vitro. However, Raman spectroscopy’s 
millimolar sensitivity may not be achievable when applying to in vivo 
physiological environment. It is also worthwhile to notice that despite the 
chemical and optical similarities with human epidermal tissue gelatin phantom 
can only be used as a calibration tool. Human factors, which will be elaborated 
later in Chapter 2, need to be considered to further understand the limitations 
and potentials of such technology. 
ii) Earlier work applied the concept of tissue modulation to the in vivo glucose 
concentration calculation. Previous work achieved acceptable results in a 
clinical study on 41 individuals in cooperation with the Joslin Diabetes Center 
at Upstate Medical University in Syracuse, NY. In this stage, to improve the 
accuracy and sensitivity, a more rigorous approach should be sought to utilize 
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the information encoded in Raman, fluorescence, as well as Rayleigh scattering 
emission, rather than just a crude subtraction.   
iii) The earlier research led to advanced instrument development including the 
tissue modulator (TM) (46). The previous prototypes made progress in 
maintaining the stable pressure applied to the back of fingertips, but there was 
no way to tell exactly how much force was exerted. Therefore, it was hard to 
fulfill the same setting across various test subjects. Besides, in the R&D phase 
of a product, it is important to monitor the changes in force and pressure in 
order to better control variables, design reproducible experiments and interpret 
any abnormal outcomes. A human-machine interface which can offer real-time 
force, contact area and pressure feedback and thus in turn perform better motion 
control is a necessity.   
Aware of the limitation of previous research, the current work is to incorporate the 
human errors that have not been previously considered and interpret the modulated 
spectra in a much more systematic way. By interpreting a viable theoretical model we 
strive to engineer appropriate solutions that further improve the reproducibility, stability 
and sensitivity of this tissue modulated quantitative noninvasive in vivo Raman 
spectroscopy technique for blood analyte sensing.  
 
1.6 Overall Scope of the Dissertation 
This research is part of an ongoing project aimed at the application of combined NIR 
Raman and fluorescence spectroscopy to noninvasive in vivo blood analysis including but 
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not limited to glucose monitoring. Coping with practicalities of human factors and 
exploring ways to obtain and use knowledge gained about autofluorescence to improve 
algorithms for blood and tissue analysis are the general goals of the long term project. 
Based on the various results from this long-term project that was initiated in 1998, this 
doctoral research aims at tackling two main factors that can degrade the analyte specific 
spectroscopic signal: human factors and autofluorescence background. These are two 
different types of research challenges and so they will be introduced separately. 
Previous research results show that the raw spectroscopic signals must be obtained 
from a well-defined location on stationary, perfusion controlled and monitored, 
plethysmographically confirmed tissue, and achieving this involves coping with the so-
called “human factors”. Human factors arise inevitably in the design and engineering of 
all medical devices that try to obtain signal from a transducer directly connected to the 
human body. In this thesis, we adopt a novel pressure based, tissue modulation 
methodology in order to exploit the spectroscopic benefits of differential spectra. Results 
have shown a dramatic improvement of stability by introducing an advanced human-
machine interface, called “position detector pressure monitor” (PDPM). Given the PDPM 
we can methodically investigate the influences of skin tone, fingertip topography, skin 
hydration and possibly long term hyperglycemia on the precision, reproducibility and 
accuracy of the spectroscopic signals. PDPM measurements provide a synchronized 
plethysmographic record that complements the optical record. 
The totality of the volume of tissue probed remits a background fluorescence signal, 
i.e., “autofluorescence”, which cannot be removed from either the Raman scattered light 
or other identifiable, e.g., Hb, sources of fluorescence. Of the spectroscopic signals 
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available, usually any fluorescence background is not desirable when Raman is wanted. 
On the other hand it can be critical when or if it can be used as a measure of plasma 
volume and perhaps tissue volumes generally. Results have shown an interesting 
quenching of fluorescence which does not necessarily come from blood. Therefore, in-
depth study in vitro and in vivo of potential fluorophores in static tissue and blood is 
performed. Pentosidine, an advanced glycation endproduct (AGE) that can be found in 
most tissues, has emerged as a central player and further study is conducted to uncover 
and quantify its fluorescence and quenching mechanism. 
 
1.7 Specific Hypothesis 
i) Some human factors, such as a) spontaneous tremor, and b) fingertip 
topography variance, can be controlled or coped with using an advanced 
human-machine interface, PDPM.  
ii) Given that inelastic scattering emission (IE) and elastic scattering emission (EE) 
contain complementary optical information from the same skin constituents 
(static tissue and whole blood) through two different processes, relative volume 
percentage change of these constituents could be deduced from simultaneous 
EE and IE measurements.  
iii) Autofluorescence quenching is due to laser exposure; potential candidates that 
contribute to the observed fluorescence include but are not limited to collagen, 
melanin, Hb, and albumin.  
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iv) Observed superabundant autofluorescence from aged and long-term 
hyperglycemia subjects is related with the abundance of advanced glycation 
endproducts (AGEs) within the skin. We further hypothesize that their 
photodynamic characteristics are related to dissolved oxygen.  
 
1.8 Layout of the Dissertation 
The dissertation is organized in the following chapters: 
Chapter 1 will first address the necessity and significance of this research for the 
public health. This is followed by a brief introduction to the fundamental concepts of 
tissue modulated NIR Raman and fluorescence spectroscopy in the context of other 
published noninvasive human blood analytes sensing technology. A summary of previous 
achievements of the Chaiken/LighTouch Group is followed by a statement of the scope 
of the thesis and the hypothesis that is going to tackle. 
Chapter 2 is designated, first of all, to demonstrate why human factors are relevant 
to this study. Some specific sources of errors attributed to human factors are located. 
Later on, the innovation of a human-machine interface, called PDPM, is introduced. 
Performance of the PDPM is quantitatively evaluated. How the PDPM feedback 
information could be used to guide in vivo experimental set-up is also discussed. 
Chapter 3 relates various in vivo empirical observations regarding human volar side 
fingertip fluorescence quenching that any model will need to explain. Qualitative analysis 
indicates the potential origins of the so observed phenomenon. The in vivo calibration for 
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a proposed hematocrit (Hct) algorithm deduced by using combined elastically and 
inelastically scattered light is also described.  
Chapter 4 puts the emphasis on a series of systematically performed in vitro 
experiments intended to supplement the database for known ultraviolet/visible (UV/Vis) 
chromophores to include their NIR excitation emission properties. Fluorescence of 
various endogenous molecules, such as antioxidants, blood proteins, skin and cellular 
pigments, are studied.  
Chapter 5 focuses on the photochemistry of pentosidine, a specific representative of 
the AGEs family. Exogenously synthesized pentosidine tri-mixture (TMX) is used to 
study its NIR excitation induced fluorescence and bleaching characteristics. A 
hypothetical mechanism to account for the autofluorescence photobleaching behavior 
involving with dissolved oxygen is proposed and tested with multiple independent lines 
of evidence.  
Chapter 6 concludes the thesis and proposes areas for future work. Considering the 
combined influence of human factors and photobleaching on quantitative analysis of 
tissue modulated Raman spectroscopy, a standard pre-experimental procedure is 
proposed to collect the spectral data in a much more systematic manner, thus greatly 
improves the reproducibility and comparability across various test subjects. 
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2. IN VIVO APPARATUS INNOVATION 
 
2.1 Introduction 
2.1.1 Haptics of Volar Side of Human Fingertips 
To obtain spectroscopic information from blood embedded in dermis, the incident 
light must first penetrate the epidermis. How this occurs determines how the 
subsequently remitted light must be detected and processed to yield the desired 
information. Therefore managing, i.e., engineering, this initial process is essential to 
making in vivo spectroscopic probing of humans more technology than art. The term 
“haptics” refers to the sense of touch generally but often more specifically to the context 
of the human-machine interface (HMI). In this chapter a number of issues are raised 
relating to the specific and peculiar requirements that must be met by apparatus and 
procedures to allow methodical and reproducible probing of fingertip skin tissues in vivo 
noninvasively. 
Initially the issue of choice of incident wavelength is discussed in some detail and it 
will be clear that this choice is influenced by considerations beyond simple propagation 
effects. The choice of which skin location to probe, detection schemes and apparatus 
among other such issues are discussed and subsequently, a substantial effort is made to 
describe the human factors engineering required to accommodate the highly irregularly 
shaped, highly variable sized fingers of human beings. In addition to the physical 
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dimension challenges, the hands are all connected to a human brain and that poses 
challenges of compliance that will also be discussed. 
Propagation of light is affected by absorption and scattering losses and our goal is to 
obtain information from the vessels above the superficial dermal plexus, i.e., the 
capillaries between the skin surface and the superficial dermal plexus. One of the strong 
NIR absorbers in human tissue is Hb, and the red blood cells (RBCs) are the strongest 
Rayleigh/Mie scattering centers. As shown in Figure 2-1, despite the strong absorption 
between 400 nm and 450 nm, the molar absorptivity in the NIR range is three orders of 
magnitude less. Using a NIR excitation wavelength of either 785 nm, 805 nm, or 830 nm, 
the depth of penetration (1/e) could reach above 1.0 mm without the consideration of 
other factors.  
However, melanin, which is another dominant absorber and also a strong scatterer, 
heavily influences how light will propagate within the turbid tissue and its strong 
absorption will further reduce the penetration depth. More importantly, the degree of 
pigmentation, i.e., the level of melanin, is quite variable across different ethnic groups 
and even across different individuals within the same group. Therefore, a testing site with 
relatively uniform pigmentation among people should be chosen. There are several 
candidates, namely the posterior chamber of eye, the tongue, the palm and the sole. First 
of all, tongue is not an easily accessible site and there are also problems related with 
hygiene concerns (11, 55). Secondly, areas around eyes are sensitive and pose special 
risks. Tightly regulated permitted power of laser radiation together with limited blood 
perfusion will produce a measurement with weak signal and low signal-to-noise ratio 
(SNR).  
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Figure 2-1: (left y-axis) Molar absorbability of Hb and oxygenated Hb (mm
-1
/M) (56); 
(right y-axis) Depth of penetration of light to the 1/e point (57). 
 
As shown in Figure 2-2(A), although the average thickness of epidermis is around 
200 µm, on soles however, it can reach 1.5 mm, which is beyond the penetration of NIR 
excitation to get into dermis. Speaking to the probing volume of interest, i.e., blood, the 
capillary density of the palm is 2.5 to 3.5 times higher than that of the forearm, abdomen, 
or thigh (58), and the fingertip appears to have an even higher capillary density than the 
palm (59). A fingertip capillary blood vessels plastination model (60) is shown in Figure 
2-2(B). As sensory probes to ascertain objects properties such as temperature, pressure, 
vibration, texture and moisture (61), fingertips possess the second highest concentrations 
of touch receptors and thermoreceptors among all areas of the human skin. Meanwhile, 
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anatomically speaking the fingertip is the second best perfused area in human body with a 
capillary density of almost 9 loops per mm (62, 63). At around 500 µm, capillary loops 
from the deeper layer vessels are already available. Previous calculation from our group 
(46, 54) shows that earlier prototype is capable of 600 µm penetration into the skin to get 
direct signal from blood. Therefore, volar side of human fingertip is practically the 
optimal site of detection. 
 
Figure 2-2: (A, left) A diagrammatic sectional view of human skin anatomy (62); (B, 
right) Tissue sample of palmar vascular system prepared by plastination (60). 
 
2.1.2 Optical Layouts of the In Vivo Apparatus 
Compared to the earlier versions of LighTouch
TM
 in vivo system (46, 51), the latest 
prototype, as shown schematically in Figure 2-3, keeps most of the geometric optical 
layouts but makes significant changes to both the optics and CCD detector. All the in vivo 
data presented throughout this paper, if not explicitly stated, are obtained using 
continuous wave (CW) external cavity diode lasers (Process Instruments, Salt Lake, UT, 
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USA and Sacher Lasertechnik Tiger Model, Marburg, Germany) with a clean-up filter 
(Semrock, Rochester, NY,USA). Due to the complicated errors caused by using an 
optical window, which will be discussed shortly, the 830 nm NIR excitation is free space 
coupled from the laser to the fingertip using a 15 cm focal length lens. In order to achieve 
reliable and reproducible optical registration the volar side of a fingertip is placed in 
contact with a rigid flat stiff spring steel surface having a 2 mm hole, chamfered 15° on 
the side facing the incident light. The size of this hole and the chamfering are chosen to 
minimize extrusion of tissue and to minimize the scattered light produced by interaction 
of the laser with the edges of the hole. 
 
Figure 2-3: Schematic diagrams of optical layouts of the current in vivo apparatus. 
 
Based on calculations (10), an angle of incidence of 53°, i.e., the Brewster’s Angle 
for an air-water interface, gives optimal results. It is primarily due to the fact that human 
tissue is mostly composed of water, and the Brewster’s Angle from air to water allows 
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the best penetration into the skin instead of being scattered or reflected from the surface. 
Therefore, the incident light that actually reaches the flat plane of the spring steel plate, 
instead of being a perfectly round spot, produces an elliptical spot with a 100 µm minor 
axis and 237 µm major axis. A microscope image of a ZAP-IT
®
 paper burn hole is shown 
in Figure 2-4. The hole is created by allowing a 20 µs blip of incident light onto the ZAP-
IT
®
 paper to create a detailed mark of the laser. The measurement of the laser spot size is 
made where the beam energy density is big enough to burn through the coated layer of 
the paper. For the image shown, an 830 nm Process Instruments laser is driven by a 2300 
mA current, which generates approximately 180 mW output emissions measured by an 
optical power meter (Model 1830-C, Newport Corporation, Irvine, CA, USA).  
Despite the capability of higher throughput capacity of the CW laser, the maximum 
NIR power that we have ever used on any human subject is no more than 200 mW, 
according to the Crouse Hospital Institutional Research Board (IRB) approval. Very rare 
cases have been reported to cause small superficial tissue burns on unclean skin at 200 
mW CW power at 830 nm after as much as 200 sec. Others (64) have been granted IRB 
approval for using as much as 300 mW NIR laser on human forearm tissue and there 
were no obvious safety issues. As will be shown in Chapter 3, at this power level, it is 
readily sufficient to obtain spectra with good sensitivity and reproducibility in relatively 
short time.  
28 
 
 
Figure 2-4: A microscope image of a ZAP-IT
®
 paper burn hole. The driving current of 
2300 mA (equivalent of 180 mW output) is applied to a Process Instruments 830 nm CW 
laser. Image is taken using a Stereo Discovery V8 Stereomicroscope (Carl Zeiss, Inc., 
Oberkochen, Germany). 
 
All optics must be thin and fused silica, e.g., Corning HPF Series, particularly in the 
excitation side, to reduce background fluorescence and Raman originating with the lenses. 
However the optics can be thick on the collection side of the optical system because the 
total signal power incident on the first collection lens is very small, i.e., approximately 
equal to four to five orders of magnitude smaller than the incident laser power. Back 
scattered light containing physiological information is collected by an optical train 
consisting of a custom triplet collection lens (Avo Photonics, Inc., Horsham, PA, USA), 
followed by a laser line filter (Semrock 830nm Razor Edge, Rochester, NY, USA), and 
then a custom doublet refocusing lens (Edmund Optics, f=50 mm, Barrington, NJ, USA). 
A 61-fiber bundle presents an anti-reflection coated circular target to the refocusing lens 
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and a line configuration at the spectrograph (Process Instruments, Salt Lake, UT, USA) 
entrance slit. The effective slit width is 70 µm and net collection of spectrograph is 
approximately f/2.0. The wavelength dispersed light is imaged onto an Andor DU420-
BR-DD CCD camera (Andor Technology plc., Belfast, Northern Ireland) operating at  
-65 °C or a Critical Link MityCCD-E3011-BICCD camera (Critical Link, LLC, Syracuse, 
NY, USA) cooled to −30 °C. 
Keeping all other optics the same, switching between CCD cameras with different 
chip configurations will significantly influence the harvested spectra. Table 2-1 compared 
the pros and cons of the most commonly used CCD chip configurations, including their 
quantum efficiency (QE), dark current, etaloning issues and also prices. 
Table 2-1: Comparison of characteristics of various CCD chip configurations. 
 
Although the front-illuminated CCD sensor has a much lower dark current (0.0005 e
-
/pixel/sec) under the maximum cooling, the silicon semiconductor materials become 
increasingly transparent in the NIR. Thus the QE drops well below 10% for wavelengths 
CONFIGURATION QE PRICE DEFECT 
Front-Illuminated QEmax ≈ 50% Less expensive 
Rugged, restricted 
detection range for 
400 nm and above 
Back-Illuminated QEmax ≈ 95% 
Twice of front-
illuminated 
Etaloning at longer 
wavelength (>700 
nm) 
Back-Illuminated 
Deep Depletion 
Enhanced long 
wavelength response 
(> 50% at 900 nm) 
Most 
expensive 
Higher dark 
current (0.008 e-
/pixel/sec) 
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above 1000 nm. As a tradeoff, the Critical Link camera uses a back-illuminated 
configuration to gain extra QE in the NIR spectral range. However, etaloning at 
wavelengths above 700 nm is observed, which complicates the interpretation of the 
Raman features.  
Most of the in vivo data before the end of 2009 were collected using the Andor back-
illuminated deep depletion CCD camera. The deep depletion CCD chip is comprised of 
high-resistance silicon with a highly doped structure that boosts the QE to above 50% at 
900 nm. Nevertheless, non-negligible thermal background noise hurts the SNR. Using 
extra coolant or liquid nitrogen cooling, the dark current density can be effectively 
lowered to around 0.008 e
-
/pixel/sec. Dark current decreases approximately twofold for 
every 8 to 9 °C drop in CCD array temperature (32, 65). Especially, at low temperature 
ranges, 1 °C change of temperature changes a significant amount of dark current. This 
means that whenever deep cooling (-80 to -100 °C) is desired, the temperature must be 
maintained with high precision. Therefore, besides the coolant circulation system, the 
Andor camera is also equipped with an extra temperature control box. It is thus 
unrealistic to make a portable version with such a bulky unit. By contrast, the Critical 
Link camera uses only a Peltier thermoelectric cooling to -30 °C with no need of precise 
temperature control. It is clear that tradeoffs in CCD camera selection are inevitable, and 
two cameras are used for different purposes of study.  
Now it comes to the discussion of whether or not to use a window to attain optical 
registration with the probed tissue. When IE is used as a part of the measurement process, 
any fluorescence or Raman scattering from a window material, or even Rayleigh/Mie 
process involving the window that produces highly off-axis elastic photon emission (66), 
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adds a background to all measurements and thereby a shot noise contribution that cannot 
be eliminated. In the optical layout and configuration the depth of focus of the input 
coupling lens ensures that some of the incident light will be focused inside the window, at 
or very near the focus of our very fast emission collection system. It is not possible to 
include any window surface, or wire grid or other approach spanning the orifice, that is 
not a source of excessive stray light of all kinds, e.g., Raman, Rayleigh, fluorescence. It is 
possible to exclude a large proportion of light from the window-laser interaction using 
more optics and confocal apertures (67) in the collection train but not without sacrifice of 
simplicity, extreme loss of total signal, and imposition of spatial resolution that does 
more harm than good to the overall measurement process. Achieving maximum SNR is 
one strong reason to free space couple the probing light into the tissue without use of a 
window and thereby eliminate or at least minimize related noise contributions. Also, 
improved SNR by not using a window allows a decreased measurement time and shorter 
measurement times favor better control of human factors, i.e., extraneous motion, tremors, 
etc., which will be discussed in the following section. 
 
2.1.3 Human Factors 
Human factors (HFs), or cognitive ergonomics, involve the engineering of what we 
know about human capabilities and limitations to the design of equipment and devices in 
order to enable more productive, safe, and effective use (68). It has gained attention to 
increasing number of healthcare device manufacturers, such as Masimo, who recently 
release a new signal extraction technology (69, 70) to their pulse oximeters (the Masimo 
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“SET” series). This technology is mainly focused on using algorithm to eliminate the 
extreme motion artifacts. 
One example of the most obvious HFs pertinent to our study is force or pressure 
maintenance.  The delicate threshold force of blood flow disruption requires an active 
part to exert the additional force during modulation and the force needs to be controlled 
with a precision of ±0.1 N. However, due to the intrinsic limitations of human control, no 
matter how hard one would try, the human sense of touch is inadequate in the contact 
force range as low as 1-2 N. When trying to maintain 100 mmHg, the normal mean 
arterial pressure (MAP), for a 1 cm
2
 fingertip, the total force needed will be 1.33 N. It is a 
substantially small force that needs additional assistance involving human factor 
engineering to maintain. Human factor engineering has become a notable part of the 
design of many modern safety critical systems, especially in the delivery of healthcare. In 
many cases it focuses on HMI, which by the definition of FDA (71) includes all 
components and accessories necessary to operate and properly maintain the device.  
Apparently when tissue is pressed against an open aperture of the correct size the 
stress field is less a reflection of the shape of the underlying bone and the exact 
positioning of the tissues and more of the viscoelastic properties of the local tissue, 
including the possible motion of subsurface tissues, i.e., blood. Yet for a free space 
coupled interface like the current LighTouch
TM
 prototype, human factors are such that 
there is inherent variability in contacting different sized and shaped fingers or even the 
same finger at different times to the same aperture, no matter how the aperture is formed. 
Moreover, choosing to probe through an open aperture is at the expense of having to 
accommodate other HFs associated with some intrinsic characteristics of fingertip tissues:  
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i) Fingerprints: All skin has surface topography, even relatively smooth forearm 
skin, and the effect on optical probing can be anticipated (10) using Fresnel’s 
equations. Ridged skin (72) such as is found on volar side fingertips provides an 
important thermoregulation function and due to the uniqueness in patterns and 
minutiae of each person fingerprints are widely used in forensic science and 
security applications. However, depending on the relative size of the probing 
light beam and the scale of surface topographical features, the presence of 
topography may lead the results to have a strong dependence on the placement 
of the laser beam on the skin surface. As showed earlier in Figure 2-4, the size 
of the incident laser spot (100 µm in minor axis and 237 µm in major axis) is 
commensurate with the breadth of fingertip ridges (on average 480 µm for male 
and 430 µm for female with a depth of 200-300 µm) (73). Whether the light 
contacts the skin on top of a ridge or at the bottom of a furrow directly 
determines the local angle of incidence and thus the propagation into the tissue. 
Therefore, in any optical instrument including the LighTouch
TM
 apparatus the 
sample, e.g., the tissue, must be brought into reproducible registration with an 
optical system.  
ii) Fingertip doming: The collection side of the optical system is aligned to obtain 
the maximum emission from the collecting cone by assuming a flat surface. 
Although minor adjustment is made according to sample fingertip, the extrusion 
into the optical orifice moved the center of incident light. Dome height also 
varies among test subjects. Note that, now, in the context of probing skin 
through an open aperture, the depth of focus of the incident laser beam can be 
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an advantage. Being much longer than any motion or extrusion of tissue caused 
by doming or pressure in the direction of propagation of the incident laser, the 
properties of the incident laser can be taken as constant regardless of the motion 
of the tissue.  
iii)  Turgor: Turgor is the normal state of turgidity and tension in living cells. In 
other words, it vividly shows the “puffiness” of a finger. The U.S. National 
Institutes of Health (NIH) define it as “the skin’s ability to change shape and 
return to normal (elasticity)” and use it as a sign to assess the degree of fluid 
loss or dehydration. Turgor is also related with the extrusion into the aperture, 
but empirical experience shows it is more relevant to skin impedance and the 
resulting stability of the PDPM dots pattern (detailed in Section 2.2.3). 
In an earlier study (50), the distribution of deviations between the noninvasive 
LighTouch™ measurements and the reference fingerstick measurements reflected various 
sources of random and systematic error. Better management of the measurement process 
with regard to the aforementioned human factors emerged as a strategy for improvement 
with feedback based on applied pressure and tissue placement. 
 
2.1.4 Modulation Pressure 
Research on human and machine haptics suggests that for contact forces below some 
threshold, probably around 0.5 N, the blood vessels in the finger pad are barely affected 
by compression (74, 75). Above that threshold, however, blood vessels in the region of 
compression collapse and the blood is driven away from the contact area. As shown in 
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Figure 2-5, decrease of grayscale color with increased force indicates less blood 
perfusion. Though not shown in the figure, there is a progressive 70% decrease in blood 
flow at 2.9 N as compared to 0.5 N (75). Notice the increase of fingertip contact area with 
the BaF2 optical window as the increase of exerted force, which is also true in the free 
space coupled interface. 
 
Figure 2-5: Typical images of fingertip deformation against a BaF2 optical window at 
each target force (74). Notice the decrease of grayscale color, which indicating decreased 
blood perfusion, with increased force. 
 
As stated earlier in Section 1.3, to achieve a successful modulation, the ideal 
scenario is that during the unpressed part of the measurement cycle the applied force is 
well below threshold so that sufficient blood perfusion is guaranteed and the capillaries 
can maintain mechanical stability. While in the pressed part of the tissue modulation 
cycle the force is only slightly above the threshold of capillary collapse so that blood is 
modulated but limited deformation is introduced to static tissue. Therefore, based on the 
research findings on human haptics (61, 74, 76, 77), the applied force should be in the 
range from 0.5 N to 2 N to obtain an optimal difference spectrum that contains a 
minimum contribution from static tissue but most blood borne Raman and fluorescence 
features. 
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On the other hand, in vivo collected data frequently reveal the occurrence of cardiac 
pulses both optically and mechanically. In Figure 2-6 the force sensor recordings of the 
real time exerted force on the aperture reveal an obvious pattern of cardiac pulses, while 
the simultaneously collected IE vs. Time curve demonstrate the same pattern but mostly 
in a complimentary way. This observation offers a pivotal evidence of the capability of 
our technology in collecting signals directly from blood. However, empirical observation 
also suggests that under various target pressures, for different test subjects, these pulses 
are not always observed and when observed, the amplitude of these pulses can be highly 
variable.  
 
Figure 2-6: In vivo observed human cardiac pulses, both mechanically (black curve, left 
y-axis) and optically (blue curve, right y-axis). Although pulses are frequently observed 
among various populations under proper pressure registration, the plotted is based on a 
single measurement from a middle age Caucasian male. The pulse rate measured with a 
blood pressure cuff is 67 bpm. 
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We postulate that the mechanism of this phenomenon is similar to the principles 
applied in determining the blood pressure (BP). Generally speaking, there are three 
mostly used techniques to take BP measurement: auscultatory, oscillometric, and 
photoplethysmographic. The in vivo observed pulse response to the applied force or 
pressure works in a very similar way as the oscillometric method. When fingertip is in 
registration with the HMI that will be introduced in Section 2.2.2, the setup is analogous 
to the upper arm confined by a sphygmomanometer cuff. Therefore, the electronic force 
transducer senses the pressure fluctuations caused by the oscillation of blood flow. 
Nowadays, the oscillometric measurement has been used as a standard among various 
commercial automated noninvasive BP monitors.  
 
Figure 2-7: Sample recording of cuff pressure during oscillometric blood pressure 
measurements. Bottom panel shows oscillations in cuff pressure obtained by high pass 
filtering above 0.5 Hz (78). 
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The upper panel of Figure 2-7 shows a typical oscillometric measurement cycle (78). 
The automated pressure cuff is initially inflated rapidly above the systolic pressure as 
indicated by the complete cessation of pulses and then deflated gradually. The recorded 
cuff pressure is high-pass-filtered above 0.5 Hz to observe the pulsatile oscillations as 
shown in the bottom panel of Figure 2-7. Clearly, on one hand, the cuff pressure 
fluctuates with the pulses, while on the other hand the magnitude of the fluctuation varies 
with the applied cuff pressure also.  
It has been shown that the pressure at which the pulse oscillations have the 
maximum amplitude is the mean arterial pressure (MAP). Knowing that MAP = 2/3 
Pdiastolic + 1/3 Psystolic, the pulses are best sensed, i.e., the observed amplitude is maximized, 
when the applied pressure is roughly the average of diastolic and systolic pressure. When 
attempting to maintain a normal MAP of 100 mmHg for a test subject with 1 cm
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fingertip contact area, the force needed is 1.33 N. Such force is in the 0.5 – 2 N range for 
optimal tissue modulation. Therefore, it is highly feasible to find a suitable applied 
pressure range for each individual in order to guarantee best blood modulation while 
maintaining a continuous flow. Last but not the least, it is worthwhile to note that after 
performing an absolute pressure calibration the potential exists to design a LighTouch
TM
 
device to measure pulse rate and BP with other analytical goals simultaneously. 
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2.2 Position Detector Pressure Monitor (PDPM) 
2.2.1 Features and Limitations of Previous Versions 
HMI engineering has been considered important from the very beginning of this 
long-term project. At the birth of the very first LighTouch
TM
 system, a “Tissue Modulator” 
(TM) was already embraced in the design (46, 48). As shown in Figure 2-8, the TM 
contains an orifice in a metal plate, where the fingertip is placed so that tissue to be 
interrogated is accessible to the excitation light through the orifice (0.95 cm diameter). A 
spring loaded plunger module is placed in a retracted position for the “unpressed” half. 
Alternatively, the plunger can be released so that a padded complementary shaped 
“piston” presses against the back of a fingertip for the “pressed” half. 
 
Figure 2-8: Schematic diagram of the 1
st
 generation “Tissue Modulator”. It comes with 
the very first LighTouch
TM
 prototype built around 2000. A spring loaded module is used 
to facilitate pressure modulation with no positioning guide or feedback. 
 
At that time, all subjects were given minimal instruction (50) on how to perform 
tissue modulation and the data were collected using an essentially “double blind” 
40 
 
procedure. The 2
nd
 generation TM comes along around 2006 and contains many 
improvements over earlier prototype. Firstly, rubber Braille-like “nubs” are arranged near 
the orifice to allow the test subject to orient the position of fingertip to the hole by way of 
touch. Secondly, the TM also employs a load cell to measure the force applied to the 
aperture. A linear array of several light emitting diodes (LEDs)  in a pattern of red, 
yellow, green, yellow, and red. During the modulation cycle, an audio cue is given to the 
test subject while the LEDs light up depending on how much force is actually being 
exerted. Light-up of the green LEDs indicate the desired force is met; while yellow LEDs 
mean mediocre satisfactory force and red LEDs warn of way-off compliance. In this way, 
real time feedback to the test subject could be offered. 
As aforementioned in the engineering of first two generation TM modules (46, 48, 
51), we employed muscle memory, visual memory, and visual and audio cues in order to 
direct the test subject him/herself to apply the appropriate force and maintain an 
appropriate finger posture in order to modulate the blood content of the capillaries. 
Perhaps, not surprisingly, even when humans are given very accurate and precise 
feedback, they vary in their competence to execute the required actions. Further, even if 
compliance requires the test subject to be passive, as for an unconscious patient, the 
probability of involuntary tremor and the known occurrence of inadvertent or 
unconscious pressing or unpressing against the aperture by the test subject requires the 
instrumentation to play an active role in producing, measuring, and recording the actual 
position and actual applied stress field in the test subject. 
It is also an empirical fact that pressure on the fingertip, even constant pressure, has 
at least two effects. As mentioned in Section 2.1.3, the pressure causes “doming” or 
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extrusion of tissues into the aperture, i.e., the exposed skin surface is not flat, 
independently of the presence or lack of ridges. In addition, over time, constant pressure 
causes some fluid, e.g., blood, to flow out of the irradiated region, without many changes 
to the static tissue. Note that as fluid moves in response to the applied pressure, the 
contact area between the tissue and the surface containing the aperture, i.e., the 
“modulating surface,” must increase necessitating an external real-time contact area 
monitoring and pressure servo system in order to produce consistent results.  
Thus, in addition to focusing our attention on the optical and spectroscopic issues of 
a particular experimentation, it is helpful to have a record of the test subject’s actual 
compliance (or noncompliance) during the measurement process in order to help sort out 
motion and placement artifacts from actual spectroscopic content. Experience with each 
of these and the desire to have a device that would be applicable to unconscious people 
led us to seek a way to modulate the skin and blood automatically under external control. 
 
2.2.2 Overall and General Description of Current PDPM 
In what follows the current instrumentation and experimental methods used to obtain 
reproducible and reliable measurements on fingertip capillary beds will be described. The 
entire apparatus is coordinated using a C++ programmed graphical user interface (GUI), 
with embedded MityDSP for the PDPM and in the CCD camera control. All transducers 
are commercial-off-the-shelf and the circuitry needed to implement them is available 
from their manufacturers. Initially an overview of apparatus and procedures will be given 
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before specific discussion in more details of placement (or positioning), contact area 
function, and force and pressure measurement and application.  
 
Figure 2-9: Details of the current used PDPM module and the control GUI. (A): close-up 
of the conductive dots on the flexible circuit board for contact area monitoring. (B): 
photo of the fingertip in place for measurement. (C): corresponding contact area and 
pressure feedback on the GUI software. (D): photo of the complete PDPM assembly 
including the stepping motor and the solenoid system for pressure servo. (E): side view of 
the load cell – spring steel lever system. 
 
To give a general picture of the mechanical design of the currently used PDPM 
module, Figure 2-9(A) shows that a conductive metal ring is oriented concentrically 
around the orifice and surrounded by conductive dots at four different orientations. When 
a finger is in contact with the circuit board (Flex Printed Circuit Sales, Redwood City, 
CA, USA), PDPM detects the electrical resistance between the center ring and each of the 
surrounding conductive dots. If there is a connection by finger, the resistance is below the 
preset threshold and corresponding red dots in the GUI display turn green indicating 
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contact, as shown in panel (C). In this way, real time contact area (calculated from the 
number of covered dots) and force, which is measured by a load cell (LCGC-150G, 
Omega Engineering Inc., Stamford, CT, USA) through a lever system as shown in panel 
(B) and (E), can be obtained. Therefore, live applied pressure can be calculated to 
provide feedback into the LighTouch
TM
 software, providing a servo signal to drive a 
plunger (shown in panel (D)) against the back of the finger to establish and maintain the 
target pressure. 
More specifically, to prepare to apply pressure after insuring appropriate placement 
with respect to the aperture, an actuator is brought to the threshold of contact with the 
dorsal surface of the distal phalanx coarsely using a stepping motor. When the load cell 
signals the threshold, the stepping motor stops (Figure 2-9(D)) and backsteps a 
predetermined amount relative to the dorsal skin surface. The solenoid can apply 
maximum force and fastest response, i.e., display optimum performance, when the shaft 
is positioned within plus or minus a few millimeters of the center of its range of motion. 
The stepping motor leaves the solenoid so that it can remake skin contact in the optimal 
shaft position. This process is mentioned as the pre-experimental “set-up” procedure 
thereinafter. 
Contact between the actuator and the skin surface is always chosen to occur between 
the cuticle and the distal joint such that the actuator does not make direct contact with the 
fingernail. The exact point of contact determines the type of modulation that will occur 
and certain characteristics of the compliance information that will be available. 
Application of pressure onto the fingernail itself produces a reproducible modulation 
effect in the volar side capillary bed that is essentially the opposite effect of pressing on 
44 
 
the volar side soft tissue. Attempt has been made to contact the nail bed capillary blood 
through the fingertip for spectroscopic purposes before (46) but the difficulty in that 
approach is bringing the rigid nail surface into reproducible registration with the aperture. 
Thus, in the present context making contact between the cuticle and the joint ensures that 
the induced stress field does not produce opposing effects on the volar side. 
Trial and error has shown that, once a measurement cycle has begun, the aperture 
must be stationary (in the direction of incident light propagation) with respect to the 
collection optics and the laser delivery lens to at most ±25 µm throughout any experiment 
to obtain consistent results. It appears that inconsistent aperture movement combined 
with inconsistent extrusion of tissue into the aperture produces an unmanageable 
spectroscopic response. However, all force transducers (in our case a 12-bit Omega 
LCGC-150 g transducer) require motion of some kind to produce an electrical signal. 
Therefore, a lever system, a simplified on-scale drawing is given in Figure 2-9 (E), is 
used to magnify the motion of the modulating surface at the transducer contact point and 
minimize the motion at the optical aperture so as to achieve sufficient sensitivity and 
stability with respect to knowing the total applied force at the aperture. Consistent with 
the specifications of the transducer no hysteresis in this system is detected, so the design 
seems acceptable. 
The position of the aperture with respect to the fulcrum determines the largest finger 
size that can be used in this type of apparatus. Related to this is the fact that the fingertip 
is not a point load. The perceived force applied to a specific point on the fingertip 
increases as the distance between the fulcrum and the point of interest increases. The load 
cell does not detect any force applied to a region of a fingertip that overlaps the fulcrum. 
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Thus, since the fingertip must overlap the aperture, the distance between the aperture and 
the fulcrum is the largest width of finger that can be accommodated. In calibrating the 
force measurements of this design, it is important that any applied load, i.e., known test 
loads, have a contact area with the spring steel plate about half the maximum and be 
centered at the aperture. A fixture was designed that mounts the second reference load 
cell to the end of the solenoid shaft so that a chosen force/pressure setting can be tested in 
the instrument for independent calibration. 
Various designs of this system have all required some temperature control of the 
modulating surface (spring steel) and nearby connected materials (aluminum and 
stainless steel) to control potentially random but usually periodic variation of the 
transducer output associated with zero applied force. The apparent zero of applied force 
can drift due to differential expansion of materials with respect to ambient temperature 
drift and, often, differential warming of the modulating surface itself by the in vivo tissue 
being modulated. Choosing to maintain the modulating system at or near 37 °C is 
advantageous and a thermistor (shown in Figure 2-9(E)) driven freestanding analog 
proportional-integral-derivative feedback loop is sufficient for this purpose. 
 
2.2.3 Placement and Contact Area 
The current PDPM system automatically measures the test subject’s volar side 
contact area with the “tissue-modulating surface,” i.e., the flat spring steel region 
surrounding the aperture, while providing feedback for initial placement and later a 
record of the actual placement during a measurement sequence. 
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The placement and contact area measurement needed as feedback for an actuator to 
maintain constant pressure is accomplished using an array of metallic gold spots on an 
insulating substrate as shown in Figure 2-9(A). This gold metallization pattern is 
deposited on a flexible Mylar™ circuit board that is glued to the spring steel surface. 
There is also adhesive on the Mylar™ surface between the metallic spots, so that when 
final placement and contact is achieved, the skin in contact with the adhesive cannot 
easily move parallel to the modulating surface. This raises a human factors issue since 
this flexible circuit board must be changed regularly due to fouling of the spots by skin 
borne fluids. 
The electrical resistance between the gold annulus enclosing the optical aperture and 
each of the gold spots is relatively low when skin is in contact with both conductors and 
infinite otherwise. Each spot in a corresponding pattern displayed by the GUI is colored 
green or red depending on the resistance state sampled in real time every 20 ms. There 
are also two sliders produced in the same GUI window (Figure 2-9(C)) depicting in real 
time the actual applied pressure to the modulating surface and the target pressure for the 
modulating cycle. Based on which and how many spots are in the low resistance state 
(green), and the spacing and dimensions of the spots, an algorithm is devised to calculate 
the contact area between the modulating surface and the fingertip. The spot pattern, 
contact area, force, and pressure can be “played back” to allow examination of the 
measurement process frame by frame. 
The electrical resistance of the skin perceived by the spots depends on many factors 
that can be distilled into two major but not completely orthogonal categories: hydration 
and turgor. Possibly there are two categories because there are two properties of the 
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tissues, electrical and mechanical, that determine the response of the gold spot system. 
Considerable experimentation with senior citizens shows that it is possible to have well 
hydrated skin and still have low net turgor causing the spot system to fail. Considerable 
experimentation with young people shows that it is also possible to have very high turgor 
but sufficiently dry skin so as to cause the spot system to fail.  
All tissues in the mechanical train that starts with the spring steel and terminates at 
the opposing distal phalange bone surface inside the finger contribute to the apparent 
turgor of the whole assembly. Each tissue in the train has its own turgor properties but so 
long as the net turgor allows good mechanical contact between the skin and spots, only 
the outermost surface skin, i.e., the stratum corneum, contributes to the apparent 
electrical impedance sensed by the spot system. 
“Hydration” is more than the simple presence of water. There is water in the stratum 
corneum, the interstitial spaces, and the cells themselves that affect the mechanical 
properties of the tissues as well as the electrical properties. In our experience, regardless 
of turgor, most commercial skin lotions and similar substances used regularly but not 
within a few hours of executing a placement will cause the apparent electrical resistance 
to decrease and the placement spots to work better than topical application of water or 
even electrolytes much closer in time to the initiation of the actual measurement cycle. 
Turgor relates to water content of each cell and the oncotic pressure that keeps the 
water inside. This determines the apparent electrical resistance in that the skin must be 
brought into sufficient mechanical contact with the metal regardless of the availability of 
charge carrying capacity. Mechanical contact requires the tissues between the bone, i.e., 
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the distal phalanx and the modulating surface, to resist further compression at some 
applied pressure. When the oncotic pressure (79) is sufficiently low, all the tissues 
between the bone and the Mylar™ surface are so compressible that the mechanical 
contact is insufficient to allow adequate electrical current to flow, even though the 
stratum corneum is sufficiently well hydrated to make the spots respond. Although better 
approaches to this problem may emerge, with regular usage of almost any over-the-
counter skin lotion, the approach presented here allows a very wide variety of test 
subjects to easily achieve proper placement and reliable contact area measurements 
without any apparent spectroscopic consequences. 
 
2.2.4 Force, Pressure and the Measurement Cycle 
There are two modes for i) positioning the fingertip in proximity to the aperture and 
ii) moving the actuator into proximity to the fingertip thereby initiating a measurement 
cycle. In one (66) the test subject places his/her own fingertip against the modulating 
surface, shown in close-up in Figure 2-9(B), achieving desired placement by visual 
feedback using the GUI provided colored spot pattern. Or as shown in Figure 2-10, a 
fixture is mounted on the solenoid, the finger is placed in a splint outside the device, and 
then the finger with the splint attached is slid into the fixture all as described in greater 
detail below. In this case positioning is followed by the “set-up” process, i.e., the stepper 
motor/solenoid moves the fixture holding the passive splint-mounted fingertip toward the 
aperture. If positioned without the splint, pressing a button in the GUI causes the actuator 
to approach the stationary finger from the dorsal side using the stepping motor. 
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Figure 2-10: Splint fixtures for fingertip positioning. Right: splint is taped onto dorsal 
side of finger. Left: a finger is attached to splint that in turn is engaged into fixture. 
 
In either case, upon first simultaneous three-way contact between the modulating 
surface, the finger and the actuator surface, the stepping motor stops and then retracts a 
few millimeters. The actuator position is then further adjusted using a solenoid to achieve 
a pre-unpressed pressure between actuator, finger, and spring steel of ≈10 gf/cm2 pressure 
in the feedback system. This is very light pressure that most test subjects cannot discern. 
Utilizing the solenoid from this point forward allows continuous adjustment of actuator 
force and displacement, in order to keep the measured pressure, i.e., the ratio of the total 
applied force and the measured contact area, constant. 
50 
 
 
Figure 2-11: Coupling between splint, fixture and the back of fingertip. Top: fixture 
showing magnetic coupling plate and guides to locator pins. Bottom: view showing 
curvature of contact surface between splint and dorsal side finger and double stick tape. 
51 
 
The actuator for applying force can be made to contact the dorsal side of the distal 
phalanx between the nailfold and the first joint in a few different ways. This can be as 
basic as a simple cylinder, or a foam-pad-tipped cylinder attached to the end of the 
solenoid shaft. An example of mounting the finger to a “splint” is shown in Figure 2-10. 
The splint clicks into place on a fixture mounted to the end of the solenoid shaft. The 
splint is magnetically coupled as shown in Figure 2-11 and swivels with movement of the 
finger at the proximal joint. The splint, i.e., actual area of contact between the dorsal side 
and the actuator, is a shaped plastic piece that is fastened to the finger with double-stick 
tape. 
This approach has the advantage that the splint can be positioned on the finger 
outside the aperture housing assuring appropriate alignment when subsequently engaged 
to the fixture, and unassisted compliance is possible for most test subjects. The fixture 
has guides that, once the locator pins are engaged, allow forward motion until the 
magnetic pins approach the magnetic plate embedded in the fixture and reproducible 
placement occurs. Providing comfortable support for the elbow and general posture of the 
arm and wrist greatly facilitates compliance. In addition, an easily adjusted vertical rod 
that fits into the webbing between thumb and forefinger placed in proximity to the 
modulator is also very helpful for hand stabilization. 
The pressure servo has several sets of important details. When the measurement 
cycle is initiated, the existing contact area and the simultaneous total force between the 
volar side fingertip and the modulating surface is measured, divided by the contact area, 
to produce a pressure feedback signal for the actuator. The actuator is driven by the 
solenoid in contact with the dorsal side of the finger to achieve and maintain the preset 
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“unpressed” target pressure. Since the contact area between the volar side skin and the 
modulating surface increases in time as the blood leaves the capillary bed, the force must 
be increased in proportion to maintain constant target pressure. The placement spots and 
the load cell are polled at 20 Hz giving the approximate bandwidth of the pressure servo. 
The initial target pressure is achieved and the system becomes mechanically stable in 
about 100 ms. 
When a tissue modulation cycle is required, after a suitable “unpressed” collection 
period, the target pressure is changed to reflect the transition to the “pressed” state, the 
actuator applies more force to achieve the new target pressure and 20 ms CCD frames are 
collected for an equal time period as the unpressed state. Afterwards, the actuator is 
retracted, and the CCD frames are stored as a record of the applied force, applied 
pressure, net contact area, and contact history of the individual placement spots. In a 
separate step, the CCD frames are processed (46, 50) for calculation of glucose or 
bicarbonate concentrations or hematocrit (Hct). Of course, other modulation schemes can 
be employed for other purposes using the same apparatus (80). 
 
2.3 Evaluation of PDPM Performances 
2.3.1 History of PDPM Outputs 
To clarify the two different measurement procedures and algorithms that are both 
enabled in the LighTouch
TM
 GUI, experiments for in vivo glucose and other blood 
constituents monitoring is configured to be done under “Glucose” mode, while Hct 
measurements are taken under “Hemo” mode. For both modes, all sensor recordings 
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including force, pressure, contact area and in-contact quadrant dots of the four directions, 
together with CCD spectra for each 20 ms frame are logged. The record of the 
measurement sequence provided by LighTouch
TM
 device allows deduction of the course 
of events. Human factor induced unexpected variations on the collected spectra could be 
verified by double checking with the sensor outputs. Therefore, rejection of unreliable 
data could be based on objective quantitative criteria and would ultimately help the 
glucose monitoring in making solid and trustworthy predictions.  
While there are many types of motion and placement artifacts, Figure 2-12 and 
Figure 2-13 show data demonstrating two frequently observed motion artifacts made 
detectable by this instrumentation. In Figure 2-12, the sensor records of an intentional 
“rolling motion” of the type described by Asada (77) are shown. In this case the initial 
placement of the finger is skewed (uneven number of spots top and bottom, i.e., 
quadrants 1 and 0, at t=0) and apparently becomes acceptable (not equal but stable 
numbers of spots for each) for the last third of the experiment. But the asymmetry evident 
in the quadrant dot pattern in the middle graph shows that the finger rolled somewhat 
from top to bottom during the first part of the measurement.  
The placement was skewed initially and remained slightly skewed after the rolling 
motion occurred, i.e., no twisting motion occurred simultaneously. We know it was a 
rolling motion and not a scraping motion because the quadrants 2 and 3 (spots are on 
either side of aperture along the axis of the finger) are relatively constant. The change in 
contact area was abrupt, so we know there was gross motion and not normal subsurface 
fluid movement due to the applied pressure. On this basis alone the data should be 
rejected. This record was generated intentionally but it also corresponds to the situation 
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when the well-meaning test subject suspected that something was wrong after the 
measurement cycle started and tried to correct the placement without informing anyone. 
 
Figure 2-12: PDPM sensor outputs for a 20 sec measurement cycle showing the rolling 
motion of a fingertip.  Top: actual pressure, force, and contact area (scaled to fit in the 
same plot) for a given measurement period. Bottom: plot of numbers of contacted dots in 
each quadrant showing that finger rolled at about 5 sec into measurement period. That 
contact is spatially skewed and abrupt motion occurs during the measurement and the 
data should be rejected. 
 
Although the involvement of rolling motion disqualified the simultaneously 
collected spectra for quantitative glucose concentration prediction purpose, the PDPM 
did maintain pressure almost constant throughout the experiment cycle. Rolling motion 
by nature is slow, subtle and is not necessarily accompanied by appreciable force changes. 
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The solenoid is thus able to compensate accordingly. However, as shown in Figure 2-13, 
stable force maintaining is always challenging for seniors and subjects with neural 
disorders even with the help of PDPM as involuntary tremors happen from time to time 
even if the test subjects are striving to be compliant.  
 
Figure 2-13: Tremor is shown on the logged force (black), contact area (red) and IE 
(blue) curves for a senior Caucasian male. Contact area is scaled (×25) in order to be put 
with force in the same plot. PDPM failed to compensate when test subject is actively 
involved.  
 
In the PDPM set-up, test subject is supposed to be passive and let the PDPM 
maintain and adjust exerted force based on preset target pressure. However, in the case 
shown in Figure 2-13, throughout the entire course of a 20 sec experiments the test 
subject waggled, causing erratic ups and downs on the force sensor recording. The 
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amplitude of such force variation exceeded the dynamic range of PDPM itself, therefore 
pressure compensation failed in this scenario. Even worse, several tremors happened 
right after 6 sec, before 12 sec and after 13 sec respectively. The abrupt push and 
releasing of force obviously interrupted collecting of spectra, as clearly shown in the IE 
vs. Time curve. Empirically, pulsatile blood flow usually causes 1000 – 2000 photon 
counts variation on IE curve. But these tremors made changes of almost 5000 counts, two 
times more than the pulses. Not shown in this figure is that the horizontal quadrant 2 
increased as the quadrant 3 on the opposite direction decreased, meaning the tremor also 
resulted in a change of fingertip position. Without question, the collected spectra could 
not be used in glucose concentration calculation. 
   
2.3.2 Pressure Registration 
Acknowledging the benefits by keep a recording of the PDPM sensor outputs, it is 
even more important to feed this piece of information back into the loop and achieve 
automated pressure servo. It is already been shown in Figure 2-13 that involuntary 
motions like tremor deteriorate the spectra. Yet it is not surprising that slight skew of 
fingertip position could also be easily captured spectroscopically. Figure 2-14 shows the 
IE vs. Time curve collected corresponding to the rolling motion in Figure 2-12. Decrease 
of IE integral around 4 sec is induced by force compensation due to an increased contact 
area, while a brief increase at 7.5 sec corresponds to a sudden contact area drop that 
might result from a poor contact.  
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Figure 2-14: IE vs. Time curve collected corresponding to the sensor history in Figure 
2-12. Rolling motion of fingertip, although not as detrimental as tremors, still produces a 
noticeable influence on the harvested spectra. Decrease of IE integral around 4 sec is 
induced by force compensation due to an increased contact area. A brief increase at 7.5 
sec corresponds to a sudden contact area drop that might result from a poor contact. 
 
Currently, the resistance change between the annular metal and surrounding gold 
dots is used as a measure of contact surface. Thus the issue arises when a fingertip is 
actually in contact, but due to lack of hydration or other possible reasons, e.g., very low 
turgor, flickering of the dots results in unstable contact area calculation. Frequent 
adjustment of force by PDPM will end up with undesired disturbance of blood flow. 
However, as mentioned in Section 2.2.3, application of a thin layer of any commercial 
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available lotion will make the patterned dots work better and to some extend help the 
measuring process. 
To compare the performance of PDPM with the human sense of touch, four test 
subjects with various levels of familiarity (see Table 2-2) with LighTouch
TM
 apparatus 
participated in a series of designed experiments. For each subject, shorter than normal 
length experiments without tissue modulation, i.e., the pressure was maintained constant 
throughout the experiments, were perform either with or without PDPM. When PDPM is 
not used, test subject was asked to keep fingertip in position and do the push to the target 
pressure by him-/herself. Four target pressures were assigned, from 60 gf/cm
2
 (44 mmHg) 
to 120 gf/cm
2
 (88 mmHg). BP, together with pulse rate, of each subject was measured 
with a commercial automatic blood pressure cuff (HEM-712C, Omron, Osaka, Japan). 
Since the BP varies at different time of the day for each individual, the number listed in 
Table 2-2 is the average of multiple measurements taken at various times of the day. 
Table 2-2: Test subjects summary for a PDPM performance study. 
 
TEST 
SUBJECT 
GENDER ETHNICITY AGE 
PULSE RATE 
(bpm) 
BLOOD 
PRESSURE 
(mmHg) 
FAMILIARITY 
WITH PDPM 
1 F Asian 27 63 90/60 Well 
2 F Hispanic 20 59 122/76 New 
3 M 
Middle 
Eastern 
78 48 126/78 Good 
4 M Caucasian 54 68 142/86 Well 
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Force records of eight short experiments, four with PDPM (black) and four without 
(red), of each test subject is plotted by stacking them with offsets in Figure 2-15. Other 
than the senior test subject, all three others show less random variations with the PDPM. 
Not shown in the graph, quadrants for subject 3 blinked on and off, thus resulted in poor 
performance even with PDPM. Clear cardiac pulses are also presented when PDPM is in 
registration with the finger, while the similar features are completely gone if test subjects 
tried to maintain the target pressures themselves, even for the experienced subjects.  
 
Figure 2-15: Force records of 4 subjects in a series of short in vivo experiments showing 
the difference between using (black curves) or not using (red curves) PDPM. Four 
pressures were applied, 60, 80, 100 and 120 gf/cm
2
 respectively. For each subject, force 
curves are plotted by stacking them with arbitrary offsets but in a consistent force 
increasing manner, i.e., bottom two curves were taken under 60 gf/cm
2
 while the upper 
two curves were taken under 120 gf/cm
2
. 
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Although arbitrary offsets make the force axis lose its numeric meaning, relative 
comparison indicates that for people with high BP such as subject 4 the maximum size of 
pulses well exceeds that for lower BP subjects such as 1 and 2. Mechanical pulses are 
always easier to be seen, which is not surprising. The y-axis span for subject 3 is almost 4 
times bigger than that for the first two subjects, indicating a much more instability, as 
shown in Figure 2-16. 
 
Figure 2-16: Comparison of force and IE variation between subject 1 and 3. For both 
subjects, no PDPM facilitation was supplied. Test subjects used their own sense of touch 
trying to maintain pressure at 100 gf/cm
2
. 
 
Usually, as shown in Figure 2-16, with a good contact the force varies within 5 units, 
but this can be magnified up to 10 times bigger in situations like tremor or random finger 
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movements, which is more likely to happen among senior test subjects. As mentioned 
before, such motions are what we are trying to avoid. By either monitoring sensor or 
optical outputs, selecting rules can be developed and used to automatically screen out 
invalid data. By taking a scrupulous look at the IE curve for subject 1 in Figure 2-16, one 
may notice a trend of decreasing. Part of such decrease corresponds to the slowly 
increased force, but most of this quench is related with some photochemistry that will be 
discussed in detail in Section 3.2 of Chapter 3. 
Most of the time, whenever mechanical pulses are observed, one could expect to see 
optical pulses. But they are not necessarily connected. Depending on how the fingertip is 
engaged with the PDPM, mechanical pulses could be easily invisible. For example, a 
simple cylinder (Nylon with a contact area of ≈0.27 cm2) was once used to replace the 
splint and fixture design, shown previously in Figure 2-10 and Figure 2-11. The shaft 
could easily fit a wide range of fingertips, no matter how big the width and curvature. 
However, it is hard to detect mechanical pulses with this arrangement, even for subjects 
with high BP.  
We notice that the way shaft is mounted to the solenoid makes it waggle, and the 
small contact with the back of fingertip causes it to slip off the finger from time to time. 
By contrast, the currently used design guarantees a much more solid contact, and that 
favors the sensitivity of force measurement. Moreover, load cell calibration also 
determines the sensitivity of the force detection. A poorly calibrated transducer will result 
in a limited dynamic range that may or may not enable us to see the mechanical pulses. 
The step-by-step instruction on how to perform a solid load cell calibration is elaborated 
in APPENDIX A. 
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On the other hand, spectroscopic signals explain the observation of pulses in a totally 
different way as mechanical force does. With our in vivo instrumental setup, as long as 
the photons collected have reached the depth of capillary layer and optically interacted 
with the molecules within blood, then optical pulses should be expected. Evidence is 
shown in Figure 2-17, where under the pressure of 60 and 80 gf/cm
2
, optical pulses were 
still clearly observed even if no sign of mechanical pulses. 
 
Figure 2-17: Offset force and IE curves under evenly spaced four increasing pressures for 
subject 4 who has the highest BP. No PDPM assistant in positioning and pressure 
maintenance. Under pressure of 60 and 80 gf/cm
2
, optical pulses were still observed even 
if no sign of mechanical pulses. 
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Figure 2-18: Optical pulses from subject 1, 2, and 4 showing various pulse amplitudes 
under different pressures. Spectra were all collected under PDPM registration. 
64 
 
Finally, as demonstrated in Section 2.1.4, principles in oscillometer indicate that 
while pulses can be detected within a relatively wide range of pressures, i.e., from below 
diastolic to well above systolic pressure, the best mechanically translated pulses can be 
achieved at MAP. Forces plotted in Figure 2-15 have already shown mechanical pulses 
for almost all test subjects in the pressure range of 44 to 88 mmHg. For comparison, 
optical pulses for subject 1, 2 and 4 are plotted in Figure 2-18. As expected, IE vs. Time 
curve also shows the existence of cardiac pulses, however slightly different amplitudes 
are observed.  
Although it is subjective to judge the quality of pulses, for subject 1 under the 
pressure of 60 gf/cm
2
 (44 mmHg) the IE curve shows the strongest pulses. Similarly, 
subject 2 shows best optical pulses under 100 gf/cm
2
 (74 mmHg) and that pressure for 
subject 4 is 120 gf/cm
2
 (88 mmHg). From Table 2-2, the MAPs calculated for subject 1, 2, 
and 4 are 70 mmHg, 91 mmHg and 105 mmHg, respectively. A reasonable connection 
could be found here that could be used to guide the selection of modulation pressure in 
order to reach the maximum optical pulses. Such a selecting standard will help in 
producing reproducible spectra for individuals and also make it possible to compare data 
collected from same person in different days. 
 
2.3.3 Fingertip Topography 
As mentioned in section 2.1.3, due to the commensurate size of the laser spot with 
the breadth of fingertip ridges, the incident light could either contact the surface skin on 
top of a ridge or at the bottom of a furrow. To validate this statement, images of fingertip 
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over the opposite side of the apertures were taken by inserting an ultra-thin 
semitransparent pellicle mirror after the triplet lens in the collection side. Additional 
white light illumination and neutral density filters were utilized to help visualize the 
bright laser spot and minimize blooming. The pellicle guided 10% of the reflected light 
into a CCD camera and frames of image were taken using Snappy video digitizer (Play 
Inc., Folsom, CA, USA). Over the time span of a week, images for seven individuals 
were collected and several typical images for a single subject are plotted in Figure 2-19.  
Direct observation through the collection system shows that nearly all test subjects 
can remain stationary to within ±10 µm relative to the aperture for hundreds of seconds, 
not including inevitable involuntary tremors and similar random motions. In panel (B), 
fingerprints together with the sweat glands could be clearly seen and in this scenario the 
laser hits across the edge of a ridge into a groove. Despite of the over glow on the right 
side of laser spot, it is still clear that the size of laser is in the similar scale as fingertip 
ridges. When a different pressure was applied, the laser spot shifted and hit right on top 
of ridge. Attributed to the uneven topography of fingertips, the local angle of incidence 
could easily deviate wildly from 53°, the angle to guarantee maximal penetration into the 
skin if it were flat. As a result, propagation into the tissue is to a nonnegligible extent 
dependant on the precise positioning of the fingertips of test subjects. 
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Figure 2-19: Imaging of the LighTouch
TM
 aperture. (A) Backlit flat Delrin
TM
 block. (B) 
Unpressed fingertip (pressure ≈45 gf/cm2), showing illumination at center. (C) Fingertip 
pressed hard (pressure >140 gf/cm
2
), showing displacement of illuminated area. (D) 
Difference between pressed (C) and unpressed (D). The images are taken by putting an 
ultra-thin semitransparent pellicle mirror right after the triplet lens in the collection train.  
 
These images also show the doming issue that is mentioned in section 2.1.3. The 
optical system is initially aligned so that the light is incident at the middle of the aperture 
if the sample is flat and in the plane of the aperture, as can be seen in Figure 2-19(A) for 
a thick flat piece of light gray Delrin
TM
. When a finger is registered into the aperture in an 
unpressed state, as in Figure 2-19(B), the ellipse of contact is slightly shifted to the side 
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of the tissue toward the incoming laser light. If additional pressure is applied, the point of 
contact moves farther toward the side of the incoming laser, as in Figure 2-19(C). This 
motion, as we discuss in detail in the following, is down the side of the extruded dome of 
tissue. However, Figure 2-19(D) shows the difference between images (B) and (C) and 
demonstrates that the total displacement, even for a very hard applied pressure, is only 10 
to 30 µm. 
In order to probe skin topography, the skin is translated relative to the laser beam, 
either by moving the finger relative to the aperture with the aperture stationary relative to 
the excitation and collection optics, or by moving the aperture relative to the excitation 
and collection optics with the skin stationary relative to the aperture. In the latter case, the 
amount of off-axis elastic light production depends on the location of the edges of the 
aperture relative to the laser. Figure 2-20 shows data obtained by the former approach. 
Here, a part of the fingertip was scanned where the ridges run perpendicular to the 
direction of motion. No precise control of distance translated per step was possible. 
Instead the total distance moved over the total observation time was divided into equal 
segments and displacement was assigned accordingly. While observing the color changes 
of the placement spots and the pressure slider on the PDPM feedback window, the 
fingertip was moved through a known distance in a known amount of time with relatively 
constant applied pressure. The calculated distance travelled was roughly 10 µm per step. 
The IE and EE integrals shown in Figure 2-20 are plotted versus steps taken. Both 
fluctuated by roughly 20% with a spacing of about 500 µm, characteristic of fingerprint 
ridges.  
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Figure 2-20: IE and EE integrals from scan of laser and detector across fingerprint ridges 
plotted against displacement of fingertip alone across a stationary aperture. The step size 
is roughly 10 µm per step. 
 
Interestingly, the spatial fluctuations in the EE integral and the IE integral are 
complementary: one increases when the other decreases. Similar out-of-phase oscillations 
are observed in pulse modulated time-dependent measurements (81), in which the pulse 
causes a periodic increase in RBC volume fraction. Increased volume fraction of RBCs 
necessarily causes an increase in the IE, but this is accompanied by a decrease in the EE. 
A model built by Chaiken and Goodisman (10) predicts the temporal fluctuations due to 
both heart pulsing and the spatial fluctuations caused by fingerprint, although the 
explanations are different.  
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Figure 2-21: IE and EE curves as a function of displacement of aperture with respect to 
collection and excitation optics. In addition, a flat Delrin
TM
 plastic sheet scan and empty 
aperture scan are shown. The subjects span three different ethnicities, 19 to 78 years old, 
from 110 lbs and 5’2” height to 260 lbs and 6’4” height, and both genders. 
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With our apparatus, a skilled test subject can scan his/her finger across the aperture, 
with known pressure and acceptable spatial precision and accuracy, using visual feedback 
from the apparatus. Nevertheless, this involvement of the test subject limits the 
reproducibility, precision, and accuracy of the results. Therefore, the data presented next 
were obtained using the second approach, in which the fingertip moves with the moving 
aperture driven by a micro-positioning actuator. The assembly containing the aperture is 
mounted on NSA12 motorized linear micro actuator (Newport Corporation, Irvine, CA), 
the step size of which could be programmed and tightly controlled to be 20 µm.  
Figure 2-21 shows data obtained for four test subjects. In each case, the pressure 
used to maintain optical registration between the fingertip and the aperture was the 
average of the diastolic and systolic pressures measured with a commercial automatic 
blood pressure cuff. The laser has a 237 µm major axis while the aperture is 2 mm in 
diameter, therefore there are about 1750 µm (88 steps) effective displacement distance. A 
large increase in EE at the extreme right due to reflection as the laser beam strikes the 
outside of the aperture has been cropped. Oscillations apparently due to fingerprint ridges 
are evident, but so is a steady decrease or increase in intensity as one goes from left to 
right. This is associated with the doming of the fingertip pressed on the aperture (10). 
When the tissue extrudes a small dome is formed in the aperture and much of the 
difference between the Figure 2-20 and Figure 2-21 occurs because the position of the 
collection and excitation optics is locked on the same part of the dome for Figure 2-20 
but the incoming lasers cans across the dome in Figure 2-21.  
A wide variation in turgor, blood pressure, finger sizes, and skin tones are spanned 
by the selected test subjects with qualitatively similar results observed for all. Yet, Figure 
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2-21 shows consistent results using this instrument for a wide variety of test subjects. The 
consistency of these observations indicates that monitoring the variation in EE and IE 
with fine adjustment of the aperture position after the set-up procedure described above 
could allow the device to automatically find and interrogate the tissues at a location of 
consistent, predetermined topography and signal content. Specifically, positions of 
maximized IE and minimized EE are preferred because they correlate to the tops of 
primary fingerprint ridges (10). 
 
2.4 Conclusions 
Fingertip skin capillary beds are highly vascularized relative to other tissues and 
present a desirable target for noninvasive probing of blood. But human hands and fingers 
in particular are also highly idiosyncratic body parts requiring specific apparatus to allow 
rigorous and methodical spectroscopic probing. In an earlier study (50), the distribution 
of deviations between the noninvasive LighTouch™ glucose measurements and the 
reference fingerstick measurements reflected various sources of random and systematic 
error. Better management of the measurement process with regard to human factors 
emerged as a strategy for improvement with feedback based on applied pressure and 
tissue placement. Therefore, instrumentation for probing of volar side fingertip capillary 
beds with free space coupled near infrared light while collecting Raman, Rayleigh, and 
Mie scattered light as well as fluorescence is described in great detail in this chapter. 
The apparatus includes means for precise and reproducible placement of the tissues 
relative to the optical aperture. Appropriate means are provided for applying and 
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maintaining pressure to keep surface tissues immobile during experiments while 
obtaining the desired blood content and flow. Soft matter, e.g., skin, extrudes into the 
aperture in response to any applied pressure, e.g., to keep the tissue in registration with 
the optical system, so the position, contact area, pressure, and force are continuously 
measured and recorded to produce feedback for an actuator applying force and to discern 
the compliance of the test subject. The compliance strongly affects the reliability of the 
measurement and human factors must be adequately managed in the case of in vivo 
probing. The present device is even more advanced since the actual application of 
pressure is automatic and could work for an unconscious test subject. 
The digital quantitative records of the measurement cycle could be used for 
interpreting sources of errors in glucose concentrations in order to improve performance 
and better understand the total measurement process. Together with appropriate criteria 
based on general quantitative experience, any specific human factor data can be 
processed to allow objective rejection or acceptance of associated spectroscopic data 
before calculation of a glucose concentration for example without operator involvement. 
Finally, despite the idiosyncratic aspects of in vivo human spectroscopic probing, the 
gross anatomy of ridged fingertip skin is constant across all but the most abnormal test 
subjects. The fingertip topographic results are reasonably consistent because the scanning 
of the different tissues samples, i.e., test subjects, has been relatively consistent. This 
general consistency suggests that the pressure is a universal variable appropriate for 
characterizing the state of perfused tissue and soft matter generally during spectroscopic 
probing. Thus it is important that the pressure be well defined in order to perform a 
spectroscopic experiment that can be executed reproducibly. It is possible that under 
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appropriate constant pressure conditions, the turbidity and relative density of the tissues 
in the probed volume do not vary much across individuals. Using this instrument, except 
for pulse driven motions and acoustic waves, the tissues can be isobaric and motionless 
during the measurement process. This does not necessarily mean that further processing 
of data acquired using this instrument for purposes of a turbidity correction (82-84) to the 
quantitative analysis of blood and other tissues are unnecessary. This must be ascertained 
with more experimentation, but using this instrument data collected for different test 
subjects or at different times for the same test subject can be compared and reproduced in 
an objective and quantitatively consistent manner. Many of the same ideas in this device 
would be applicable to spectroscopic probing of other types of soft matter, including ex 
vivo tissue samples for biopsy. 
 
 
 
74 
 
3. SIMULTANEOUS NONINVASIVE IN VIVO 
OBSERVATION OF IE AND EE 
 
3.1 Elastic and Inelastic Emissions 
3.1.1 Background 
Figure 3-1 shows a Jablonski diagram that illustrates various vibrational and 
electronic states within a typical molecule with arrows to present scattering processes and 
electronic transitions associated with Raman, fluorescence and phosphorescence. 
Rayleigh scattering can happen when the incident photons hit an object, e.g., a molecule, 
which is much smaller than the wavelength of light with no energy transferred but only 
altered direction of propagation. Thus, this process is elastic. Not shown in the diagram, 
another similar elastic scattering i.e., Mie scattering, can happen when the size of the 
object is roughly the same as the incident wavelength. In our experiments we cannot 
differentiate between these two sources of elastic emission.  
Of all the incident photons, roughly only one out of a hundred million will scatter 
from the sample at a shifted wavelength generating the extremely weak Raman scattering 
(32). A molecule in a very strong electric field, e.g., produced by a laser, has excited 
states, i.e., “virtual states”, that only exist in the presence of the radiation field. 
Interaction with another photon from that same laser field in the manner indicated by the 
arrows can produce Raman scattered light as well as the aforementioned Rayleigh and 
Mie scattered light. Usually, part of the energy in an incident photon is transferred to the 
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molecule resulting in a remitted light that has a longer wavelength than the incident, 
which is called the Stocks emission. The Stokes Raman is the inelastic scattering that is 
observed in this study. Raman, Rayleigh and Mie are all scattering process and there is 
essentially no time delay between the incident radiation and the production of either 
elastic or inelastic emission. 
 
Figure 3-1: Jablonski diagram illustrating the electronic states within a molecule and 
transitions between them. 
 
Similar to Raman, fluorescence and phosphorescence are inelastic processes. But for 
the latter two cases the incident photons must have enough energy to excite the molecule 
to an actual excited electronic state of the molecule, i.e., that is present regardless of an 
applied electric field, which is not necessary to produce Raman emission. Once excited, 
as a general rule, molecules in condensed phases, like the environment in the essentially 
water tissue, rapidly (10
-12
 – 10-15 sec) relax to the lowest vibrational level of the excited 
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electronic state and then give off an emission with a typical lifetime of 10
-7
 – 10-9 sec for 
fluorescence and 10
-3
 – 10-6 sec for phosphorescence (85). The excited state has different 
spin angular momentum from the ground electronic state for phosphorescence and it is 
the same for fluorescence. From the Jablonski diagram, it is obvious that both Stocks 
Raman and fluorescence processes involve energy loss and thus are both inelastic 
emissions. Experimentally we cannot separate the different sources of inelastic emission 
from each other without additional information, e.g., temporal properties. 
In this study, the EE is Rayleigh and Mie scattered light, whereas the IE consists 
mostly of fluorescence and in absolute magnitude, only a small amount of Raman 
scattered light. The collected EE reflects the net absorption at the excitation wavelength 
but more importantly in terms of the relative amounts of collected EE, propagation losses 
due to physical scattering from structural and formed elements, e.g., collagen fibers and 
RBCs. Production of IE is initiated by absorption of the excitation light but there are 
other factors, e.g., the quantum yields for fluorescence and the cross sections for Raman, 
that contribute to determine the net collected IE. At least some of these factors would 
seem to be independent of the absorption process and thus for analytical purposes the 
measured EE and IE are effectively independent quantities with regard to their 
information content. 
 
3.1.2 Potential In Vivo Application of EE and IE 
In vivo, the NIR spectral range is the most advantageous for probing blood in human 
skin mainly because of the relatively low propagation loss and the low net absorption 
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such that the probing is nondestructive and therefore noninvasive. In the optical geometry 
as shown in Chapter 2 we believe we irradiate and collect light that mostly probes only to 
a depth of the capillaries in skin and with narrow bandwidth NIR excitation leads to 
easily separated EE and IE light.  
The probed volume of human fingertip tissue can be modeled as a three-phase 
system: plasma and RBCs phases that are mobile, and a static tissue phase. The static 
tissue, different from the anatomic definitions of various skin layers, includes the cells in 
addition to the extracellular structural components and interstitial fluids, i.e., everything 
that does not move quickly under the influence of cardiac pulsing. The optical properties 
(86-88) of the three phases for 830 nm incident light are listed in Table 3-1. Static tissue 
has a tenfold larger scattering coefficient than plasma, and that of RBCs exceeds that of 
static tissue by at least a factor of 20. Thus, as will be demonstrated in a greater detail in 
the following context, the net propagation of light is mostly determined by the RBCs.  
Table 3-1: Absorption and scattering coefficients at 830 nm for three phases, i.e., RBCs, 
plasma and static tissue. 
PHASE 
ABSORPTION 
COEFFICIENT 
SCATTERING 
COEFFICIENT 
r = RBCs αr = 4.5 cm
-1
 µr = 300 cm
-1
 
p = plasma αp = 0.3 cm
-1
 µp = 0.6 cm
-1
 
t = static tissue αt = 5 cm
-1
 µt = 12 cm
-1
 
 
The IE that originates from fluorescence and Raman scattering contains overlapping 
components from all tissues in the irradiated volume, i.e., plasma, RBCs and static tissue. 
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Yet their fluorescence yields per unit volume are different. Resulting from fundamentally 
different physical processes, the apparent IE yields differ between RBCs, plasma, and 
skin in a manner that is uncorrelated with the variation in elastic scattering yields across 
the same tissues. Therefore, a model that takes these parameters into account should 
allow us to simultaneously estimate the relative volume fractions of the three phases in 
the probed volume, in vivo and noninvasively. 
 
Figure 3-2: IE and EE as a function of time for a single very short and weak mechanical 
impulse starting at t=0 sec, followed by active pressure maintenance at 50 gf/cm
2
. Inset: 
same data at shortest times. 
 
Figure 3-2 shows the complete EE and IE curves collected for a typical 100 sec 
experiment with the pre-experiment “set-up” as described in Chapter 2. The IE and EE 
integrals are each plotted as a function of time. The data were transformed to have a 
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mean of 0 and standard deviation of 1 to facilitate their comparison. In the inset, we show 
the data for t<0.5 sec. Initially, the IE drops rapidly while the EE is nearly constant. 
Figure 3-3 shows some of the same data as Figure 3-2 but using an expanded temporal 
scale to show the complementary and very nearly proportional behavior of EE versus IE 
light. 
To understand the relative time dependence of the EE and IE data on the time scale 
of the pulses and faster, two facts are important. First, the previously published (49, 50, 
54) in vitro data for 785 nm excitation of methemoglobin over the concentration spanning 
the normal capillary blood range demonstrates that the integrated fluorescence, i.e., IE, 
increases linearly with increasing hemoglobin (Hb) volume percent. Moreover, as will be 
shown in Chapter 4, in vitro plasma fluorescence also increases linearly from infinite 
dilution in Normocarb™ to pure plasma. Thus, fluorescence measured in vivo is a 
measure of both plasma volume and Hb volume. 
Second, the amount of elastically scattered light collected decreases as the volume 
percent of RBCs increases. In perfused skin, the volume percentages of the plasma, RBCs, 
and static tissues are constantly changing. A volume containing only static tissue and 
plasma would not scatter appreciably because the scattering coefficients are small. But 
propagation through a perfused volume may experience much larger changes because of 
changed RBCs volume fraction, because RBCs scattering coefficients are very large as 
shown in Table 3-1. If, for a heart-driven pressure wave, i.e., pulse, the volume 
percentage of plasma decreases, the volume percent of RBCs must increase, even if none 
actually moved, and the net elastically scattered light collected will decrease. 
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Figure 3-3: Same data as in Figure 3-2, shown at higher temporal resolution to show 
complementary behavior of EE versus IE. 
 
At the shortest times as shown in the inset of Figure 3-2, when the actuator is 
establishing control over the pressure applied to the tissue, the behavior of the two plots 
(substantial decrease in IE with a small relative change in the EE) suggests that mostly 
plasma motion occurs. Because plasma motion out of the irradiated volume decreases the 
relative total blood volume percent and causes a decrease in the collected inelastically 
scattered light, we infer that the observed change in IE over the long timescale is due 
mostly to plasma removal. Apparently the small observed change in EE signal is due to a 
small movement of RBCs out of the irradiated volume, which keeps the change in 
volume percent of RBCs in the irradiated volume very small. This seems reasonable 
because, in the depth range we observe in Figure 3-2 plasma and erythrocytes are mostly 
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confined to narrow capillaries and the discharge and tube hematocrit (Hct) are very 
nearly equal (89). The effect of a relatively large change in IE due to plasma motion is 
compensated by a very small modulation of RBCs so the RBCs volume fraction is nearly 
constant. 
Once the desired pressure value has been established, the pulses and other regular 
temporal oscillations in both the IE and EE data can be observed. The IE temporal 
behavior corresponds to the increasing and decreasing local blood volume as blood 
pressure pulses propagate through the capillaries in the irradiated volume. The capillaries 
become slightly distended as an increased volume of plasma and RBCs occupies the 
capillary lumen during the increasing pressure pulse. Because the RBCs have by far the 
largest scattering coefficient, change of EE collected light is most strongly associated 
with RBCs movement. Although most of the observed Rayleigh/Mie light originates from 
static tissue because that tissue has the highest volume fraction, the efficiency of 
propagation of the excitation light to the static tissue and of the elastically scattered light 
to the collection zone decreases as RBCs volume percent increases. 
Therefore, simultaneous observation of elastic scattering, fluorescence, and inelastic 
scattering from in vivo NIR probing of human skin allows discrimination of the 
movement and presence of RBCs independently from plasma. Control of the mechanical 
force needed to obtain reliable optical registration of in vivo tissue with the optical system 
allows reproducible observation of blood flow in capillary beds of human volar side 
fingertips. The time dependence of the elastically scattered light is complementary to that 
of the combined fluorescence and Raman scattered light due to the changing volume 
fractions of the three phases in the irradiated volume with normal homeostatic processes 
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over time, i.e., heart-driven pulses, and the impeding effect of RBCs on optical 
propagation. Thus, there is a potential to use these combined pieces of information to 
calculate the volume fractions of the three phases, i.e., plasma, RBCs and static tissue, 
which naturally leads to the Hct — the volume fraction of RBCs relative to whole blood. 
This in vivo application will be further discussed in Section 3.3. 
 
3.1.3 Negative Influences of Fluorescence Quench 
For purposes of volume normalizing Raman spectroscopic signals that might be 
associated with specific molecules in order to obtain concentrations of those analytes in 
vivo, it is proposed earlier (46, 50, 51, 54, 81) to normalize the associated Raman signals 
to the IE, the majority of which is fluorescence.  
 
Figure 3-4: Fluorescence from various tissues and cells investigated in vivo or ex vivo 
under NIR excitation. 
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As shown in Figure 3-4, for various tissues and cells that have been probed in vivo or 
ex vivo, fluorescence is ubiquitously observed and is related with the fluorophores within 
the probed volume. If all tissues produce fluorescence in proportion to the concentrations 
of fluorophores in those tissues and if the concentrations are constant in time then the 
hypothesis for volume normalization is supported. 
 
Figure 3-5: BV vs. Time curve screenshots of a typical in vivo collected human fingertip 
(A, top) and gelatin tissue phantom (B, bottom). Obvious trend of gradual IE decrease is 
observed in volar side human fingertip spectra. 
 
Unfortunately, except for the drop of fluorescence in the middle of an experiment 
due to the pressure modulation of tissue, as shown in Figure 3-5(A), a typical in vivo BV 
vs. Time curve always shows an abrupt drop at the very beginning (usually within the 
first few seconds), and then slowly decreases with time. Ideally, as shown in the bottom 
panel of Figure 3-5, fluorescence change should only be observed when tissue 
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modulation occurs. Clearly, the in vivo decay indicates the change of fluorophore 
concentrations that is oppose to our hypothesis. Therefore, using the decreasing IE for 
volume normalizing will introduce uncertainties of inelastic emission that does not result 
from tissue modulation, which is detrimental to proper normalization.  
To tackle the negative influences of such skin tissue fluorescence quenching, it is 
essential to study the origins and characteristics of in vivo human skin NIR fluorescence. 
Hopefully, the study in Section 3.2 provides an understanding to guide us in modifying 
our algorithm or experimental procedures to eliminate its detrimental effects. The 
relevance to the quantitative monitoring of glucose concentrations or Hct will be 
discussed in Section 3.3. 
 
3.2 Characterizing Human Fingertip Autofluorescence 
3.2.1 Dependence on NIR Irradiation 
Besides the pressure administration exerted by PDPM, all the tissues of an organism 
are simultaneously under i) the oncotic pressure exerted by the osmotic pressure across 
physiological compartments due to changing electrolyte balance (44, 79), ii) the pressure 
exerted within the circulatory system, and iii) the hydrostatic pressure exerted by gravity 
on all the body tissues. From the outset we were suspicious that these pressure factors 
could be contributors to the gradual fluorescence drop as observed in the BV vs. Time 
curve in Figure 3-5(A). Thus, it is important to determine the timescale of possible fluid 
equilibration driven by hydrostatic pressure, if any, due to the changing body posture of 
the test subject in contacting with the apparatus, i.e., changing from a standing position to 
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a sitting position. In the extreme this can leads to the so-called “orthostatic hypotension”, 
i.e., the dizziness upon standing sometimes experienced by people with low blood 
pressure. This process is also sometimes referred as “hydrostatic relaxation” (79). To 
appreciate and separate the effect of bringing the tissue into optical registration from that 
of changing the systemic hydrostatic pressure just before beginning the measurement 
process, the measurement sequence depicted in Figure 3-6 was executed. 
 
Figure 3-6: In vivo photobleaching and hydrostatic relaxation study. Condition: A) initial 
100 sec experiment; B) a consecutive 100 sec experiment following immediately upon 
finishing of the initial experiment; C) a separate 100 sec experiment following initial 100 
sec hydrostatic relaxation only, i.e., no laser exposure. 
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For the BV vs. Time curve A, a normally closed shutter placed immediately after the 
incident laser source was triggered open by starting the spectrum acquisition process 
following a quick “set-up” routine as described in Section 2.2.4, during which the finger 
was passively under the pressure administration fulfilled by PDPM. Immediately 
following the completion of curve A, the finger was maintained motionless (±20 µm or 
less than about 10% of the physical dimensions of the laser spot) and the acquisition of 
curve B started.  
To obtain curve C, the finger was retracted from the device and the test subject stood 
upright and walked around the laboratory for a total of at least 50 ft while executing 
movements of all appendages in order to re-equilibrate the blood in the entire body, 
thereby restoring normal hydrostatic status throughout. Then, with the laser blocked, the 
test subject re-registered with the device by selecting a slightly different spot with respect 
to the fingerprint ridges and running the same initial “set-up” routine. The hand was kept 
motionless and in contact with both the actuator and the aperture as the A run but not 
irradiated for 100 sec, a period of time equal to that of curve A collection. In this way, 
any fluid redistribution due to the changing hydrostatic pressure associated with 
assuming different body posture, i.e., sitting versus standing, would have the same time 
to occur but without laser irradiation. 
As shown in Figure 3-6, obvious heart pulsing was observed throughout all the data. 
But in curve A, the initial value of the IE is large followed by a fast roughly 10
0
-10
-1
 
seconds decay and then a slower exponential decay over the next tens of seconds. In the 
case of curve B, however, the initial IE is nearly the same as the end of the A and not 
much drop in IE is observed. The dynamics of the C curve is nearly identical to that of 
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the A although the value of IE is greater than that of the A data. Since the difference in 
data acquisition between curve B and C is only the 100 sec pre-experiment laser exposure, 
we conclude that the drop in IE is associated with the presence of the laser and not due to 
any change in hydrostatic pressure. Hereafter, such laser induced decrease of 
fluorescence is mentioned as “photobleaching” and this photobleaching has been 
observed for all subjects without exception. 
The power dependence of the observed skin autofluorescence was also measured for 
three test subject. Not surprisingly, the results shown in Figure 3-7(A) demonstrated that 
the in vivo autofluorescence increases as the laser power increases. In addition to the 
increased size of probed volume with greater incident laser power, higher power also 
increases the penetration depth from which signal is obtained. Therefore, the observed 
fluorescence at various powers could probably contain different relative contributions 
from superficial static tissue and deeper blood components. This could in turn result in 
change of rates and characteristics of photobleaching. Radiation transfer equation (RTE) 
modeling including the correct probing and collection geometry (10) suggests that the 
signal that is the IE has a power index of 1.0 when the excitation transition that produces 
fluorescence is a one photon transition. 
Recognizing that interpretation of the power dependence of the autofluorescence is 
therefore complicated at best, we measured the quantity in order to i) satisfy engineering 
needs, i.e., the scaling of signal with incident power is an important design parameter, 
and ii) check for any evidence that the excitation process is a multiphoton process. 
Measurement of the power index, i.e., the slope of a log power vs. log fluorescence plot, 
is commonly used in the laser chemistry literature (90) to establish the order of the 
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slowest excitation step in any multiphoton process. While non-integral indices are 
commonly observed in complicated systems, e.g., representing an averaging over perhaps 
more than one excitation sequence, in well defined and simpler systems, such indices are 
rigorous proof in establishing the order of a multiphoton process. 
 
Figure 3-7: Laser power dependence of the skin autofluorescence. (A, top) IE integrals 
for three test subjects under six different laser powers. Data were collect on the same day. 
(B, bottom) Linear fit to the logarithmic values of both laser power and fluorescence 
integrals. Both panels show obvious IE increase as the increase of laser power. 
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As can be seen in Figure 3-7(B) the measured index was 0.74 for all the test 
subjects. While we have not yet tried to observe emission e.g. at 415 nm for 830 nm 
excitation, this index is consistent with the hypothesis that the autofluorescence is 
produced with NIR excitation of skin by a one photon absorption process. In analogy 
with simpler but possibly analogous systems, the power index could be less than 1.0 
because in parallel with the excitation process, there is another laser induced process that 
causes a decrease in the collected fluorescence with increasing incident power. 
Another study on the characteristics of photobleaching at different laser powers was 
performed on six test subjects. For each test subject, only one laser power was 
investigated a day to avoid any possible accumulative influence of such bleaching. Thus 
the data collected covered a relatively longer period of time. The firstly clear observation 
in Figure 3-8 is that the data collected for a diabetic patient stand out. The 
autofluorescence from the diabetic subject not only has almost three times bigger starting 
fluorescence, but also bleaches more than 60% toward the end of a 200 sec experiment. 
Similar excessive fluorescence and bleaching are observed for a senior subject, but not to 
an extent like the diabetic patient.  For all the rest subjects, fingertip autofluorescence 
typically bleaches 15-20%, with a slight increase toward higher laser power to around 20-
30%. 
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Figure 3-8: Photobleaching study of various test subjects at different power levels. (A, 
top left) Starting points of the skin autofluorescence; (B, top right) Ending points of 
fluorescence after 200 sec of 830 nm laser exposure; and (C, bottom) Ratio of the 
bleached fluorescence to the baseline, i.e., the equilibrium fluorescence after bleaching. 
 
All fluorescence photobleaching curves were fitted into a two-component 
exponential decay equation to obtain the two lifetime τ1 and τ2 which is shown in Figure 
3-9. Despite of the relatively large deviation and spread of the data, the two time 
constants definitely represent two separate processes, one quick and one slow. With not 
much difference among test subjects, τ1 is of the order of magnitude of 10
1
 to 10
2
 sec, 
while τ2 is typically below 10 sec. Lastly, although vaguely, τ1 decreases slightly with the 
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increase of laser power, indicating a slightly quicker bleaching at higher power. This is 
consistent with what Zeng et al. have reported (91), and they have related the fast 
decrease term to laser induced photobleaching in stratum corneum and the slow decrease 
term to fluorophore changes in the dermis. In our point of view, relating such processes 
to constituents within stratum corneum and dermis, as will be demonstrated in Chapter 4,  
might be more proper than a generate classification to skin layers. 
 
Figure 3-9: Time constants of the two-component exponential decay fit to the in vivo skin 
autofluorescence photobleaching. (A, left) Time constant, τ1, represents the slower part of 
the photobleaching of 10
1
 to 10
2
 sec. (B, right) Time constant, τ2, represents the initial 
quick bleaching typically happens within 10 sec.  
 
3.2.2 Relative Contribution from Static Tissue and Blood 
The tissue under investigation is roughly divided into two major categories: static 
tissue and blood. Knowing that the laser interacts with probed tissue, it is essential to 
verify the relative contribution of static tissue and blood to the observed fluorescence and 
photobleaching respectively.  
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In the experiment depicted in Figure 3-10 two shutters were included and 
programmed to control the laser exposure as shown in the upper right corner inset. In this 
case the fingertip was set-up and brought to 60 gf/cm
2
 with laser blocked. The laser was 
unblocked at t=2±0.1 sec with pressure already equilibrated and the IE was observed to 
fall exponentially again in the first 27 sec. As shown in the lower left inset of Figure 3-10, 
pulses were shown in IE indicating that systemic circulation under modulation was not 
blocked. At this point the laser was again blocked for 8 sec in order for a dozen or more 
pulses to bring new previously unexposed blood into the irradiated volume.  
 
Figure 3-10: Shuttered in vivo IE profile of a human fingertip, attempting to observe 
fluorescence recovery by allowing fresh unexposed blood to flow into the probed volume. 
Lower left corner inset zooms in the 10-20 sec frames to show in vivo heart-driven 
pulses. Upper right corner inset illustrates the shutter programming sequences. 
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The hypothesis here is that static tissue remains the same either before or after the 
laser is blocked, while heart-driven pulses keep on pumping previously non-bleached 
blood into the illuminated zone. Therefore, after the 8 sec “dark time” it is expected that 
the bleaching effect on static tissue remains, if there is any, but now fresh unbleached 
blood components are present. Checking the IE curve on the point of reopening the 
shutters enables us to differentiate the influence of laser on the two separately. If blood is 
the main contributor to the bleached fluorescence observed at t=2 sec of the test, then 
fluorescence should recover back to the previous level on reopening of the shutters. As 
shown in Figure 3-10, fluorescence returned to where it was before the shutter was closed 
but not to a significantly greater level than where it was at the initiation of the experiment. 
Also noticeably, upon reopening of the shutters no exponential decay was observed. Thus 
it is evident that using 830 nm excitation most of the bleachable NIR autofluorescence 
originates in the static tissue. 
Figure 3-11 also shows a typical BV vs. Time curve collected by a precious 
colleague using 805 nm excitation (51). Actually, under either 805 or 830 nm excitation, 
the blood, i.e., the sum of plasma and RBCs, and unbleached static tissue fluorescence 
per unit volume are comparable with the blood being somewhat greater. If the 
fluorescence per unit volume of the blood and the static tissue were the same, then pulses 
would not be observable. If the blood fluorescence were twice that of bleached tissue per 
unit volume then increasing the perfusion due to a cardiac pulse by 2% would increase 
the fluorescence by 2% and this is very roughly what has been observed. The appearance 
of the dichotic notch (51) compared with that observed using photoplethysmography also 
shows that the blood fluorescence per unit volume is larger than that of the tissue. 
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Despite of the low Hct in the capillaries probed, e.g., 0.1 – 0.3, the fluorescence per 
unit volume of Hb is greater at 805 nm (66) than 830 nm, thus resulting in the differences 
in the pulses in Figure 3-11 and Figure 3-12 with the expanded scale. Under 805 nm 
excitation the pulses are more visible throughout even at the very beginning. 
Nevertheless, the fluorescence fluctuation due to cardiac pulses either under 805 nm or 
830 nm excitation is of the very similar size relative to the baseline fluorescence, i.e., 
around 2% in both cases, suggesting the same fluorophore(s) of the pulse fluorescence.  
 
Figure 3-11: Comparison of two 100 sec IE vs. Time curves obtained under 805 nm and 
830 nm excitation respectively. Although cardiac pulses are clearly shown on both 
curves, these under 805 nm excitation are less noisy and much easier to discern.  
 
It is also noted that working at 830 nm, averaging among different test subjects 
roughly 10-15% of the initial fluorescence from tissue in vivo bleaches away in the first 
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several tens of seconds. The fresh blood in a background of bleached tissues adds little 
additional baseline fluorescence. Therefore, it is concluded that at least 15% of the 
fluorescence originates within the static tissue. Although bleaching of blood cannot be 
totally settled at this point, it is safe to say that the photobleaching of the static tissue 
contributes majority of the observed exponential fluorescence decay and once bleached it 
does not recover in a couple seconds of no irradiation. 
 
Figure 3-12: Re-plot of the IE vs. Time curves with expanded x-axis range from 0 to the 
first 10 sec. Under 805 nm excitation, discernible optical pulses could be seen 
immediately upon the start of the experiment, while pulses gain visibility gradually under 
830 nm excitation. 
 
96 
 
3.2.3 Recoverability of Quenched Fluorescence 
To observe whether and if so to what extent the laser bleaches the static tissue, two 
shutters were used to allow only 60 ms slices (chosen based on the 20 ms frame sampling 
time) of the CW laser to contact the skin during the scanning across the fingertip from tip 
to joint for the length of the entire aperture. The same setup described in Section 2.3.3 in 
Chapter 2 was used to obtain the fingertip topography. Driven by a NSC200 controller, 
both fingertip and the aperture were moved simultaneously relative to the stabilized laser 
source. At a scanning rate of 1 sec/spot, the actual duty cycle of laser exposure to skin 
was only 6%, which is hoped to greatly reduce the bleaching at each spot and offer  
unbiased fingertip topography. 
A typical scan obtained in this manner is shown in Figure 3-13. The concave up 
gross appearance of the scan is an artifact of the tendency of the tissue (and all soft matter) 
to extrude into the aperture when held under any pressure as explained in Chapter 2 and 
previously published theory paper (10). After a first low duty cycle pre-scan was obtained, 
the laser was allowed to contact and thereby photobleach the motionless skin at the center 
of the aperture for 50 sec at 200 mW with 100% full duty cycle. Immediately following 
this and at various times afterwards, low duty cycle scans were conducted to reveal the 
effect of the photobleaching step. The fluorescence in the irradiated region is decreased 
by about 15-20% in the case of the non-diabetic test subject shown in Figure 3-13.  
It is also observed that for all test subjects the bleaching effect persists for as long as 
45 min without any notable recovery. However, it does not seem possible to detect the 
spot 24 hrs later. Since interstitial fluid exchanges materials with the blood stream and 
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the lymphatic system on a time scale of only a few tens of minutes, it could be concluded 
that at 830 nm and the power levels used the bleaching is faster than the interstitial fluid 
exchange between the bleached and unbleached static tissue constituents. Although many 
more test subjects need to be included to produce a statistically meaningful result, so far 
test subjects with diabetes photobleach roughly twice as deeply as the non-diabetic test 
subjects, regardless of age. 
 
Figure 3-13: Two individual IE fingertip topography scans performed on the same subject 
w/o moving hand out in between. The second scan (dotted line) is performed after 50 sec 
bleaching under 200 mW laser exposure in the center of aperture at the end of the first 
scan (solid line). 
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3.2.4 Summary 
A series of measurements in vivo intended to establish some of the basic empirical 
properties of the autofluorescence and photobleaching phenomena are described. To 
summarize, in vivo results show that the observed bleaching of human fingertip skin with 
830 nm excitation is laser induced coming mostly from the static tissue rather than blood 
components, and is unrecoverable within the time span of 10
1
-10
2
 min. On a given trial 
the exact amount of tissue fluorescence varies from person to person in manner that we 
and others are actively studying (91-96). And an initial bleaching process always occurs 
and the magnitude is roughly as what is suggested. Therefore, for a single test subject in 
comparison with him or herself, utilizing a reasonable pre-bleaching period in a 
consistent manner could still allow for using IE as a volume normalizer. 
 
3.3 Hct Monitoring Using Combined EE and IE 
3.3.1 The Theoretical Model and Algorithm 
Since we are interested in using fluorescence for volume normalization, in this 
section we first briefly review a new algorithm Goodisman and Chaiken developed to 
include turbidity changes simultaneously with fluorescence changes in order to 
consistently estimate plasma and RBC volumes. As we do we mention engineering issues 
which are now important to consider. As briefly introduced in Section 3.1.2, probing 
tissue with NIR radiation simultaneously produces IE plus EE that noninvasively give 
chemical and physical information about the materials and objects within. Therefore, it is 
reasonable to presume that EE and IE represent two independent observations that can be 
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used to obtain the volume fractions of two independent phases: the plasma and the RBCs. 
Having these two quantities is equivalent to having the Hct and the total blood volume, as 
shown in Equation 3-1and Equation 3-2 with ϕ being the volume fraction of each phase. 
r
r p
Hct

 


     Equation 3-1 
Total Blood Volume r p      Equation 3-2 
 
Goodiman and Chaiken proposed a model (10) for the propagation and scattering of 
radiation through skin based on radiative transfer equation (RTE) that includes the 
attenuation of incoming radiation by scattering and absorption, the scattering of the 
radiation from all tissues, and the propagation of scattered radiation from scattering 
centers to the detector. As shown in Table 3-2, the model divides the structure of skin 
into three layers: a relatively thin (100 µm), static, bloodless, and nonviable outer layer a, 
covering a somewhat thicker (200 µm) relatively blood-rich layer b that is bounded from 
below by dermis, a less blood-rich layer c whose depth is essentially infinite. Of course, 
in reality the thicknesses of all the layers vary across all test subjects. But what is critical 
here is the ability to reach the 200 µm thick layer b which is a contiguous volume 
containing the perfused viable epidermis. 
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Table 3-2: Assumed volume fractions of the three phases in the three layers based on 
estimates (41, 42) of average capillary density, dimensions and an Hct of 0.10 for the 
blood in the most vascularized layer b. 
Phase Layer a Layer b Layer c 
r = RBCs 0.00 0.0040 0.00067 
p = plasma 0.00 0.0360 0.00600 
t = static tissue 1.00 0.9600 0.99333 
 
In vivo, any volume of tissue naturally experiences spatial and temporal fluctuations 
of blood plasma and RBCs content. Assuming there is no void volume in viable tissue, or 
that void volume is constant. Then, this could be summarized in Equation 3-3 and 
Equation 3-4. 
1 r p s          Equation 3-3 
0 r p sd d d         Equation 3-4 
Chaiken and Goodisman have also proposed an algorithm (80) for calculating these 
volume fractions based on their theoretical RTE-based model. Using literature absorption 
and scattering coefficients as shown in Table 3-1, the RTE calculated contribution of IE 
and EE from the three phases vary linearly with the various volume fractions of plasma 
(ϕp) and RBCs (ϕr). This linear relation enables the prediction of two unknowns, i.e., ϕp 
and ϕr, from the two known quantities, i.e., EE and IE, using Equation 3-5 and Equation 
3-6.  
r
0 0
EE IE
a b c
EE IE

   
     
   
    Equation 3-5 
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0 0
p
EE IE
d e f
EE IE

   
     
   
    Equation 3-6 
In these equations IE0 and EE0 represent the average IE and EE for a specific test 
subject and real time measured IE and EE will be fed into the model. Hct is then 
calculated using Equation 3-1.  
 
3.3.2 In Vivo Calibrations 
There are six parameters a–f for which numerical values must be obtained by using 
constraints based on empirical data or assumptions. First, consistent with Jacques (88) 
and our own geometrical approach for very well-perfused skin, it is reasonable to assume 
that ϕr = 0.004 and ϕp = 0.036 on average and that EEave = EE0 and IEave = IE0. A cursory 
examination of other parameter sets suggests that some flexibility in choosing these 
values could be exercised because only deviations from the baseline values, not the 
absolute Hct, are the interested values to be monitored. According to Equation 3-5 and 
Equation 3-6, this gives two constraints: a + b + c = 0.004 and d + e + f = 0.036. 
Additional constraints can be obtained from changes in EE and IE that can be 
correlated with known physiology. Normally with each cardiac pulse (97) about 75 ml of 
0.45 Hct blood is injected into the arterial side of the 4000 ml total supply. Uniformly 
distributed, this would result in a 1.9% transient increase in blood volume, i.e., in both ϕr 
and ϕp assuming constant Hct. Thus, it could be assumed that with each pulse ϕr and ϕp 
increase by 0.000076 and 0.0006.84, respectively. Meanwhile, the raw spectral data in 
Figure 3-3 show −2.08% and +2.63% changes in EE and IE, respectively, with each 
cardiac pulse, i.e., systolic EE and IE minus diastolic EE and IE. By taking derivatives of 
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Equation 3-5 and Equation 3-6, the changes of pulse ϕr and ϕp can be expressed using the 
two equations below: 
r
0 0
EE IE
b c
EE IE

    
     
   
    Equation 3-7 
0 0
p
EE IE
e f
EE IE

    
     
   
    Equation 3-8 
Therefore, the two aforementioned conditions can be inserted into Equation 3-7 and 
Equation 3-8 to generate two more constraints on the values of the parameters a–f: b = -
0.00365 + 1.264 c and e = -0.0329 + 1.264 f. 
 
Figure 3-14: IE and EE as functions of time for two different modulation cycles. In one 
cycle, the pressure went from low = 60 gf/cm
2
 to high = 200 gf/cm
2
; and in the other, 
went the opposite. (A) EE for low to high, (B) EE for high to low, (C) IE for high to low, 
and (D) IE for low to high. Trials (A) and (D) were used to provide the calibration. 
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Finally, it has been shown in Chapter 2 that tissue modulation could significantly 
redistribute the blood flow. Figure 3-14 shows IE and EE integrals of a test subject whose 
fingertip was modulated between 60 and 276 gf/cm
2
 of pressure. As shown, EE increased 
by 3.03% and IE decreased by 9.6%.  
In obtaining these results, the maximum applied pressure was three to four times the 
normal systolic blood pressure; thus, the amount of blood displaced is roughly three to 
four times the amount displaced by a pulse. The changes in ϕr and ϕp are estimated based 
on: i) the applicability of the Poiseville–Hagen equation to optimization in the 
cardiovascular system (98), and ii) the variation in appearance of tissue-modulated 
spectra with varying amounts of modulating pressure (99). Although we probe the 
capillaries, they are fed by the superficial dermal plexus, with vessels large enough to 
demonstrate well-known microcirculation anomalies (100, 101), i.e., plasma skimming 
and the Faraeus and Faraeus–Lindquist effects, associated with nonproportional plasma 
and RBC movement. Under greater applied pressure, relatively more plasma is expected 
to move than RBCs because the viscosity of plasma is less than that of RBCs.  
Under our experimental conditions, we estimate the discharge Hct as 0.075. The 
decrease in ϕr is therefore 3×0.019×0.004 = 0.000228 and the decrease in ϕp is 
4×0.019×0.036 = 0.002736. This corresponds to three and four times the amount of 
RBCs and plasma moved by a single pulse. Again, by putting these volume fraction 
changes together with IE and EE changes in Equation 3-7 and Equation 3-8, two more 
constraints could be obtained: b = −0.00752 + 3.168 c and e = −0.0903 + 3.168 f. 
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The above examples yield four constraints on the six parameters. The remaining two 
parameters could be determined by minimizing the standard deviation of the Hct from the 
mean over some time range of measurements when no blood interference is introduced in 
any form. This is justified because, normally, Hct is constant under homeostasis (98). The 
mean value will be ≈0.1 because the assumed reference values of ϕr and ϕp are 0.004 and 
0.036, respectively. Again, it is emphasized that the assumed capillary Hct values are not 
important – what matters is the deviation of the calculated ϕr and ϕp from the reference 
values. 
With no doubt, there are various more approaches involving empirical observations 
of IE and EE modulations that are associated with known physiological effects that could 
be applied to obtain constraints on the six parameters. Already, the empirical calibration 
of the Hct model as described above could apparently lead to very stable results with 
sufficient sensitivity. However, it is imported to obtain steady IE0 and EE0. From the 
study on in vivo tissue fluorescence in Section 3.2, it is known that photobleaching 
introduces artifacts. Therefore, to unambiguously and accurately observe and interpret 
effects of blood volume changes, it is important to reach photobleaching equilibrium 
before monitoring EE and IE for quantification. Nevertheless, the measurement of 
absolute Hct could be limited in accuracy and precision if we cannot account for and 
cope with the person to person variation in autofluorescence and photobleaching 
characteristics. 
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3.3.3 In Vivo Monitoring of Hct 
3.3.3.1 Arm Swings 
To utilize and evaluate the algorithm, experiments were performed in which the 
homeostatic blood volumes are intentionally perturbed in a manner that may be 
comparable to an autonomic response to hemorrhage, e.g., shifts in peripheral body fluids. 
Of  a number of means for accomplishing such purpose (5), results for a method analog 
to “centrifugal loading” was shown in Figure 3-15. Before taking the measurements of 
Hct, test subject rotated the arm about the shoulder with the arm, elbow, and fingertips 
outstretched so that all joints and long straight members of the circulatory system have a 
projection along the centrifugal force direction. If the maneuver was properly executed, 
then the test subject could feel tingling in the fingertips after the swinging.  
Estimating the rotating arm length as >30 cm and the rotator motion as 120 rpm, we 
calculate >4 G applied force using the standard relative centrifugal force equation. For 
the results that follow, the loading was continuous for a period of at least 30 sec. Because 
G-force induced loss of consciousness (102) is known to occur as a result of transient 
application of 2-4 G forces to the human body, 30 sec of continuous motion 4 G force 
could be expected to lead to transient minor hemoconcentration in the fingertips or 
leakage through the capillary walls, just as centrifuging leads to hemoconcentration in an 
Hct tube. And this is what has been observed in Figure 3-15.  Several trials of soaking 
hand in hot water before making Hct measurement were also performed. The vessel 
dilation caused by heating, although does increase the blood volume fraction in the 
irradiation zone, is not necessarily to cause significant changes in Hct. 
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Figure 3-15: Calculated Hct based on the parameters predetermined by a separate 
calibration trial. Each point represents an averaged Hct of 20 sec of data. Baseline of the 
test subject was established before performing the arm swinging. 
 
To correlate the noninvasive approach with Hct measurement gold standard, 
conventional centrifuge fingerstick Hct measurements were obtained (103, 104) using a 
UNICO centrifuge (UNICO PowerSpin BX C884, Dayton, NJ, USA). The standard 75 
mm Drummond micro-hematocrit tubes (VWR, Radnor, PA, USA) were spun at 11000 
rpm for 5 min. All of tubes were then read by the same person for consistency in 
estimating the buffy coat.  
The conventional Hct measurements established that the absolute value of the 
difference between measurements of Hct before and after the centrifugal loading step is 
roughly three times greater than the variation in Hct readings obtained from consecutive 
samples going forward in time but without the loading in between. However, 
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hemoconcentration was not always observed for everyone. This might partially due to the 
fact that blood sampling by itself has various sources of errors (105). Moreover, the 
influence of swing arm on blood flow could also be easily dependent on the timing and 
execution of the procedure, and the time course is apparently variable. Nevertheless, the 
arm swinging procedure definitely causes blood imbalance in the fingertips. 
 
3.3.3.2 Valsalva Maneuver 
Another demonstration involves the Valsalva maneuver (106). The Valsalva 
maneuver refers to the test subject attempting to push air through any closed orifice. 
When executing the Valsalva maneuver the test subject must constrict the chest muscles 
and clench the abdominal muscles causing them to occupy a greater volume of the 
abdominal cavity. This expansion impedes the venous return of blood to the heart thereby 
decreasing net cardiac output and simulating central hypovolemia. The calculated 
changes in apparent Hct by a Valsalva maneuver are shown in Figure 3-16. 
At around 135 sec, the test subjects started a Valsalva maneuver, and on Hct trace 
after a brief increase Hct gradually decreased in the first 5 sec of the maneuver. This 
could result from the rush of blood flow due to the initial pressure wave. Afterward, the 
held pressure impeded the venous return and thus caused a pooling of RBCs. Plasma 
movements, on the other hand, although is hard and slow but not completely blocked, 
therefore resulting a slow but obvious incline in the Hct. Correspondingly, upon releasing 
the pressure, sharp drop in Hct was observed but the pooling effect needed some time to 
regain equilibrium back to steady state.  
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Figure 3-16: Typical Hct changes observed when executing the Valsalva maneuver. The 
test subject initiated the maneuver at about 135 sec and released at about 185 sec. The IE0 
and EE0 were calculated from the prebleached data earlier in the experiment.  
 
Valsalva maneuver is a fairly subtle physiological process whose influence is much 
more obvious in blood pressure and pulse rate than in Hct. Depending on how much 
pressure a test subject could exert and how long such pressure could be held, the 
amplitude of Hct change caused by a Valsalva maneuver could vary in a fairly large 
range but has been observed nearly every time. The fact that it is discernible at all using 
the proposed noninvasive Hct algorithm is surprising, which demonstrate the high 
sensitivity of the algorithm. 
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3.3.3.3 Blood Pressure Cuff 
As a final experiment, a manual blood pressure cuff was used as a tourniquet to 
induce hemoconcentration for a sufficiently long enough time to make as much Hct 
change as possible. After determining the test subject’s BP and pulse rate using an 
automatic cuff, IE and EE were collected with no applied tourniquet beyond that needed 
to maintain mechanical registration of the tissue with respect to the optical system, in 
order to define homeostasis for 60 sec.  
Then, the tourniquet brought the pressure to its final planned value within five to 
seven cardiac pulses by a single increase in pressure (in several pumps on the manual 
bulb), at around 60 sec. The final pressure was chosen to be just above the systolic 
pressure in order to insure venous occlusion, which can be confirmed with a stethoscope. 
Once complete occlusion was established, it was maintained without modification for 60 
sec. Thus, at 120 sec from establishing homeostasis, the tourniquet was released as 
quickly as possible. The associated changes in EE and IE can be seen in Figure 3-17. 
Both scattering intensities decreases gradually after the tourniquet is applied and 
rebounded quickly to their original values when the tourniquet is released. The decrease 
is ≈10% for EE and ≈20% for IE.  
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Figure 3-17: EE/EE0 and IE/IE0 versus time for application of tourniquet at t ≈ 60 sec and 
release at t ≈ 120 sec. Sufficient prebleaching was performed before data collection. 
Plasma and RBCs volume fractions and Hct, derived from this data, are shown in Figure 
3-18. 
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The resulting RBCs and plasma volume fractions, and the Hct, are shown in Figure 
3-18. Both volume fractions rise gradually during the period over which the tourniquet is 
applied, showing that the main effect is trapping blood in the irradiated volume. When 
the tourniquet is released, both volume fractions drop quickly to their pre-tourniquet 
values. The Hct, because of our parameterization, is much more constant, changing by 
only 0.5%, but also increases on application of the tourniquet and decreases on release. 
The increase, which is a little sharper than the increases in volume fractions, shows that 
relatively more red blood cells are trapped than plasma. Interestingly, the Hct shows 
some post-tourniquet effects. After release, the Hct drops to its original value, but then 
increases gradually to a value about 0.5% higher. By 200 sec, it has leveled off; the 
measurements do not go far enough to determine how long it takes to come down again. 
For direct comparison, three test subjects exercised the tourniquet maneuver using a 
blood pressure cuff pumped above systolic pressure for 2 min four times in a week’s time 
span, and meanwhile the conventional Hct determination technique was employed. For 
each subject, two to four blood samples were taken both before and after the maneuver 
each day, which yielded a total number of 61 data points, 30 before and 31 after. The 
average Hcts before applying tourniquet were 0.379, 0.372, and 0.406; whereas the 
averages after were 0.402, 0.381, and 0.414, respectively. The result is plotted in Figure 
3-19. The statistics show a clear trend of increased Hct after the tourniquet is applied.  
 
112 
 
 
Figure 3-18: Volume fractions and Hct calculated from the data of Figure 3-17. Both 
calculated volume fractions increase gradually when the tourniquet is applied and drop 
quickly to their initial values when it is released. The Hct follows roughly the same 
pattern, but shows some residual effects after tourniquet release. 
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To support the statement in a more statistically meaningful way, the null hypothesis 
is tested by splitting the raw 61 data points into two sets, 30 before and 31 during 
application, without differentiating test subjects and the dates on which the experiments 
are performed. The result yields a p-value of 0.039, which is significant at >90% 
confidence to reject the null hypothesis that assumes there is no Hct change due to the 
tourniquet. It is important to be pointed out here that within any set of personal Hct 
values, the behavior is much more consistent; thus, the statistic just quoted tends to 
underestimate the Hct change on a single person basis. Therefore, personal average Hct 
was used as a normalizer for each individual. And instead of using raw Hct, the relative 
change of Hct was used to test the null hypothesis. A p-value of 0.0219 resulted, even 
more strongly supporting the probability that Hct increases with the tourniquet applied, as 
shown in Figure 3-18. 
 
Figure 3-19: Box plot of Hct changes before and after the tourniquet experiment for three 
different test subjects. The Hct values were measured using conventional fingerstick 
method and the heights showed the mean values of about 7-10 Hct measurements for 
each bar. 
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3.3.4 Summary 
Measuring the IE and EE simultaneously and applying the algorithm leads to a 
sensitive probe for volume changes of both RBC and plasma. Obviously, a number of 
approximations have been made to demonstrate calculation of volume fractions and Hct 
from EE and IE. The first assumption is the Hct of layer b in the model. As might have 
been noticed, the absolute Hct number assumption has been changed to generate different 
a-f parameters. In the deduction of the algorithm and arm swinging experiment, an Hct of 
0.1 was assumed; while in the Valsalva and tourniquet experiments 0.3 was assumed. 
Nevertheless, in both cases meaningful Hct change predictions could still be produced. 
Since the immediate goal is to monitor changes in Hct over a long time period. Thus, the 
particular value assumed for the Hct is not very important.  
What is essentially required in this model for the algorithm to work as designed is 
for all three phases to remit detectable fluorescence at different rates per unit volume. 
When the fluorescence per unit volume of any phase changes during a monitoring period, 
as when photobleaching that has been elaborated in Section 3.2 occurs, or if the 
parameters are not well chosen to properly balance the contributions from the different 
phases to each type of remission, the algorithm can produce inaccurate results. Therefore, 
unless we can quantitatively account for or otherwise cope with the effects of 
autofluorescence and photobleaching, absolute calibration of this technique across 
patients may not be possible. Nevertheless, Leypoldt et al. (99) have demonstrated 
potentially useful clinical information having the capability to monitor relative variation 
from homeostasis of Hct and fluid volumes. 
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Lastly but importantly, the same set of parameters a-f produces from a single 
calibration has been used for different test subjects in different days to produce Hct 
predictions as shown in Figure 3-16 and Figure 3-18. Although not shown in the graph, 
Hct results of similar experiments have show surprisingly identical qualitative responses 
for any number of different test subjects spanning a wide variety of skin tones and 
textures. It indicates that it may be possible to empirically calibrate the LighTouch
TM
 
device once and still produce quantitatively accurate Hct changes across various subjects 
for a longer period of time, e.g., a month.  
 
3.4 Conclusions 
This chapter begins to tackle the empirical photophysical and photochemical 
properties of human skin autofluorescence, which are of pivotal importance to the 
implementation of volume normalization as proposed for the noninvasive in vivo human 
blood glucose measurement. The quenching of IE is laser induced photobleaching, the 
majority of which comes from the static tissue, not blood components. Nevertheless, 
blood fluorescence from RBCs and plasma under 830 nm excitation is of similar order of 
magnitude as that from static tissue, therefore optical pulses are always discernible. The 
in vivo observed photobleaching is a process that starts with a relatively quicker 
bleaching and follows a slower decay that could extend to hundreds of seconds. Once 
bleached, the tissue does not readily recover within 10
0
-10
1
 min. Therefore, a 
prebleaching process may allow for more effective use of fluorescence for in vivo data 
normalization. 
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The potential of utilizing combined IE and EE to noninvasively monitor Hct change 
is also introduced. Assuming constant blood perfusion, increase of Hct will cause an 
increase in IE and decrease in EE. However, as shown in Figure 3-17, this 
complementary IE and EE feature is no longer true when interference of blood perfusion 
and flow is introduced intentionally to an extreme level that exceeds the normal range of 
pressure that is typically applied by the PDPM. The empirical calibration of the Hct 
algorithm built based on RTE could monitor the Hct deviations reasonably well with high 
sensitivity that enables the observation of Hct changes due to Valsalva maneuver. It 
might be equally important that the algorithm also produces the plasma and RBCs 
volume. Notwithstanding the problems associated with autofluorescence photobleaching 
in producing absolute measurements, these two quantities could be used in glucose 
prediction as a better turbidity corrected volume normalizer. 
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4. IN VITRO STUDY OF ENDOGENOUS 
FLUOROPHORES 
 
4.1 Motivation 
Chapter 3 has shown that transdermal in vivo spectroscopic analysis or imaging of 
tissue analysis involving NIR excitation always produces some broadband NIR 
fluorescence. Depending on what spectroscopy is being employed, such fluorescence 
background can degrade SNR and dynamic range. Well known to originate from blood 
and various other endogenous materials associated with the static tissue, such NIR 
fluorescence of biological tissue is frequently mentioned as “autofluorescence” (107). 
The propagation of NIR light in tissue in vivo can be described reasonably well and in 
detail (10, 62, 108), nevertheless the production of fluorescence is much less so easily 
explained and little investigation is reported in the literature to clarify the exact origins 
and distribution of all of the NIR fluorophores in detail. The sources and characteristics 
of such NIR fluorescence are important to us because as stated in Chapter 3 fluorescence 
was proposed as a measure of the probed volume in the earlier work (46, 54, 81) for our 
long-term project of noninvasive glucose monitoring.  
From a chemical substance point of view, a significant amount of fluorescence might 
be associated with the two biggest absorbers and scatterers in skin, i.e., Hb and melanin 
(14, 57). In addition, substantial fluorescence is ubiquitously observed for all tissues, 
therefore commonly existed proteins such as albumin and elastin are also suspected to 
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produce noticeable fluorescence.  Advanced glycation endproducts (AGEs) which are the 
products of a chain of chemical reactions initiated with the Maillard reaction have long 
been found to fluorescence under UV/Vis excitation (109). Most importantly, AGEs level 
has been shown (110, 111) to correlate with UV/Vis fluorescence but no work has been 
done to extend the knowledge to the NIR. Therefore, it is also worthwhile to investigate 
AGEs fluorescence properties in NIR. This topic will be elaborated separately later in 
Chapter 5 due to the intriguing mechanism involved.  
In fact there are probably a number of minor contributors, porphyrins and non-
porphyrin, and this makes a complete description of the net fluorescence more difficult. 
From the experimental side, one difficulty in attempting to associate a specific amount of 
fluorescence with a particular volume of tissue in vivo is that the sample is perfused and 
so cannot be studied in the absence of blood, the single largest contributor to the net 
fluorescence on a per unit volume basis. Therefore, although it is unlikely to settle all 
relevant issues in this study, recent work directed at clarifying the origin and nature of 
such fluorescence will be presented. 
 
4.2 Experimental 
4.2.1 Methodology of the Study 
From the previous chapter, it is learned that volar side human fingertips fluoresce 
copiously under NIR excitation. Not only that, but such fluorescence also gets quenched 
about 10-15% within 10
1
-10
2
 sec with 200 mW 830 nm laser irradiation. The 
photobleaching is not a quick process but it could finally reach a relatively steady state. 
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Once bleached, no recovery is observed up to 45 min. However, repeating the same in 
vivo experiment next day on the same test subject showed no sign of revisiting the 
bleached spot from any previous experiment. It is suggested that either the bleached 
species could partially recover slowly or it could be cleared from the probed volume and 
replenished through routine metabolic processes.  
Trying to categorize the potential endogenous contributors and associate them with 
the observed NIR fluorescence, the in vitro study is guided by the aforementioned 
characteristics of in vivo human tissue fluorescence and carried out in the sequence as 
shown in Figure 4-1. First of all, for every compound under investigation the first thing to 
check is whether it fluoresces or not under NIR CW diode laser excitation. As shown 
later in Section 4.2.3.1, the concentrations used were relevant to their physiological levels 
although most of the species only have limited quantity in skin or blood. However, it is 
fundamentally the absorption ability and fluorescence quantum yield that determine and 
characterize the fluorescence activity per molecule. If these are zero or very small then 
the relevant concentration is almost always too small to make that fluorophore 
responsible for much in vivo emission. Therefore, experiments with much higher than 
physiological concentrations were also carried out to determine whether there was even 
weak fluorescence or not. 
For those species that fluoresce, experiments were further performed to characterize 
their photobleaching properties. To do that, samples were exposed to 450 mW 785 nm 
irradiation for tens of minutes while continuous spectra were collected. Without 
repositioning, samples were left in complete darkness for up to 24 hours and revisited to 
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check if there was any occurrence of fluorescence recovery. To help better interpretation 
of the data, Raman and UV/Vis absorption spectra of some species were also presented.  
 
Figure 4-1: Flow chart showing the interconnection between the in vivo and in vitro 
photochemical studies of NIR fluorescence of various endogenous species. 
 
As shown in Figure 4-1, potential contributors are divided into three different 
categories based on their NIR fluorescence properties. Type I fluorophores give 
significant fluorescence that does not bleach. Thus they participate in building up the 
solid and strong background as observed in vivo. Since autofluorescence is reported for 
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nearly all living cells, tissues and organs it seems reasonable to expect that type I 
fluorophores include at least 2-3 strongly fluorescent species that could be found 
ubiquitously throughout the whole body. 
According to Figure 4-1, type II and type III fluorophores differ in whether or not 
the bleached fluorescence recovers. Since different mechanisms may be involved for 
different fluorophores and tissues, contributions from type II and III fluorophores to the 
in vivo observed photobleaching phenomenon should be cautiously assigned bearing in 
mind the physiological and anatomical issues as will be discussed below. 
 
4.2.2 In Vitro Apparatus 
All the in vitro spectra are collected using a separate Raman spectrograph, the 
optical layout of which is shown in Figure 4-2 below. Most of the filters and focusing 
lens serve the same purpose as they do in the in vivo setup shown in Section 2.1.2 of 
Chapter 2. However, the most striking differences are the excitation laser wavelength and 
the angle of incidence. A Process Instruments (Salt Lake City, UT, USA) external cavity 
diode laser produces 785 nm excitation with a maximum power of 500 mW. The focused 
incident light is steered 90° to the vertical by a periscope and reaches the sample surface 
at normal incidence through a hole drilled in the center of a downward facing mirror. The 
100% backscattered Raman and fluorescence emission is directed back to the horizontal 
direction by the plane mirror and free space coupled by a pair of 2 inches diameter fused 
silica plano-convex lenses into the dispersion apparatus (Kaiser Holospec, f/1.4, 100 µm 
122 
 
slit width, Ann Arbor, USA) after passing through a Kaiser Super-Notch laser line 
rejection filter.  
 
Figure 4-2: Schematic diagram of in vitro experimental setup. There are two major 
differences between this and the in vivo apparatus: i) instead of 830 nm, the excitation 
wavelength used in vitro is 785 nm, and ii) in vitro spectroscopic system collects 180° 
back scattered emission. 
 
 Fused silica cuvettes (2 ml or 5 ml capacity) fabricated with side filling tubes are 
used for in vitro samples because they minimize the unwanted fluorescence and ensure 
that there is ample sample along the whole depth of focus of excitation. This design 
enables long experiment times without evaporation, thus guaranteeing a more constant 
sample volume compared to open top cuvettes. However, the fluorescence of fused silica 
requires background subtraction to isolate the sample fluorescence, and such correction is 
performed on all displayed spectra unless stated otherwise.  
So far, there is no knowledge based way to separate Raman from fluorescence other 
than an arbitrary polynomial fitting based background subtraction (53, 112-114). The 
methodology used in this study to extract Raman from the raw spectra was elaborated in 
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multiple previous publications (54, 113). Simply put, a 101-point adjacent average 
smoothing is performed on the background corrected raw spectrum which, based on 
known electronic spectroscopy and the condensed phase nature of our spectra, is 
dominated by fluorescence. Thus the wide window smoothed spectrum helps to establish 
the broadband fluorescence features. This smoothed spectrum is then subtracted from the 
raw and another narrower window 7-point adjacent average smoothing is applied to get 
the final spectrum shown in this thesis. 
But in this study we do not concern ourselves with the Raman contribution to the 
fluorescence since by exciting with 785 nm light the amount of fluorescence produced 
relative to Raman is at least 6-7 times greater and even greater compared to that produced 
using e.g. 830 nm. Thus, photon counts in the Raman shift range of 400-1900 cm
-1
, 
including undifferentiated Raman and fluorescence emissions, are integrated as one 
fluorescence data point. 
Also notice that instrument function should be applied to harvested spectra for the 
purpose of comparing features like Raman peak sizes or ratios collected on different 
apparatus. However, in our application we pay attention only to broad band fluorescence, 
and mostly the relative change of fluorescence. Therefore, no attempt is tried or needed to 
implement the instrument function correction.  
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4.2.3 Materials and Sample Preparation 
4.2.3.1 List of Materials 
The specific materials chosen for study in vitro are certainly not expected to account 
for all possible sources of in vivo fluorescence. Fluorescence is very easily detected. 
Since a very tiny amount of fluorophore could have a strong emission and there are a 
multitude of potential in vivo sources, there will always be some doubt that all sources in 
vivo have been identified. The ultimate goal is to account for the majority of the total 
fluorescence on a volume basis and a process of elimination has been started to approach 
that goal. Certain specific materials chosen were intended to either i) sample classes of 
materials that are commonly found in vivo, ii) account for materials that occupy a 
significant volume of all tissues or iii) could contain chromophores with specific activity 
in the production of NIR emission. Thus protein is ubiquitous both as structural materials, 
e.g., collagen fibers in the extracellular matrix, and active molecular species in all tissues, 
e.g., enzymes and transport proteins like albumin. 
Table 4-1 lists the cutaneous and subcutaneous constituents of human skin and blood 
tissue that are investigated. To get relevant result as reference for interpreting in vivo 
observed human skin autofluorescence, physiological concentration of each constituent 
was obtained (42). Yet, for those compounds that are found widely spread within the 
whole body, such as antioxidants, coenzymes, and collagen, the physiological 
concentrations refer to their levels in blood, interstitial fluid or in skin only. Some 
compounds, e.g., melanin, fat-soluble β-carotene and α-tocopherol, are poorly soluble in 
water as they are probably membrane bound or found in adipose tissues in vivo. In these 
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cases, stock solutions were made without knowing the exact concentrations. Various 
dilutions however were made to offer a relative comparison of the absorption and 
fluorescence capability. In this table, ×5 means five times of the physiological 
concentration. Similarly, /2 means half the physiological or stock solution concentration. 
Table 4-1: In vitro investigation of fluorescence and photobleaching properties of some 
cutaneous and subcutaneous constituents of human skin tissue. 
NAME SOLVENT 
CONCENTRATION SOURCE 
EXP. PHYSIOL. MFR CAT. # 
L-Glutathione DI water ×5, ×125 ≈1.09 mM Sigma-Aldrich G4251 
Uric Acid DI water ×2, stock 234-456 µM Aldrich 16,118-7 
β-Carotene Cyclohexane Stock, /2, /4, /25 1.23-1.75 µM Sigma C9750 
Cholecalciferol Cyclohexane 
×5, ×125, 
×3125, ×78125 
40-80 nM Sigma C9756 
L-Ascorbic 
acid 
DI water ×5, ×125, ×3125 50-60 µM Sigma A5960 
(±)-α-
Tocopherol 
Cyclohexane Stock, /4, /25 ≈24 µM Sigma T3251 
Collagen DI water 0.5-7.5 g/dL N/A Aldrich 27,160-8 
Melanin DI water Stock, /2, /4 Various Sigma M8631 
NAD/NADH PBS 
×10, ×50, ×100, 
×500, ×1000 
64 µM Sigma N3014 
Hb DI water 1.3-14.5 g/dL 12-17 g/dL Freshly harvested 
Plasma PBS Stock, /2, /3, /4 N/A Freshly harvested 
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4.2.3.2 Antioxidants & Coenzymes 
Water soluble materials, e.g., L-glutathione (reduced), L-ascorbic acid and 
nicotinamide adenine dinucleotiede (NAD/NADH), were readily dissolved either in de-
ionized (DI) water or phosphate buffered saline (PBS) with pH adjusted in physiological 
level of 7.4 (44). The solubility of uric acid is dependent on both pH and temperature 
(115). At room temp (25°C) neutral pH it only dissolves around 68 mg/L, which is about 
404 µM. In order to prepare higher concentrated samples, pH of uric acid solution was 
adjusted to a little bit alkaline (pH=8). Stable solution with two times the upper 
physiological level could be obtained. More crystalline uric acid was added to form a 
stock of an even higher concentration. However, the absolute amount dissolved was not 
known. 
For those that are not or are only barely soluble in water, such as β-carotene, 
cholecalciferol, and (±)-α-tocopherol, cyclohexane was used as the solvent because of its 
fairly flat baseline other than the six well-defined Raman peaks spanning the range of 
interest (116). Evidence of fluorescence growth could still be quite discernible even with 
the interference of cyclohexane Raman features. The nature of the study is for internal 
comparisons of fluorescence coming from one particular sample itself at various 
concentrations or under certain time of laser exposure. Therefore, constant Raman 
features from the solvent system will not bias the results in such a substantial way that 
would lead to misleading interpretation.  
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4.2.3.3 Collagen 
Commercial product of gelatin produced from porcine skin was used. Though not a 
pure form of collagen, gelatin is 98-99% protein by dry weight extracted by boiling swine 
skin, tendons, ligaments and bones in water. The transparent, colorless solid substance 
dissolves in water when heated and gels when cooled down. In this study, 0.5 g of gelatin 
was dissolved in 10 mL DI water. The sample was contained in a cylindrical plastic cup 
and put onto a water-containing glass Petri dish. An electric heater was used to offer a 
warm “water bath” for the gelatin samples for 10 min. Then the samples were let cool in 
room temperature for another 2 min. During this process, the sample was frequently 
stirred to let the air bubbles release. It was then refrigerated for around 1 hr before the 
formed gel was taken out for tests. 
 
4.2.3.4 Melanin 
Synthetic melanin is purchased from Sigma-Aldrich. This skin pigment and photo-
protector is isolated in the form of a biopolymer that does not easily dissolve in water and 
other commonly used organic solvents. Therefore, an excess amount of melanin was 
placed in DI water, stirred well and left overnight for maximal stock solution 
concentration. The stock solution produced has light brown color with black particles 
suspending throughout. Further filtration with various pore sizes filters, 20 nm, 100 nm or 
200 nm (inorganic membrane syringe filters, Whatman Ltd., UK), was performed to 
avoid accumulating additional particles apparently by precipitating from unfiltered 
sample over a long experimental period.  
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As shown in Figure 4-3(A), raw spectra for filtered samples show significantly less 
fluorescence than the unfiltered one, apparently associated with the successful removal of 
larger aggregates. The sample without filtration shows broadband melanin Raman 
features at 1380 and 1580 cm
-1
, the similar bands observed in vivo of cutaneous melanin 
(117). The Raman of filtered samples (Figure 4-3(B)) resemble with each other and both 
show less melanin Raman, indicating the dissolved melanin might have less degree of 
polymerization than that in vivo. Since the radius of melanin granules in vivo is estimated 
to be 40-50 nm (118) we used 100 nm or 200 nm filtration to preserve as much soluble 
melanin as possible.  
 
Figure 4-3: Raw (A, left) and normalized Raman (B, right) spectra for melanin solutions 
with various pore sizes of filtration. 
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4.2.3.5 Blood components 
The blood sample was extracted from a healthy volunteer into a sodium heparin 
Vacutainer
®
 tube (BD, Franklin Lakes, NJ, USA). The blood was centrifuged (3500 rpm 
for 12 min) to form a buffy coat. The supernatant plasma was removed and because it 
was not completely homogeneous, i.e., there were proteins and other materials that did 
not dissolve, a certain amount of glucose was intentionally added into it so that the stock 
plasma sample had a measurable glucose concentration (0-444 mg/dL) using HemoCue 
D-glucose meter (HemoCue Inc., Lake Forest, CA, USA). Using this as an internal 
reference provided dilution information for later sample preparation. Several drops of 
normal saline solution were then added into the remaining RBCs to wash off any lipid or 
proteins. Finally, Hb was released by adding DI water directly into hematocrit and Hb 
concentrations were measured by HemoCue Hb meter for different dilutions. Before the 
spectra were taken, Hb samples were further processed by passing through a 450 nm 
glass fiber low protein binding Durapore 
®
 (PVDF) membrane syringe filter (Millex, 
Millipore Corporation, Billerica, MA, USA) to remove any cell debris which might 
introduce additional turbidity into samples. 
 
4.3 Results 
4.3.1 Antioxidants & Coenzymes 
Raw spectra of all the six antioxidants and the coenzyme NAD are shown in Figure 
4-4, Figure 4-5 and Figure 4-6.  
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Figure 4-4: NIR spectra of three water soluble antioxidants, namely L-glutathione, uric 
acid and α-Tocopherol.  
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Figure 4-5: NIR spectra of three antioxidants that do not dissolve in water, namely β-
carotene, cholecalciferol, and (±)-α-tocopherol. Cyclohexane was used as solvent. 
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Figure 4-6: NIR raw spectra of crystalline NAD (A, top) and its solutions with various 
concentrations (B, bottom). In panel B, PBS background is buried within the spectra of 
four NAD aqueous samples with lower concentrations and thus is invisible. 
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Except for the samples with the highest concentration which also showed their 
corresponding Raman features, others showed no difference from the background. 
Considering their low physiological concentrations, these antioxidants and coenzymes 
could not contribute to the observed human fingertip autofluorescence under NIR 
excitation. 
 
4.3.2 Collagen 
Figure 4-7 shows a raw spectrum accumulated over 10 min for gelatin powder. As 
shown in the top panel, the broadband fluorescence stretches through the whole spectra 
range with Raman features visible on top. This feature is obviously absent from the 
aforementioned spectra for the pure form antioxidants and coenzymes in Section 4.3.1. 
Not shown in Figure 4-7 top panel is the flat baseline. Due to the dramatically different 
amplitudes, such baseline is indistinguishable from the x-axis and thus is left out. The 
bottom panel showed the Raman spectra for the same solid gelatin. The strong protein 
peaks, i.e., amide I and amide III around 1668 and 1248 cm
-1
, are obvious and consistent 
with literature (119).  
Not surprisingly, the fluorescence shown in Figure 4-7 is also concentration 
dependent in jelly form samples. Figure 4-8 shows the fluorescence integral growth with 
increasing gelatin concentrations used to prepare ten samples. Although the data has a 
noticeably big standard deviation, a linear fit still yield a correlation coefficient of 0.8 
with a positive slope.  
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Figure 4-7: Spectra of gelatin powder with 10 min accumulation. (top) Raw spectrum; 
(bottom) 101-7 smoothed Raman spectrum. 
 
Empirically, the big variation might result from experimental difficulties. Collagen 
gels were transparent and propagation of the laser within the gel could easily be seen by 
the naked eye. The penetration depth, i.e., probed volume, plays an important role in 
determining the yield of fluorescence. To guarantee relatively consistent thickness of the 
gel samples, customized parallel blades were used to cut the gelatin into a rectangular 
block with a fixed thickness of 12.5 mm. However, at lower gelatin concentrations the 
samples contained more water and the watery texture was hard to handle. This partially 
explains the relatively larger calculated residuals for samples contain less than 0.5 g 
gelatin per 10 ml water. Therefore, for the purpose of photobleaching experiment that 
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will be presented next, samples were prepared to contain 0.5 g gelatin per 10 ml water for 
the convenience of handling. 
 
Figure 4-8: Fluorescence integral growth with increasing gelatin concentrations in jelly 
form. The gelatin concentrations increased by 0.1 g per 10 mL water. The third sample 
was left out as an outlier. Each spectrum was accumulated for 10 min. 
 
Three bleaching curves are shown in Figure 4-9. Sequence 1 got the laser exposure 
first and showed a substantial amount (around 8%) of quench in its fluorescence. After 85 
min of recovery in complete darkness, although the similar photobleaching pattern was 
expected, however, sequence 2 and 3 showed only randomly changing fluorescence 
integrals. Other sets of results from similar experiments also could not give definite 
answer on whether gelatin, i.e., collagen, fluorescence recovers or not. 
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Figure 4-9: Three 1 hr bleaching curves for gelatin. The used gelatin concentration was 
0.5 g/10 mL water and spectra were collected every 2 min. Sequence 1 was collected first 
and followed by an 85 min recovery period, during which the sample was left in complete 
darkness. Then sequence 2 and 3 were collected continuously afterward.  
 
It is also an empirical fact that gels have some texture change issues if allowed to set 
in air for substantially long time. To obtain the data shown in Figure 4-9, the gelatin 
sample was left in air for a total time of almost 4.5 hr. Upon finishing the whole 
experimental procedure, noticeable sign of dehydration had been observed. To evaluate 
to what extend such texture change brought to the observed fluorescence, a control 
experiment was performed following the exact procedure but without laser exposure 
during the period of the three bleaching sequences in Figure 4-9. 
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Figure 4-10: Gelatin control experiments showing texture variation during the 
experiments had nonnegligible influence on the fluorescence integrals. 
 
As shown in Figure 4-10, three 2 min spectra were collected corresponding to three 
different times along the procedure: i) at the beginning of sequence 1, ii) during the 
recovery period, and iii) at the end of sequence 3. The range of fluorescence variation for 
the control group is similar as that for the bleaching experiments. The patterns are also 
analogous to each other. It is suggested that the influence of gel texture could not be 
overlooked when interpreting either the bleaching or recovery results shown in Figure 4-9. 
Laser radiation also introduces artifacts by heating and thus probably melting of the 
gelatin samples. There is no evidence that the same physical sample is being tested on 
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successive trials due to melting and resulting physical redistributions of the material, 
therefore bleaching cannot be evaluated. 
Despite of the ambiguity of the bleaching property of gelatin it is clear that collagen 
fluoresces significantly under NIR excitation. Actually, in the timescale of an in vivo 
experiment, collagen does not show discernible bleach as shown in Figure 4-11. 
Therefore, it is evident that as a major constitute of extracellular matrix the structural 
protein collagen contributes as type I fluorophore to the in vivo observed fluorescence 
under NIR excitation. 
 
Figure 4-11: Fluorescence of three gelatin samples measured on different days using in 
vivo apparatus showing no sign of photobleaching during a 100 sec short period of time. 
Y-axis has an offset.  Before offset, the average fluorescence of each 20 ms frame was 
3053, 2221 and 2350 respectively. 
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4.3.3 Melanin 
Melanin, a chromophore carried in melanocytes, is one of the main light-absorbing 
pigments in skin and is present only in stratum basale of the epidermis, i.e., it is not 
possible to excite blood without also irradiating melanocytes. As a skin photoprotectant, 
melanin absorbs UV/Vis radiation and disperses the energy through ultrafast internal 
conversion as heat. Microscopically, melanin is a granular biopolymer which is an 
aggregate of smaller component molecules. The melanin granule also has a much higher 
refractive index and therefore behaves as a strong scatterer as well as an absorber (108, 
120). The fluorescence of melanin under multi-photon excitation has long been observed 
(121, 122), and it has been acknowledged as one of the major endogenous fluorophores 
of human skin under UV/Vis excitation. 
Figure 4-12 shows the melanin fluorescence spectra under NIR excitation. The 
Raman and fluorescence from the cuvette and DI water is obvious. Nevertheless, the 
growth of broadband Raman (Figure 4-12(A)) from melanin at 1380 and 1580 cm
-1
 
almost makes the cuvette Raman at 1650 cm
-1
 a shoulder peak in the stock solution. 
Fluorescence integrals for various melanin concentrations were calculated after the 
background emission from the DI water containing cuvette was subtracted. As shown in 
Figure 4-12(B), melanin fluorescence by NIR excitation increases linearly with 
concentration.  
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Figure 4-12: (A, left) Raw spectra of melanin solutions (30 min accumulation each) at 
various concentrations with 100 nm pore-size filtration; (B, right) Linear fit of 
fluorescence integrals vs. concentration for melanin. All spectra have DI water 
background subtracted. Correlation coefficient equals 0.999. 
 
Figure 4-13 shows the bleaching curves for 200 nm pore-size filtered water soluble 
melanin. For both curves, NIR irradiation caused a quench around 25-30% from its 
original fluorescence. After 2 hr of exemption from the laser irradiation between the first 
and second exposure, fluorescence integral almost stayed where it was indicating no 
obvious recovery. Although not shown here, a 24 hr recovery time was also tested and 
still the same was observed. 
141 
 
 
Figure 4-13: Photobleaching of 200 nm pore-size filtered melanin solution. 2 hr recovery 
time was allowed between the first and second exposure. 
 
As a photoprotectant, melanin is susceptible to get oxidized by exposure to light with 
the generation of hydrogen peroxide in the photochemical process. It has been reported 
(123) that oxidation of melanin molecules causes it to fluoresce under UV/Vis excitation. 
Thus, the role of oxygen in NIR melanin fluorescence was studied by purging oxygen 
and argon till saturation in the melanin solutions. Results are shown in Figure 4-14. 
Oxygen purged sample shows no difference in the rate of bleaching from that without any 
gas purged. It is indicated that oxygen is not involved in the mechanism of melanin 
photobleaching in the same way as pentosidine that will be demonstrated in Figure 5-17 
in Chapter 5. 
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Figure 4-14: Bleaching curves of melanin with argon or oxygen purge.  
 
Once again, it should be emphasized that the melanin samples used in this in vitro 
study are highly diluted water soluble solutions. The in vitro observed NIR melanin 
fluorescence may have limited relevance to the in vivo observation. As a strong absorber 
the melanin absorbance increases exponentially toward the UV/Vis range (124). The 
absorption of melanin in the NIR is extremely weak. Besides, its fluorescence quantum 
yield is also low, i.e., in the order of 10
-4 
(125). To this extend, melanin NIR fluorescence 
may not be a dominant factor in vivo. It is also an empirical observation that test subjects 
with difference skin tones do not always necessarily produce fluorescence that could be 
related with melanin levels, i.e., the darkness level. Melanin is also known as a tough 
substrate to be broken down through natural biodegradation process (126).  Thus, 
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unrecoverable bleaching of melanin would have an accumulative effect on test subjects 
who frequently participated in this study, i.e., the more often a test subject is exposed to 
the NIR laser, the less his/her fingertip fluoresces. However, no such photobleaching 
effect has ever built up within the normal metabolic period of skin. Therefore, as a type II 
contributor to the in vivo human skin autofluorescence, its contribution to the observed 
photobleaching might also be limited.  
 
4.3.4 Blood Components 
As shown in Figure 4-15, plasma produced copious NIR fluorescence. By contrast, 
although not shown here, the NIR fluorescence of the Hb samples actually decreases as 
the increase of Hb concentrations. However, it should be noticed that in the NIR spectral 
range, Hb absorbs more than 10 times of plasma (10). The mismatch of the refractive 
index of the cuvette and the Hb samples formed a shielding effect that reduces the 
contribution of the cuvette while the Hb fluorescence increases. Less incident light 
reaches the cuvette as the Hb concentration increase. Actually, Hb fluoresces but the 
contribution to the total is not adequate to replace the cuvette fluorescence that decrease. 
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Figure 4-15: NIR fluorescence of plasma at various concentrations. Both raw spectra (A, 
left) and linear fit to fluorescence integrals (B, right) are presented. Fifteen 1 min spectra 
were collected for each concentration. The relative percentages were calculated based on 
the glucose added in to the plasma stock solution as an internal reference. 
 
Nevertheless, evidence of Hb fluorescence could be suggested in the bleaching 
experiments shown in Figure 4-16(B). An obvious trend of fluorescence loss can be 
observed in Hb solutions, while in plasma solutions (Figure 4-16(A)) no such pattern is 
shown and total fluorescence fluctuates randomly. This indicates that it is Hb, not blood 
plasma, that contributes the most to the photobleaching in whole blood. In Hb samples, 
about 50% of fluorescence loss happens in the first 5 min. Although photobleaching 
slows down thereafter, there is no sign for the total fluorescence to become stable at 20 
min. The rate of photobleaching is observed to increase with the increased concentration 
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of Hb. The most concentrated sample, which has an Hb concentration of 7.2 g/dL 
(normal range for human blood Hb level is 12-15 g/dL) bleaches the quickest.  
 
Figure 4-16: Photobleaching study of plasma (A, left) and Hb (B, right). The rate of 
bleaching is concentration dependent for Hb samples. 
 
To characterize the bleaching properties of Hb NIR fluorescence, the Hb sample was 
put under laser exposure for 15 min and then left in the same place but without laser 
exposure to allow any possible recovery for 1.5 hr before the collection of the second 
spectra sequence. As shown in Figure 4-17 although not fully recovered, the total 
fluorescence did mostly restore back and the whole bleaching process could be repeated. 
Another similar overnight experiment also shows the same phenomenon, demonstrating 
that the observed Hb photobleaching is recoverable, or in other words, is reversible.  
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Figure 4-17: Recovery study of Hb photobleaching. The sample was left in complete 
darkness for 1.5 hr for possible NIR fluorescence recovery. 
 
The photochemical explanation for the observed Hb photobleaching phenomenon is 
not fully understood. But, aggregation of Hb under laser exposure is observed in higher 
Hb concentration samples that are close to physiological level (not shown). As a strong 
absorber, whose absorbance coefficient is at least 10 times larger than that of plasma at 
785 nm excitation, the aggregation further facilitates the absorption of excessive laser 
energy. As reported by Puppels (21, 127) and Franzen (128), a photo-induced 
aggregation phenomenon could cause the observed Raman spectra of single RBC to 
change with exposure time. Aggregation of large metal containing molecules in low lying 
but excited electronic states, perhaps of high spin multiplicities (90) and intrinsically long 
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emission lifetimes, would certainly create a very large density of vibronic states in which 
to thermalize electronic excitation and quench fluorescence. 
To summarize, similar to collagen, plasma is a type I contributor to the in vivo 
observed human skin autofluorescence. While the bleaching and recovery properties of 
Hb suggest that the emission from whole blood, reaches a steady state in vivo when the 
laser induced emission is balanced against the photobleaching. Heart driven pulses are 
always observable in vivo and so equilibrium is apparently reached very quickly, relative 
to heart rate and blood flow rate in vivo. 
 
4.4 Discussion 
It should be pointed out firstly that in vitro solution environments, such as for Hb 
and melanin, are by no means comparable to their in vivo ones, no matter how 
concentrated the samples could be. Therefore the nature of the tissue fluorescence cannot 
be described unequivocally in vitro. For example in tissue, i.e., RBCs, Hb is tightly 
packed into erythrocytes, approximately 270 million per cell. Thus, biomolecular 
photochemistry within a RBC is likely to be much faster and more efficient than any in 
vitro environment which must be more dilute. Therefore, although the photodynamics 
observed here is capable of offering reference to in vivo phenomenon, it is only partially 
representative and should be interpreted warily in the context of in vivo observations.  
A variety of antioxidants and free radical scavengers, i.e., vitamins and coenzymes, 
were also tested in vitro. Functionally important in vivo (129), surprisingly these 
materials generally do not produce NIR emission despite producing copious UV/Vis 
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emission. So while not every known metalloprotein was tested, the mere presence of 
amide linkages without any metal present, even thousands of them, does not seem to offer 
an explanation for the fact that nearly every protein displays some NIR fluorescence.  
Endogenous and exogenous porphyrins (130) may also contribute as porphyrins are 
well known to produce copious fluorescence  under either UV/Vis (123, 124, 131, 132) 
or NIR excitation. However, their fluorescence properties were not studied since 
cytochrome species that are found exclusively in the static tissue, i.e., cytosol and 
mitochondrial membranes, exist only in extremely small quantities (≈3 nM porphyrins 
per gram tissue) in skin (133, 134).  This is not surprising since most of the natural 
porphyrins in human body are metabolic intermediates, such as protoporphyrin, and 
photochemical reactions upon irradiation produce reactive oxygen species (ROS) that are 
toxic to cells.  Bacteria are known (130, 131) to produce porphyrins on the skin that for a 
given test subject could be significant. However, fingertips skin tissue is less prone to 
have abnormal overproduction of porphyrins through this pathway than facial skin as 
inflammation and acne vulgaris (135). Therefore, endogenous porphyrins are probably at 
most a minor contributor to the net in vivo fluorescence.  
As shown in Figure 4-13 the melanin fluorescence does not recover but for the 
specific in vivo experiments it is noted that there is much less melanin on the volar side of 
fingertip skin, i.e., ridged skin is generally weakly pigmented if at all. Therefore, it is 
concluded that most of the observed fluorescence does not originate with melanin. 
Anecdotally strongly pigmented fingertips have only been observed in certain people, e.g., 
from the Indian subcontinent, but for most test subjects the pigmentation of ridged skin 
actually is very low. Furthermore sun induced pigmentation, i.e., sun tan, requires tens of 
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hours to develop and this timescale is also in disagreement with the in vivo characteristics 
of the fluorescence recovery that have been observed. 
It is commonly stated in the cosmetic literature that natural exfoliation limits the 
lifetime of viable skin cells to about 28 days. Clearly this depends on the type of skin, i.e., 
smooth body or facial skin is probably well described with ridged skin having a longer 
lifetime. So skin that is bleached today is unlikely to be exfoliated completely by the next 
day. Since the penetration is greater than the thickness of the nonviable and viable tissue, 
i.e., 500-700 µm, the bleached spot should be able to be detected if that is the site of 
bleaching chemistry and it does not repair overnight. Since we never have had evidence 
of detecting a bleached spot under such conditions the contribution of the melanin to the 
bleaching does not seem significant. 
Even the dead outer cells of the stratum corneum in direct contact with the 
atmosphere cannot be guaranteed to remain attached to the irradiated surface. Therefore 
to obtain the result which is always observed in vivo it is suggested that the bleaching 
behavior occurs below the outermost layers of cells whether they are viable or not. Thus 
on the basis of direct in vivo observations and comparison with specific in vitro materials, 
it is suggested that the fluorescence from so called “static tissue” mostly originates from 
the cells and extracellular spaces and fluids in contact with the viable tissues.  
Most commercially available proteins like gelatin or bovine serum albumin fluoresce 
although it is possible that they could contain preservatives, e.g., antioxidants, and 
impurities, e.g., ash. However, according to the manufacturer there are no preservative 
impurities and the ash is an extremely small percentage of the material so these do not 
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seem to be viable sources of the observed emission. It should be also noted that many 
proteinaceous materials as well as nonproteinaceous materials are purified on sucrose or 
sepharose columns and these could promote the formation of AGEs as will be discussed 
later in Chapter 5. Therefore freshly harvested serum and plasma were tested. These 
samples were also found to fluoresce but it is difficult to obtain either plasma or serum in 
vitro that absolutely contains no residual Hb. Therefore, to date it is hypothesized that 
plasma has intrinsic fluorescence separate from that of RBCs but that it apparently does 
not bleach. On this basis we suggest that in vivo the bleaching of blood that is not 
impeded in its cardiac driven motion is not as important as tissue bleaching. 
 
4.5 Conclusions 
The presence of ubiquitous NIR fluorescence from human skin in vivo is well-known 
but poorly understood at least partly because there are many potential sources with only 
limited means for separating the different contributions. In this chapter, in vitro study on 
the photochemistry of various blood and static tissue constituents was performed in an 
effort to narrow down endogenous sources of the observed in vivo spontaneous NIR 
fluorescence from biological tissues. Of all the substances investigated in this chapter, 
four of them stand out, namely collagen, melanin, plasma and Hb: two major static tissue 
constituents and two major blood proteins. The major skeletal protein in static tissue, e.g., 
collagen, and another important blood protein, e.g., plasma, contribute significantly to the 
non-bleachable part of the baseline in vivo observed skin autofluorescence. Based on in 
vivo observations at the site probed, it is suggested that melanin fluorescence though not 
151 
 
negligible has only limited influence. Hb fluorescence bleaches but also recovers quickly, 
thus it is more likely to form a dynamic equilibrium with cardiac pulses during in vivo 
measurements. However, no observations or statistics have been reported supporting the 
idea that these tissue constituents vary in some way between healthy and diabetic patients. 
But, as shown in Figure 3-8 in Chapter 3, it has been observed in vivo that there is 
considerable difference between the autofluorescence and bleaching properties of healthy 
and diabetic patients. Therefore, the photochemistry of another potential fluorophore, e.g., 
AGEs, needs to be investigated. 
 
 
 
 
 
 
 
152 
 
5.  PHOTOCHEMISTRY OF ADVANCED 
GLYCATION ENDPRODUCTS (AGES) 
 
5.1 Advanced Glycation Endproducts (AGEs) 
5.1.1 Motivation of AGEs Study 
It was established in Chapter 3 on the basis of in vivo experiments on human volar 
side fingertip skin that: i) the majority of the photobleached fluorescence does not 
originate within blood, ii) the bleaching (1/e point) occurs in 10
1
-10
2
 sec timescale with 
200 mW 830 nm excitation, and also iii) a photobleached region remains bleached for at 
least 45 min but recovers completely within several hours. From the in vitro 
investigations of various tissue and blood constituents in Chapter 4, it was shown that 
among the constituents that fluorescence under NIR excitation, e.g., collagen, plasma, 
melanin, and Hb, only the last two show the trend of photobleaching.  
In vitro experiments suggest that when disconnected from biochemical processes 
characteristic of metabolic homeostasis, Hb photobleaching is reversible whereas melanin 
is not. However, melanin production requires longer than days to accumulate, resulting in 
inconsistency with respect to the timescale of the fading of the bleached spot observed in 
vivo. Combining these with the fact that volar side ridged skin is not usually strongly 
pigmented it is suggested that the majority of the bleachable fluorescence that recovers 
on a several hour to 1 day timescale may be associated with something else. 
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Among the different ethnic groups encountered, African American, some Indians 
and Hispanic subjects are more pigmented than Caucasian and Asian. However, in vivo 
spectra collected for tens of test subjects that participated in this study for the past several 
years have indicated that the baseline IE is not necessarily positively related with skin 
melanin levels. By saying baseline IE, it means the part of IE that is not modulated by the 
blood movement. What has been observed in a systematic way is the excessive IE for 
senior and diabetic patients, similar as what has been reported by others (136). 
 
Figure 5-1: IE integrals collected on the same day for four individuals showing the 
fluorescence from senior and diabetic patients are stronger than others. Six and eight data 
points are used for non-diabetic and diabetic subjects respectively. Upper and lower 
edges of box represent 75
th
 and 25
th
 percentile. Smaller square represents mean value. 
Top and bottom whiskers represent maximum and minimum data respectively.  
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Figure 5-1 shows the in vivo IE integrals for four subjects collected on the same day 
under the PDPM settings that are optimal for each individual respectively so that 
differences cannot be attributed to differing blood content, i.e., perfusion. Within the 
same ethnic group, diabetic patient fluoresces significantly more than healthy people. 
Though not as distinctive, senior test subject also tends to produce more fluorescence. 
Such tendency leads us to seek age or diabetes related endogenous tissue constituents that 
have potential to contribute substantially to the in vivo observed fluorescence. 
Advanced glycation endproducts, or AGEs, are a family of complex and reactive 
compounds that result from a chain of chemical reactions started with a glycation 
reaction (137, 138), i.e., a reaction between certain amino acid side chains, e.g., lysine or 
arginine, and various sugars, e.g., ribose and glucose. After the formation of AGEs, the 
accumulation in the tissues is dependent on the half-life of the proteins to which the 
crosslink is bound (139). Therefore, on long-lived proteins like skin collagen, AGEs 
accumulate over the lifetime. In the AGEs family, compounds like N-carboxy-methyl 
lysine (CML) and pentosidine are known to be highly fluorescent in UV/Vis spectral 
range. But before this work there was no knowledge of the photochemical behavior under 
NIR excitation. Therefore, it was necessary to investigate the fluorescence features of 
these compounds under NIR excitation in order to hopefully shed some light in 
explaining our in vivo observations.   
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5.1.2 Endogenous Formation Pathways of AGEs 
The formation of AGEs is part of normal metabolism in vivo. Although 
physiologically there is more than one pathway leading to the ultimate synthesis (109, 
140), they all include a glycation step at the early stage, which is called the Maillard 
reaction. This chemical reaction involves bonding and crosslinking between amino group 
containing compounds, such as proteins and amino acids, and the carbonyl group of 
reducing sugars. During this process chemically reversible early glycosylation products 
with proteins, such as Schiff bases and Amadori adducts, are formed. Over time, these 
intermediate products undergo slow and complex processes comprising condensation, 
rearrangement, fragmentation, and oxidation reactions to finally form AGEs. At this stage, 
the alteration of circulating, cellular, and extracellular matrix proteins is final and 
irreversible.  
Of all reducing carbohydrates and sugars in protein glycation, the physiologically 
relevant D-glucose is one of the least reactive. That is possibly an evolutionary reason 
why it is the most important free sugar in vivo being widely used in organisms as a source 
of energy (141). While by contrast, it is well known that D-ribose is much more reactive 
in the Maillard reaction (109, 142) due to a higher fraction of the more reactive acyclic 
form. However D-ribose does not elevate in human but D-glucose does when excessive 
carbohydrates are consumed. Pooling of dietary D-glucose in interstitial fluid or blood 
flow has been proved to result in an elevated AGEs level (139, 143, 144). Albeit at a 
slower rate, AGEs formation in vivo from glucose is possible through oxidation of 
glucose to arabinose or even ribose (145). 
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As shown in Figure 5-2, dietary glucose goes through the pentose phosphate 
pathway which reduces hexoses into ribose-5-phosphate, and further into pentoses, such 
as ribose. Although there may be other established metabolic pathways that connect 
glucose to more reactive sugars, the point here is that ribose is always available for new 
AGEs formation to replace prior AGEs within hours if they are consumed by the 
photobleaching reactions reported earlier in Chapter 3. Then through the Maillard 
reaction, these reducing sugars build crosslinks with the free amino groups of protein and 
form intermediates. A variety of other AGEs are eventually generated by more thorough 
and complicated oxidation of these precursors within living organisms.  
 
Figure 5-2: One possible endogenous pathway of AGEs formation from the free sugar D-
glucose. 
 
5.1.3 Clinical Aspects of AGEs 
There are three different mechanisms by which AGEs contribute to some long-term 
diseases and complications (139): i) binding and crosslinking with a primary amino group 
of a protein; ii) interaction with AGE receptors (142, 146); and iii) binding to lipoproteins. 
Of the three mechanisms, the first one brings detrimental pathogenetic effect even in the 
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process of AGEs formation. Upon bonding with structural protein within the extracellular 
matrix, e.g., collagen, related tissue and organs lost their original elasticity. In vascular 
system, increasing stiffness leads to angiosclerosis and related cardiovascular diseases. In 
tissue, AGEs could cause widespread damage through up-regulation of inflammation and 
oxidative stress.  
As will be shown in Table 5-1, AGEs exist in almost every tissue and organ within 
human body, with higher concentrations in cartilage, dura mater, vascular base membrane, 
skin, and the circulatory system. By nature protein glycation is a slow process; however 
the lifetime of AGEs is determined by the protein to which they are bound. In the 
circulatory system, e.g., the blood stream, the turnover times for both albumin (15-20 
days) and Hb (120 days) are short (147-149). Therefore, the best known AGE 
hemoglobin H1c (HbA1c), is a biomarker for the 120-day moving average of plasma 
glucose concentration (150, 151). Yet in long-lived protein as collagen or other structural 
materials, AGEs could stay for the life time of the organism due to their low clearance 
rate in kidney (152). It has been well established (143, 153) that AGEs build up with age 
and the accumulation is increased under long-term hyperglycemia, which is common for 
many diabetic patients. 
Excessive accumulation of AGEs in long lived tissues is believed to play a pivotal 
role in diabetes (154-156), and even a causative factor in several other age related chronic 
diseases, such as vascular disease, cardiopathy, neuropathy, nephropathy, retinopathy, 
cataract, and arthritis (137, 138, 157-159). On the other hand, monitoring the UV/Vis 
fluorescence of AGEs has been proposed as a marker of inflammation and oxidative 
stress in renal failure in kidney transplant, or as a substitute for the HbA1c as an indicator 
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of diabetes duration and time-averaged glycemic status in diabetes mellitus (91, 111, 160-
162). 
 
5.1.4 Pentosidine and Tri – Mixture (TMX) 
Among the entire AGEs family (163), pentosidine is one of the most frequently 
studied molecules and has been proposed by Monnier and Sell (153, 160) as a 
prototypical AGE. In vivo pentosidine is derived from a pentose crosslink between 
arginine and lysine residues in collagen. In late 1980s, Monnier first isolated pentosidine 
in human collagens and other tissue proteins (153).  
Table 5-1: Summary of pentosidine levels in different tissues (153). 
TISSUE 
YIELD 
(nmol/g) 
TISSUE 
YIELD 
(nmol/g) 
Dura mater 117 Skin 27 
Tracheal cartilage 142 Cortical bone 9 
Aorta 33 Cardiac muscle 29 
Lung 29 Liver 12 
Kidney medulla 25 
Purified isolated glomerular basement 
membrane 
21 
Red blood cells 10 Blood proteins 8 
Lens 0.7 
Placenta (commercial type III, IV, V 
soluble collagens) 
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As shown in Table 5-1, it is ubiquitous in all tissues this noninvasive spectroscopic 
study is interested in, namely skin, RBCs, and blood proteins. Similar to other AGEs, 
pentosidine is also found to accumulate in tissue (primarily forms crosslink with collagen) 
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with age (143, 144). Its association with aging related processes diseases and diabetes has 
been declared over the past decades by multiple individual research groups (155, 160, 
164, 165). 
The structure of pentosidine molecule is shown in Figure 5-3. Residues from 
arginine and lysine are attached to the core imidazo pyridinium ring. Obtaining adequate 
quantities of pure pentosidine with which to explore properties and processes relative to 
NIR photobleaching effects in skin is presently not practical since the published 
syntheses are currently beyond our skill level. Pentosidine is commercially available 
though very rarely; it is extremely pricy (2 mg for $450, 5 mg for $1000) and might 
contain impurities from living tissues that preclude performing spectroscopic 
investigations.  
 
Figure 5-3: Molecular structure of pentosidine. Pentosidine could be synthesized 
exogenously by heating up ribose, lysine, and arginine and then be purified from this 
TMX. The structure shows the apparent residues from the two amino acids and the ring 
structure from the pentose. 
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Alternatively, pentosidine can be formed following the approach proposed by 
Monnier (109, 153, 160). Theoretically, all reducing carbohydrates, pentoses, hexoses, 
and even disaccharides can potentially be involved in the Maillard reaction and ultimately 
form AGEs. D-ribose is the sugar counterpart in most of the in vitro studies, not only 
because it reacts 30 times faster than D-glucose but also because of its 10 times higher 
yield. Therefore, in this study an aqueous solution termed as the “tri-mixture” (TMX) is 
produced in order to study the photochemistry of pentosidine.  
TMX is produced by heating L-lysine, L-arginine and D-(-)-ribose in phosphate 
buffered saline (PBS) solution at 65 °C for at least1 hr under continuous stirring. Further 
purification of this TMX is available (166) but at extreme reduction of net yield. 
Nevertheless in living tissues AGEs are accompanied by variety of intermediates. Thus, 
keeping the unpurified form of TMX could be more appropriate for exploring the source 
of our in vivo observations. As will be shown in Section 5.4, this solution displays many 
of the properties of skin NIR autofluorescence photobleaching and it allows some in vitro 
experiments that we hope will shed some light on the in vivo photobleaching process and 
our hypotheses concerning volume normalization.  
 
5.2 Singlet Oxygen (1O2) Chemistry 
5.2.1 Triplet Oxygen (3O2) & Singlet Oxygen (
1
O2) 
Energetically more favorable, the oxygen molecule has a triplet ground state (
3
O2), 
which is unusual for the vast majority of other molecules. When excited, 
3
O2 can get to 
two singlet excited states, 95 kJ/mol and 155 kJ/mol above the ground state respectively. 
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However, in the condensed phase the singlet state which is 155 kJ/mol above the ground 
state is not significant because of the increased chance of radiationless deactivation to the 
lower 95 kJ/mol singlet state. Therefore, 
1
O2 is usually referred to the lower lying singlet 
excited state of molecular oxygen.   
Among the few species that exhibit a triplet electronic ground state, molecular 
oxygen is the one that actively participates in a variety of chemical and biochemical 
processes. During the normal metabolism of oxygen, the natural byproduct 
1
O2 is 
generated, which has been known to play an important role in cell signaling and 
homeostasis (167, 168). In fact 
1
O2 is way more reactive than ground state oxygen. It can 
initiate a plethora of events that lead to cell death. Therefore, one of its major clinical 
applications is to kill cancerous cells in photodynamic therapy (PDT) (169-172). In this 
radiation treatment, 
1
O2 sensitizer is injected into the blood flow and depending on the 
absorption property of the sensitizer either UV/Vis or NIR radiation from a laser or light 
emitting diode (LED) is guided to the site of operation. When radiated, the sensitizer 
excites the oxygen molecules in the surrounding tissue to 
1
O2. Malignant cancer tissue 
and cells are characterized with high metabolic rate, thus are over-plethoric and highly 
oxygenated. More 
1
O2 molecules are generated in cancer than in normal tissue. Therefore, 
an effective treatment is achieved. 
 
5.2.2 Photosensitized Process of 1O2 Formation 
1
O2 could be generated by direct photoexcitation from triplet ground state oxygen 
(173). Alternatively, energy could be gained during the collision of 
3
O2 with another 
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excited molecule to ultimately form reactive 
1
O2. The whole process always includes a 
step that enables the nonradiative transitions between two electronic states with different 
spin multiplicity, which is known as intersystem crossing (ISC).  
 
Figure 5-4: Normal processes of electron interaction with light inside a molecule. Most of 
the time the ground state (blue curve) of a molecule has singlet spin coupling. (S: singlet; 
T: triplet) Although not always favorable, the energy could be transferred to a 
neighboring triplet excited state through ISC. 
 
As shown in Figure 5-4, normally the absorption of photon(s) excites a ground state 
molecule to its singlet excited electronic state. Most of the time, the energy of absorbed 
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photons is directly spent on fluorescence emission. However, for some heavy-atom 
molecules, such as metal containing porphyrins and some iodine/bromine bearing 
molecules, overlapping singlet and triplet excited vibrational levels exist. In this case, the 
probability of ISC occurring is more favorable. Thus, the absorbed energy is transferred 
from the singlet excited state to a metastable excited triplet state without any photon 
emission.  
ISC is one of the slowest forms of relaxation with a time scale on the order of 10
-8
 to 
10
-3
 sec (174). In an isolated molecule, as a result of ISC, energy is trapped in the triplet 
state since the electron transition from an excited triplet state to a singlet ground state is 
quantum mechanically forbidden. However, phosphorescence still occurs at a 
significantly slower rate (10
3
 to 10
0
 sec) for such “forbidden” transition (85). In a solvent 
system where molecular oxygen is present, the trapped energy could be transferred to the 
ground state oxygen through the well-known triplet-triplet annihilation (TTA) process, 
which gives rise to 
1
O2 (175). A schematic drawing of this complete process of 
1
O2 
photosensitization is shown in Figure 5-5. It is also the working principles of 
photodynamic therapy (PDT) in treating cancer (172, 176). 
Molecules that are capable of generating 
1
O2 by photosensitizing 
3
O2 are called 
singlet oxygen sensitizer, or photosensitizing dye. To be a singlet oxygen sensitizer, the 
molecule should first of all have two overlapping singlet and triplet excited states, since 
in the ISC transition little or no energy must be gained or lost. In addition, the triplet 
excited state of a sensitizer should be slightly higher than that of 
1
O2 relative to the 
ground state to achieve effective energy transfer (177). Finally, its lifetime should be long 
enough to undergo the TTA with ground state oxygen. For a sensitizer to be used in in 
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vivo PDT, not only should it be water soluble but also be able to exhibit a high quantum 
yield of 
1
O2, leading to the death of a cell or biological tissue. Hypericin, rose bengal 
diacetate, and methylene blue are all among the most efficient reagents for 
1
O2 generation. 
 
Figure 5-5: Schematic drawing of singlet oxygen photosensitization. S0: singlet ground 
state; S1: singlet excited state; T: triplet state; S: singlet state. Destination of the energy 
from the absorbed photons: 1) emits as fluorescence; 2) goes through ISC, TTA and 
finally excite the 
3
O2 to 
1
O2. 
 
5.2.3 Detection of 1O2 
Singlet oxygen can be directly detected by its characteristic NIR luminescence at 
1270 nm, corresponding to its lower singlet state at 95 kJ/mol. The chemiluminescent 
emission is so weak that highly sensitive optical system is needed in order to detect it. 
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Such system usually has a high power fast repetition rate Nd:YAG pulsed laser source 
and an IR sensitive photomultiplier (169, 171). In low pressure gas phase, 
1
O2 has an 
extremely long lifetime around 72 mins (178). In condensed phase, however, its lifetime 
is significantly shortened to microseconds or even nanoseconds (179), and is highly 
dependent on the medium. In water, the lifetime of 
1
O2 is around 2 to 3 ms (180). 
Therefore, D2O is widely used as solvent to extend its lifetime to 10-fold longer (181, 
182) for the detection purpose. However the fluorescence quantum yield is still extremely 
low.  
To overcome this limiting feature, one solution is to use fluorescent probes that 
chemically trap 
1
O2 and consequently form compounds that bear different fluorescent 
features from the original probes. Recently, some research groups (183, 184) have been 
using a novel commercial 
1
O2 marker, called Singlet Oxygen Sensor Green 
®
 (SOSG). 
Unlike other fluorescence and chemiluminescent reagents, SOSG is designed to be highly 
selective for 
1
O2 and shows no appreciable response to other reactive oxygen species 
(ROS) like peroxide. Although the exact structure of SOSG is not disclosed by the 
commercial source, according to literature speculation it consists of two components 
tethered together (184-186).  
Figure 5-6 shows a suggested SOSG structure and its mechanism of detecting singlet 
oxygen (185). Prior to the reaction with 
1
O2, the bonding between the chromophore and 
dimethylanthrancene derivative quenches the fluorescence by electron transfer (ET) from 
the trapping moiety. Thus, only weak emissions at 395 and 416 nm are observed. 
However, upon reacting with 
1
O2 the formed endoperoxide can no longer be an 
intramolecular electron donor. Therefore, strong emission at 525 nm (green) with UV/Vis 
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excitation is observed (187). The greater the 525 nm emission the greater the 
1
O2 
concentration but it must be noted that the immediate product of SOSG and 
1
O2 by itself 
is also a sensitizer. Therefore, the background response must be understood for each 
system to obtain acceptable results. 
 
Figure 5-6: Mechanism of SOSG reacting with 
1
O2. Upon reaction with 
1
O2, 
endoperoxide (EP) forms in the anthrancene moiety, forbidding the intramolecular 
election transfer (ET). Therefore, the chromophore starts a strong green emission at 525 
nm. That fluorescence peak is an indicator of 
1
O2 capture. 
 
5.3 Experimental 
While there is extensive literature on the UV/Vis photochemistry of relevant 
biomolecules there is much less involving direct one photon NIR excitation as what 
occurs in biomedical spectroscopic applications. In this study a range of techniques are 
employed to explore the role of oxygen in the NIR fluorescence and photobleaching of 
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the TMX system. In the subsequent paragraphs, experimental apparatus and setups will 
be described before the results are presented. 
First of all, TMX stock solution was produced by exogenous synthesis following the 
procedure described by Monnier (153, 160). 25 mM (in some cases 100 mM) L-lysine 
(16,971-4 or L6001), L-arginine (A5006) and D-(-)-ribose (R7500, all from Sigma-
Aldrich Co. LLC., St. Louis, MO, USA) solution was mixed in PBS and heated at 65 °C 
for 2 hrs under continuous stirring. Since pentosidine is sensitive to ambient light, the 
flask is kept in dark by shielding with aluminum foil throughout the process. Both 
temperature and pH have an influence on the final yield of pentosidine. Based on 
Monnier, in a slightly alkaline environment (pH=9) the yield (3.9%) is higher (153), yet 
the more neutral environment is closer to physiological pH in living tissues and organs. 
Under pH=7.8, a yield of 2.75% could still be achieved and a pentosidine concentration 
on the order of several hundreds of micro molar could be anticipated in the TMX at 
equilibrium. After stopping the reaction, the remaining amino acids and ribose might 
continue to produce pentosidine and drive subsequent reactions to produce larger 
agglomerates. However there is no evidence that they are involved in the observed 
chemistry, which is an assumption at this point. During the synthesis, 5 mL TMX was 
sampled every 20 min and investigated using the in vitro apparatus described in Section 
4.2.2 of Chapter 4. It will be shown later in Section 5.4.1 that as described by Monnier 
the mixture started out a colorless, transparent solution and then turned brown with a 
little bit red hue toward the end. Further characterization and experimentation with this 
TMX is described below.  
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UV/Vis absorption spectra of various TMX stock concentrations were collected 
using Cary 50 UV/Vis spectrophotometer (Varian Inc., now Agilent Technologies, Santa 
Clara, CA 95051). A medium sweep rate of 600 nm/min with 1 nm wavelength resolution 
was set for all the UV/Vis absorption data that were collected. The fluorescence spectra 
were collected using a PTI fluorimeter system (Photon Technology International, Inc., 
Birmingham, NJ). The entrance and exit lit widths were kept constant for all data 
collected. Most of the time regular excitation or emission scans were performed at a scan 
rate of 1 nm/sec. For the results shown in Section 5.5.3, each solution was monitored 
consecutively 1) for emission at 525 nm for 30 sec under 488 nm excitation without the 
laser present, and then 2) set in the dark without any excitation for 20 sec before 
repeating step 1. This “baseline” cycle was repeated 4 times before actually irradiating 
the solution with 500 mW 830 nm CW laser (Innovative Photonic Solutions, Monmouth 
Junction, NJ, USA) during step 2 beginning 250 sec into the experiment.  
The 
1
O2 reagent SOSG is extremely sensitive to light. It is packaged in sets of 10 
vials of 100 µg effective compound. It was stored desiccated and protected from light at 
below -20 °C until required for use. The SOSG stock solutions were prepared 
immediately before use in 33 µL methanol due to its limited solubility in water. This 
yielded a concentration of about 5 mM. The stock was further diluted by 500 or 1000 
times in either PBS or water to get the suggested working solution concentration of 5-10 
µM. No reuse of SOSG occurred and all solutions were disposed at the end of each work 
session. It should be noted that the SOSG is provided as a small amount crystalline 
material and great care must be taken in order to insure that all the crystals are dissolved 
for consistent and reproducible baseline. 
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To observe the effect of the laser irradiation (450 mW, either 780 nm or 830 nm) on 
the dissolved oxygen concentration, a Model DO-166MT-1SXS micro dissolved oxygen 
electrode (LAZAR Research Laboratories Inc., Los Angeles, CA) is used. The oxygen 
electrode produces a voltage reading proportional to the partial pressure of molecular 
oxygen in contact with a semi-permeable membrane. The data logging system 
automatically saves the data every 1 sec into an Excel workbook. A 10 cm long square 
fused silica open top cuvette was used in this study for the convenience of gas purging. 
Pure oxygen and argon was bubbled into the TMX samples in an extremely low flow rate 
to avoid overflow. Although the TMX samples would be purged completely within 
couple minutes, for all the samples tested in this study at least 30 min of either oxygen or 
argon was bubbled before any measurements were taken to guarantee gas saturation. The 
purged samples are sealed with Parafilm M
®
 all-purpose laboratory film to reduce gas 
exchange. The cuvette was also fully covered with aluminum foil leaving only a 5 mm by 
10 mm rectangular window for laser to enter if necessary.  
An ab initio electronic structure calculation using Gaussian 03 program with 
restricted Hartree Fock, 3-21G basis set (Revision E.01, Gaussian, Inc., Wallingford, CT, 
USA) was also performed in order to guide our speculation of the possible underlying 
photochemistry. The ground state singlet molecular structure was optimized for all bond 
lengths and angles in Figure 5-3 before the energies of the lowest excited singlet and 
triplet states were calculated (ZINDO) using that optimized ground state structure.  
 
170 
 
5.4 Results 
5.4.1 TMX Fluorescence with NIR excitation 
UV/Vis fluorescence of pentosidine and other AGEs has long been observed in vivo, 
and has been proposed (111, 161) as a measure of long-term diabetic compliance of 
individuals with physician directed treatment. However, no obvious absorption and 
fluorescence is reported in NIR. In the following sections, AGEs fluorescence in NIR 
regime will be studied in great detail. 
Along the process of preparing the TMX stock, aliquots were taken every 20 min, as 
shown in Figure 5-7, the colorless mixture of 100 mM arginine, lysine, and ribose in PBS 
gradually gained some browning color and darker toward the end. Browning in color 
indicated the forming of crosslinks between reduced sugars and amino acid. This explains 
why in food chemistry the Maillard reaction is frequently referred as “browning reaction”. 
 
Figure 5-7: Browning of the TMX along the timeline of preparing the stock. From left to 
right, aliquots were taken from 0 min to 120 min in 20 min interval. 100 mM of each of 
the three reactants were used. 
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Figure 5-8: Fluorescence and bleaching properties of the TMX. (A) Raw spectra across 
400-1800 cm
-1
 Raman shift range at various time points (0 min, 20 min, 40 min, 60 min 
and 80 min respectively) along the reaction course, shown in increasing gray scale. (B) 
Total fluorescence integral at each five time point, fitting with a simple exponential 
curve. (C) 50 min photobleaching curve (square dots) followed by the second profile 
(round dots) taken after an overnight recovery. 
 
Spectra shown in Figure 5-8(A) was obtained by examining the aliquots using the in 
vitro Raman system detailed in Section 4.2.2 of Chapter 4. As observed, the fluorescence 
increases rapidly with the level of intermediate or final Maillard reaction. Upon the end 
of TMX stock preparation, the bleaching experiment as described in detail in Section 
4.2.1 of Chapter 4 was performed. As shown in Figure 5-8(C), its fluorescence is 
bleachable and not easily recoverable for as long as 24 hrs. For in vivo skin tissue 
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fluorescence, although no recovery is observed for up to 1 hr, it is usually impossible to 
locate the bleached spot from the previous day. The time scale for in vitro and in vivo 
seems quite different. Nevertheless, one should realize that AGEs, though at a slow rate, 
are constantly forming in vivo. While in vitro, once consumed there is no newly formed 
pentosidine to replenish the quenched fluorescence. Since stirring introduce disturbance, 
no attempt was tried to facilitate the mixing and diffusion of the exhausted molecules, 
either pentosidine or dissolved oxygen, in and out of the irradiated volume in vitro. 
 
Figure 5-9: Fluorescence yields for various lysine, ribose, and arginine combinations. The 
reactant molarity was 25 mM for all three combinations. Since no browning effect was 
observed for arginine + ribose (black square) and lysine + ribose (red triangle) solutions, 
the synthesis was stopped at 60 min. 
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Various combinations of the three reactants, i.e., lysine, arginine, and ribose, were 
tested to establish the mechanism of pentosidine and possibly other fluorescent 
compounds formation. Not surprisingly, as shown in Figure 5-9, pentosidine yield in 
TMX increased almost exponentially, but the combination of lysine and ribose for 
example barely gave rise to any pentosidine product. The combination of arginine and 
ribose did get some nonnegligible yield, but was by no ways comparable to the yield 
from TMX. Thus, it is suggested that the observed TMX fluorescence comprises of 
mostly that from the formed AGE, i.e., pentosidine. 
 
5.4.2 TMX UV/Vis Absorption 
Fluorescence is a process that involves two steps, the first of which is the absorption 
of a photon. Therefore, Figure 5-10 also checked the growth of the UV/Vis absorption 
spectra for aliquots taken along the timeline. The successive increase of absorbance is 
found to be consistent with that observed by Monnier and Sell (109, 153) as the 
concentration of pentosidine increases for an identical TMX. Notice that also in Figure 
5-10, the size of the 335 nm peak was comparable with that of 300 nm at the beginning of 
the reaction. But the 300 nm absorption peak grew in faster toward the end, thus resulting 
in a slight shifted absorption center. 
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Figure 5-10: UV/Vis absorption peak growth for aliquots taken every 20 min during the 
process of TMX synthesis. Notice that all the aliquots were diluted in PBS to 10% of the 
original concentration to avoid saturation. 
 
Since special interest of this study lies in the absorption characteristic in the NIR 
range, extended spectral range up to 1100 nm is shown in Figure 5-11 for the final TMX 
products after 2 hours of synthesis. The shoulder peak at 335 nm proves the existence of 
pentosidine while a stronger peak to the left at 300 nm may reflect the absorption of other 
AGEs or intermediate products. Yet, there are only very weak clump-like spectral 
features to the red of 600 nm. Although the readily observed fluorescence and 
photobleaching with 785 nm excitation as shown in Figure 5-8 implies absorption in NIR 
should exist to some extent, the empirical result showed difficulty in detecting it.  
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Figure 5-11: Baseline corrected absorption spectrum of pentosidine producing TMX. The 
sample tested used 25 mM reactants to produce the stock and then diluted to 20% using 
PBS. 
 
If the same solution is irradiated with 500 mW 785 nm loosely focused light in a 
roughly 200 µm diameter spot for 20 min and another UV/Vis absorption spectrum is 
obtained, the difference between that spectrum and the original spectrum is shown in 
Figure 5-12. In order to more clearly observe the spectral changes to the red of 400 nm a 
relatively high starting TMX concentration (20% of stock) was chosen for study even 
though the absorption spectrum blue of 400 nm was saturated in some regions. It is 
observe that the difference spectrum in Figure 5-12 has the same strong peaks as the 
starting TMX solution (with some distortion blue of 250 nm because of saturation effects) 
but also there are some broad and diffuse absorption features starting at about 600 nm 
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and extending to the red limit of the instrument. These features might also be evident in 
the starting TMX spectrum but more discernible in the difference spectrum. The strength 
of the absorption in the 600 nm and longer range is about 5% of that at about 335 nm 
which is not too saturated at that wavelength. It is noticeable that the stronger absorption 
peak at 300 nm is almost completely subtracted off in the difference spectrum, suggesting 
the laser induced chemistry is mostly related with pentosidine, probably not other as yet 
unknown compounds and intermediates.  
 
Figure 5-12: Difference absorption spectrum obtained by subtracting UV/Vis absorption 
spectrum of TMX obtained after irradiation with 785 nm laser from UV/Vis obtained 
before irradiation as described in the text. 
 
177 
 
5.4.3 TMX Fluorescence with UV/Vis Excitation 
The fluorescence excitation and emission spectra of TMX were collected and shown 
in Figure 5-13, Figure 5-14, and Figure 5-15. The excitation/emission peak pair is 
consistent with that reported by other groups (153). In addition, the emission was 
extended into NIR spectral range to check the appearance of any possible emission.  
 
Figure 5-13: Emission and excitation scans in UV/Vis spectral range for TMX at various 
concentrations. The emission scans were extended to NIR range to check whether 
emission could be observed. The insert is a close-up of the NIR spectral range from 600 
nm to 950 nm. Though weak, fluorescence emission was observed. 
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Figure 5-14: NIR fluorescence of TMX at various concentrations. (top) Excitation scans 
by detecting fluorescence emission at 785 nm and 830 nm respectively. These two 
wavelengths correspond to the laser wavelengths used either in vivo or in vitro. (bottom) 
Emission scans at two more UV/Vis excitation wavelengths, 372 nm and 385 nm. 
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As shown in the insert of Figure 5-13, compared to the PBS baseline, TMX samples 
show various sizes of NIR emissions (from at least 720 nm to 920 nm) according to the 
concentration gradient. The sharp peak at 708 nm is an excitation artifact caused by 
overlapping grating orders. When the grating at the emission end steers to selectively 
pass the preset excitation at 354 nm, any wavelengths that are whole number multiples of 
excitation will also be selected to pass at the same time, such as the 708 nm in Figure 
5-13.  
Also noticed, not only in Figure 5-13 but also Figure 5-14, is the much weaker 
emission for higher concentrated sample, especially the TMX stock, no matter in UV/Vis 
or NIR. As shown in Figure 5-7, TMX stock is highly colored. Although not shown in 
figures, the absorption of the stock solution in UV/Vis was extremely high and saturated 
at every wavelength below 400 nm. Based on empirical experience, to make comparable 
fluorescence spectra, however, the optical density, i.e., absorbance, of each sample 
should be around 1, which is obviously not the case for stock solution. Compensation for 
absorption loss requires the quantum yield of TMX fluorescence of the spectral range of 
correction, which is not available. Therefore, direct quantitative comparison between the 
fluorescence of various TMX concentrations has to take the absorption loss compensation 
into consideration. Despite of that, NIR fluorescence of TMX could still be characterized. 
Corresponding to the two NIR wavelengths used in all in vivo and in vitro 
experiments, i.e., 785 nm and 830 nm, excitation scans as shown in Figure 5-14 were 
collected. For both wavelengths, weak but still discernible NIR excitation beyond noise 
level was observed. Comparing the excitation peaks from 350 to 390 nm, the amplitude 
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for generating NIR emission (20000 – 25000 photons per second) is much less than that 
for UV/Vis emission (80000 – 90000 photons per second) shown in Figure 5-13.  
Two more emission scans under UV/Vis wavelengths, 372 nm and 385 nm 
respectively, were collected. Since only NIR range was investigated, data acquisition 
time was much shortened, allowing the collecting of multiple spectra to get smoother 
curves. The sizes of the emission are of the same order of magnitude as the one shown in 
the inserted graph in Figure 5-13.  
 
Figure 5-15: (top) Steady state and (bottom) time gated emission of 10% TMX stock after 
excitation at 385 nm.  
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In addition to the observation of NIR emission from pentosidine containing TMX in 
steady state fluorescence spectra, time correlated experiments as shown in Figure 5-15 
showed the same emission, but with a 30 µs to 100 µs (no shown) delay. The time scale 
of the delayed emission matches that of ISC mentioned in Section 5.2.2. This might 
indicate a photochemical process involving the oxygen molecules dissolved in the solvent 
system. 
 
5.5 1O2 Involved Photochemistry of Pentosidine  
5.5.1 Role of Dissolved Oxygen in Pentosidine Photobleaching 
The observation of delayed emission encourages the consideration of a possible role 
of dissolved gases. Given that most bleaching phenomena are oxidation reactions (175, 
188-190), it is natural to explore the role of oxygen in the NIR excited autofluorescence 
and photobleaching of TMX, i.e., pentosidine. Figure 5-16 shows a schematic depiction 
of a hypothesis, where pentosidine acts as both a 
1
O2 sensitizer and scavenger. As 
detailed in Section 5.2.2, ground state pentosidine gets excited by the incident photon to 
its singlet excited state. Through ISC of a time scale from tenth to hundredth of seconds, 
energy is transferred to a neighboring triplet excited state. If such triplet state satisfies all 
the requirements as described in Section 5.2.2 to be a sensitizer, then the oxygen 
molecules that are dissolved within the solvent can be excited to 
1
O2.  
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Figure 5-16: Hypothetical photochemical process between pentosidine and oxygen. ISC: 
intersystem crossing; TTA: triplet-triplet annihilation; RL: lysine residue; RA: arginine 
residue. 
 
Notice that although pentosidine participates in this process by playing the critical 
role of photo-sensitizer, there is no consumption of the molecule by itself. Excited 
pentosidine molecule finally relaxes to its ground state without giving any emission. 
Meanwhile, the indole ring structure within the pentosidine molecule has long been 
known to quench 
1
O2 (191) and form endoperoxide (192). Thus, the generated 
1
O2 could 
readily get captured by pentosidine again and forms an endoperoxide, which does not 
fluoresce in NIR.  
The hypothesized mechanism could explain what have been observed in the 
previously presented results in Section 5.4, and would also help the understanding the 
photobleaching of fingertip tissue autofluorescence in vivo. The following sections will 
try to build evidences to support this hypothesis. 
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5.5.2 Rate of Dissolved Oxygen Loss 
To support the involvement of dissolved oxygen in pentosidine bleaching process as 
proposed in Section 5.5.1, the effect of purging the TMX solutions with various gases is 
summarized in Figure 5-17. Purging entails bubbling the specified gas through the 
solution for a sufficiently long enough time to ensure saturation, i.e., no further change in 
the concentration of the particular gas. This actually is a fast process since the diffusion 
coefficient of dissolved O2 in water is on the order of 10
5
 cm
2
/sec (193). 
 
Figure 5-17: Integrated emission, i.e., between 400 to 1900 cm
-1
 Stokes shift, using 785 
nm excitation, as a function of time, for solutions saturated with gases in the legend. 
 
It is shown that an argon purged solution has very little decrease in fluorescence 
intensity over 60 min of irradiation with 785 nm radiation. The oxygen purged solution 
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produces less IE than the solution in contact with air and only about half of that observed 
from the argon purged solution. All solutions have a quick initial drop as if some emitting 
species within the irradiated zone are quickly bleached and the later loss of emission are 
slowed by the need for species to diffuse into the excitation-observation zone. Once again, 
bear in mind that no stirring of mixing while bleaching curves were recorded. Purging 
with oxygen produces an over 50% decrease during the same interval and purging with 
air produces a decrease approximately 1/5 as much as the pure oxygen. 
Given the obvious effect of oxygen on the bleaching of the TMX solution, i.e., the 
decrease in fluorescence, an electrochemical oxygen sensor was employed to directly 
observe the effect of 785 nm light irradiation on the oxygen concentration. It must be 
noted from the outset that obtaining a saturated solution of a gas is much easier than 
obtaining and maintaining any particular lesser concentration. Given this practical 
challenge and limitation in experimental technique and methodology, the decrease in 
oxygen partial pressure was still able to be observed in the irradiated volume of the TMX 
solution for varying starting pressures of oxygen and dilutions of the TMX stock solution. 
The best data are shown graphically in Figure 5-18 and Table 5-2. These four runs 
compare the initial rates of oxygen loss, i.e., the slopes of the lines fit to the O2 vs. time 
data in Figure 5-18, for varying TMX (in units of stock) and the same starting O2 
concentration (in mV). Similarly, comparison could also be made to see the effect of 
varying initial O2 concentrations with the same TMX concentration as shown in Table 
5-2. The results in Table 5-2 are consistent with the empirical rate law given in Equation 
5-1 in which the net rate of dissolved O2 loss is first order in both pentosidine and O2 
concentration. Notice that the data in Figure 5-17 which is based on loss of fluorescence 
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and not electrochemically detected O2 loss are also consistent with the proposed rate law, 
i.e., there is no variation in pentosidine concentration but there is in O2. 
      2 2/ /d O dt k O pentosidine d IE dt                   Equation 5-1 
 
 
Figure 5-18: Oxygen electrode response as a function of time for various starting 
combinations of O2 concentration and TMX dilutions. Laser power was constant at 0.5 W 
785 nm in all cases. 
 
Anecdotally we found that under ambient conditions the partial pressure of dissolved 
oxygen in any TMX solution is always 10% or less than that in ambient water or in 
contact with ambient air. That means TMX solutions are always hypoxic and ≈90% 
depleted in dissolved oxygen relative to water.  
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Table 5-2: Rates of dissolved oxygen loss from various starting concentrations of TMX 
and oxygen based on the data shown in Figure 5-18. The rates are the slopes of the linear 
fits to the data and all had a correlation coefficient r>0.88 and p<0.001. 
TMX Concentration 
(% stock) 
O2 
(mV) 
Rate of O2 Loss 
(mV/sec) 
Error 
(mV/sec) 
100 750 -0.09 0.001 
100 250 -0.027 0.002 
50 750 -0.04 0.003 
50 250 -0.011 0.001 
 
5.5.3 Generation of 1O2 in TMX 
To probe specifically for a role for singlet oxygen in particular, a commercially 
available sensor system (187) known as SOSG was employed. In order to see the effect 
of 830 nm excitation, each solution was monitored using the systematic method described 
in the experimental Section 5.3.  The 500 mW NIR laser irradiation during the 20 sec in 
step 2 was continued for 6 ½ cycles as can be seen in Figure 5-19 and Figure 5-20.  
In order to illustrate the response of a known 
1
O2 sensitizer, a run was completed 
using saturated and filtered aqueous solution of dicarboxylated porphyrin (T1239, 
Frontier Scientific, Inc., Logan, UT, USA). The cycle when the 830 nm excitation begins 
is obvious. The baseline signal using D2O for solvent is greater than for H2O as expected 
due to the extended 
1
O2 lifetime in presence of D2O. More SOSG emission is observed 
for the TMX solutions, unfiltered greater than filtered, but both are much less than that 
for the porphyrin. 
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Figure 5-19: SOSG monitoring of 
1
O2 for different solutions with and without NIR laser 
irradiation. Blue stripes indicate the 30 sec 488/525 nm excitation/emission fluorometer 
measurement cycle. Yellow stripes indicate 20 sec 500 mW 830 nm CW laser irradiation. 
 
Whereas laser irradiation of porphyrin produced a large sustained increase in 
reported emission and thus 
1
O2 signal, both TMX solutions only produced a decrease in 
the loss of emission. Porphyrin produces a stronger SOSG response than TMX does 
partially because of a greater porphyrin concentration. Also, pentosidine appears much 
more vulnerable to be attacked by 
1
O2. Thus in Figure 5-19 there is no evidence for 
pooling of 
1
O2 for the TMX samples.  
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Figure 5-20: A close-up view of the same data sets shown in the bottom of Figure 5-19. 
Linear fit trend lines for laser-irradiated and non-laser-irradiated cycles are shown to 
facilitate the interpretation of the data. 
 
However, by taking a closer look at Figure 5-20, under NIR laser irradiation the rate 
of SOSG sensor fluorescence is obviously slowed down. This indicates the generation of 
1
O2 in the TMX. However, the pentosidine molecule is very vulnerable to 
1
O2. Thus, the 
quickly formed endoperoxide trapped the newly excited 
1
O2 within its structure. SOSG 
has to compete with pentosidine in trapping 
1
O2 in order to emit green fluorescence. In 
this sense, although it is clear that 
1
O2 production could be sensitized by pentosidine, a 
better understanding of how efficiently pentosidine works is hard to get using this 
approach. The influence of the probe thus should be taken into consideration also. As 
shown in Figure 5-20, the decline in SOSG emission for the two PBS baselines results 
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from the consuming of 
1
O2 by SOSG itself. The situation is certainly not completely 
understood and more work is needed to determine between porphyrin and pentosidine 
which produces 
1
O2 more efficiently, i.e., with greater net quantum yield.  
 
5.5.4 Gaussian Calculation of Pentosidine Electronic States 
In order to approach the relevant photochemistry of pentosidine, the electronic 
structure was calculated using standard Gaussian calculation with the most salient points 
summarized graphically in Figure 5-21.  
 
Figure 5-21: Jabronski diagram of Gaussian calculated pentosidine singlet and triplet 
excited states showing the 
1
O2 formation through photochemical reactions with 
pentosidine.   
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The positions of the strongest UV/Vis absorption features in Figure 5-11 could be  
rationalized given calculated positions of the singlet states and strengths, i.e., f values of 
the transitions from the ground states (f = 0.30). According to the Gaussian calculation 
for pentosidine there are no allowed one photon transitions involving NIR excitation at 
all. Nevertheless the observed photobleaching and other observed “actions” caused by 
NIR irradiation are obvious and energetically well-defined. For example it is clear from 
difference spectrum in Figure 5-12 that one of the carriers of the spectrum in Figure 5-11, 
i.e., pentosidine, is consumed by the action of the laser. The ratio of the two calculated f 
values for the S0 → T1 (f = 0.02) and S0 → S1 (f = 0.30) transitions is roughly equal to the 
ratio of the induced NIR absorption near ≈800 nm to that near ≈390 nm in the difference 
spectrum in Figure 5-12. This reinforces the suggestion that 1) the difference spectrum is 
that of a single species, i.e., pentosidine, and 2) that pentosidine itself is consumed by the 
1
O2. 
Figure 5-13 and Figure 5-15 also show that direct one photon excitation (OPE) into 
the predicted lowest excited singlet state (385 nm) produces copious UV/Vis emission as 
reported by Monnier but also delayed emission across a wide range of NIR wavelengths 
in accord with the predicted presence of relatively low lying triplet states for pentosidine 
across the appropriate energy range. Because this emission can be observed in steady 
state and in single photon time resolved mode, it can be concluded that NIR excitation 
produces a long lived species associated with NIR emission that actually pools to some 
undetermined extent. 
The requirement that this species might be connected to oxygen is clearly 
demonstrated by the purging experiments and the oxygen electrode experiments. That 
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D2O produced greater evidence of this species than experiments in H2O solvent in Figure 
5-20 is also a specific connection to known 
1
O2 photochemistry. The specificity of SOSG 
for singlet oxygen as opposed to superoxide, or any peroxide strongly supports the 
mechanism depicted in Figure 5-16 and Figure 5-21.  
To explain this mechanism and the subsequent reaction sequence that results in 
photobleaching it is first asserted that in condensed phases, NIR or UV/Vis absorption 
features are broad and that 5-10 nm variation in exact wavelength of excitation is not of 
any consequence. Furthermore, the accuracy of the Gaussian calculations is far from 
perfect. Small differences between the experimental results and the calculation are quite 
consistent with the explanation provided. 
Indeed, the ZINDO formalism applied to this problem is inappropriate to the extent 
that the molecule is charged since ZINDO is only applicable to closed shell systems. 
There are a number of resonance structures for pentosidine and some are charged and 
others are not. The value of this calculation is to validate the possibility that pentosidine 
has low lying triplet states available to participate in singlet oxygen sensitization. Future 
experiments with solutions of the pure authentic material can reveal the solution 
ionization states and these are planned.   
It is essential to realize that two photon excitation (TPE) using a continuous wave 
(CW) laser is commonplace in fluorescence microscopy (194, 195) and as shown in 
Figure 5-21, the energy of two NIR photons is roughly resonant with the lowest energy 
allowed one photon transition. The presence of near resonant interactions between lower 
lying states and the incident photons makes the absorption of addition photons after the 
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first much more facile. In this case there is a symmetry allowed but spin forbidden 
transition almost resonant with the incident photons.  
Despite being spin forbidden the S0 → T1 transition from the ground state singlet has 
a calculated f = 0.02 whereas the lowest energy fully allowed transition, i.e., the S0 → S1, 
only has f = 0.30, i.e., just 15 times stronger. The presence of 
3
O2 opens the possibility of 
1) direct excitation of the oxygen itself to 
1
O2, or 2) the pentosidine to the T1, or 3) 
production of T1 by ISC if S1 pentosidine is actually produced. It seems probable that 
some pentosidine is first excited to S1 by TPE and then relaxes nonradiatively into T1 
which can undergo TTA with ground state molecular oxygen, i.e., 
3
O2, to produce 
1
O2. 
Otherwise pentosidine has its interaction with the incident NIR photons interrupted at the 
T1 level and undergoes TTA with 
3
O2 to produce the 
1
O2. In either case, after transfer of 
some energy to the solvent, vibrationally hot pentosidine and 
1
O2 are produced. The 
1
O2 
goes on to attack pentosidine itself producing a non-NIR fluorescing endoperoxide. This 
is the mechanism proposed earlier in Section 5.5.1 for the photobleaching of AGEs in 
TMX that also leads directly to the delayed TMX NIR emission as shown in Figure 5-15, 
and presumably in vivo too. 
Figure 5-22 shows the power dependence of TMX fluorescence yield of two 
different starting reactants concentrations, e.g., 25 mM and 100 mM, respectively. The 
less than 1 non-integer slopes of the linear fit to the double logarithmic plots indicate that 
the fluorescence probably in a great extent results from an OPE process by direct 
excitation of pentosidine molecule from S0 to T1. However, the dissolved oxygen 
partially consumes the excited pentosidine that leads to fluorescence quenching, thus the 
fitted slopes show power indexes smaller than 1. While in 100 mM TMX the slope is 
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0.93 which is fairly close to 1, the power index in 25 mM TMX is only 0.69. This might 
be related with the limited availability of dissolved oxygen compared to the 
overwhelming amount of excited pentosidine molecule in a higher concentrated sample. 
Thus the 
1
O2 induced fluorescence bleaching has less significance on the power index in 
the more concentrated TMX solution. 
 
Figure 5-22: Double logarithmic plots showing the laser power dependence of TMX 
fluorescence under 450 mW 785 nm laser excitation. (A, left) TMX stock solution with 
25 mM starting reactants; slope equals 0.69; (B, right) TMX stock solution with 100 mM 
starting reactants; slope equals 0.93.  
 
Note that as shown in Figure 3-7 of Chapter 3 the double logarithmic plot of the 
incident laser power and the observed NIR fluorescence in vivo is linear with a slope of 
0.74. Given the interactions that can occur involving excited pentosidine and 
3
O2 between 
the absorption of the first and second photons (90), this is not surprising that a 
inconsistent with an overall linear dependence of the emission on the incident power. 
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5.6 Conclusions 
 Nonenzymatic glycation and oxidation of ubiquitous proteins in vivo leads to 
irreversible formation of AGEs. Due to their relatively long half life and low clearance 
rate AGEs tend to accumulate within static tissues and the circulatory system. Spectra 
obtained using 830 nm NIR excitation suggest that the so-called “autofluorescence” from 
all tissues has a finite number of sources. But the fact that senior and diabetic subjects 
produce more than other members of the general population suggests that a significant 
portion of the total autofluorescence from all sources originates from AGEs. Using 
pentosidine generated in a reaction mixture as representative, an in vitro study unveiled 
very similar fluorescence and photobleaching pattern as observed for autofluorescence in 
vivo. A series of oxygen, air and argon purging experiments on the TMX suggest that 
pentosidine is a singlet oxygen sensitizer and secondary reactions between the 
pentosidine itself and/or other fluorophores and the photosensitized singlet oxygen 
explain the observed photobleaching. Ab initio Gaussian calculations on pentosidine 
reveal the existence of low-lying triplet excited states required for the sensitization of 
ground state oxygen. A commercially available product known as SOSG that specifically 
serves as a singlet oxygen detection reagent suggests the generation of singlet oxygen 
from NIR irradiated pentosidine TMX. This study provides one definite chemical 
mechanism for understanding in vivo human skin autofluorescence and photobleaching. 
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6. OVERALL DISCUSSION, FUTURE WORK AND 
CONCLUSIONS 
 
6.1 Overall Discussion 
The goal of the research presented in the dissertation is to better understand and 
hopefully overcome two major obstacles, i.e., fluorescence and human factors, in 
noninvasive in vivo blood analysis using Raman spectroscopy. Therefore, the research 
seeks solutions in two seemingly irrelevant fields: one is more engineering and the other 
one is more chemistry. Nevertheless, they are both critical to this study due to their close 
relationships with the underlying physiological process, in other words, the human tissue 
properties and blood flow dynamics.          
We have established that maintaining a good contact and steady pressure helps 
generate data with less random errors and uncertainty. With better reproducibility of the 
collected spectra, it could be expected to reduce the experimental length. And this could 
in turn further alleviates the influence of human factors. However, one should be aware 
of the fact that the selection of optimal pressure is of equal importance. Since the optical 
geometry of our in vivo apparatus only allows a penetration to less than 200 µm of the 
most superficial blood-filled volume of the epidermis, the delicate capillary wall is 
sensitive to tissue deformation either related with external pressure or not. 
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Figure 6-1: IE vs. Time curves showing different shapes of pulses under two pressures, a 
low and a high, in a single tissue modulated experiment for a test subject. Excitation 
wavelength is 805 nm. 
 
As shown in Figure 6-1, the optical pulses on an IE vs. Time curve for a single test 
subject vary in a 200 sec tissue modulated experiment. On the first half when the pressure 
is low, the pulses though sitting on top of a bleaching baseline show no sign of 
impedance. However, on the second half when the pressure is high, the down-stroke of a 
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pulse is much sharper than the up-stroke. Although it has not been verified, we speculate 
that under high modulated pressure the capillaries are constantly squeezed but depending 
on the relative pressures they get dilated upon arrivals of cardiac pulses. However, 
halfway between relaxing from systolic to diastolic, the external pressure forces the blood 
vessels to close, thus causing the abrupt drops on the optical pulses.  
The phenomenon observed in Figure 6-1 not only further validates that our spectra 
do contain information directly from blood but also justified the importance of 
controlling experimental conditions including human factors. The two quantities that we 
extract useful information from, i.e., EE and IE, are very sensitive to the relative volume 
fraction changes of the three phases, i.e., static tissue, plasma and RBCs. And these 
volume fractions could be easily disturbed by not tightly controlled human factors. Thus, 
without proper apparatus, i.e., PDPM, that could address these issues, random errors 
could not be effectively controlled which might lead to inaccurate interpretation of the 
spectral results. This is of extreme importance in our noninvasive in vivo Hct monitoring 
protocol. 
However, it has to be pointed out that in order to allow PDPM perform the way it is 
supposed to, the test subject should act passively pretending to be unconscious. 
Practically, no automated self-compensated human machine interface could possibly 
function without the compliance of the subjects. To facilitate evaluating the compliance, 
real-time pressure, force and contact areas are logged along the acquisition of spectral 
signals. These could be used as a separate piece of information to rule out any collected 
spectra that are suspicious to involve human interference. 
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Another important finding of this research concerns the in vivo observed 
photobleaching. Autofluorescence from biological tissues has been observed to be 
ubiquitous, nevertheless photobleaching has been reported by more than one group 
besides us, such as Morris (95) from University of Michigan and Feld and Dasari (93) 
from MIT. In fact, it is not only observed in vivo in tissue. Our lab collaborated in a 
separate project in which chemical changes during glial scar formation were investigated 
using Raman spectroscopy. Figure 6-2 shows the ex vivo fluorescence of a saline 
perfused rat spinal cord used in that project. The spectra were taken by exposing the 
spinal cord at the same spot continuously for up to one hour under 200 mW 785 nm NIR 
laser. As shown in the right panel of Figure 6-2, the fluorescence photobleaches more 
than 30% and shows no sign of reaching final steady state in 1 hr, which is even deeper 
bleaching than most of the in vivo tissues. 
 
Figure 6-2: Sequence of 5 min raw spectra (left) and fluorescence integrals (right) from 
extended irradiation by a 200 mW 785 nm NIR laser of a single point on a saline 
perfused rat spinal cord. 
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The first thing to mention is that the spinal cord was thoroughly perfused with saline 
water before testing. Therefore, little blood if any is present in such ex vivo sample. But 
still, substantial photobleaching is observed. Although central nervous system tissue 
bears very different cell types from skin tissues, the chemical constituents of cytosol and 
extracellular matrix (113) are not that distinct at all. Therefore, in another angle the 
photobleaching observed in Figure 6-2 supports our conclusion that it is static tissue not 
blood that contributes the majority of the fingertip tissue photobleaching.  
Another interesting phenomenon is that the fluorescence from saline perfused cord 
not only bleaches but also bleaches in significant amount. Based on our in vitro study in 
Chapter 4 and 5, only five major tissue constituents, i.e., plasma, Hb, melanin, collagen, 
and AGEs, are narrowed down as contributors to the observed skin fluorescence and 
photobleaching. Obviously, there is no melanin in spinal cord and only trace amounts of 
Hb and plasma in the saline perfused rate spinal cord. Spinal cord does have collagen in 
its extracellular matrix, but our in vitro results show that collagen by itself does not 
bleach. However, when it gets crosslinked with sugars the resulting AGEs fluoresce and 
also bleach substantially. As shown in Table 5-1, the outmost layer of the meninges 
surrounding spinal cord, i.e., dura mater, contains the second highest levels of 
pentosidine among the tissues investigated (153). Thus, it is speculated that 
photobleaching of AGEs may play an important part here.  
In the effort to associate our in vivo observed fingertip autofluorescence 
photobleaching with static tissue and blood constituents, we performed a series of 
systematic in vitro studies. Comparing Hb bleaching curves shown in Figure 4-16 with 
pentosidine and melanin bleaching curves in Figure 5-8 and Figure 4-13, Hb only 
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bleaches 1% within 20 min while pentosidine and melanin bleaches more than 15% in an 
hour. Both melanin and AGEs show stronger potential of photobleaching than Hb. But, as 
stated previously, the in vitro environment of these tissue constituents are quite different 
from in vivo. Therefore, these results could only offer limited explanations to what is 
happening in vivo.   
For purposes of understanding the role of the autofluorescence and photobleaching 
in the technology of noninvasive blood and tissue analysis by NIR spectroscopy, the 
results suggest that NIR emission per unit volume likely changes somewhat from test 
subject to test subject. Nevertheless, our study shows that the possible interferences are 
not that serious and can be overcome. For a single test subject in comparison with him or 
herself, using fluorescence as a volume normalizer is quite adequate. Since the bleached 
tissue does not easily recover after up to several hours, utilizing a reasonable 
prebleaching period in a consistent manner in order to remove the contribution of the 
bleachable components could provide a consistent basis for utilizing the fluorescence as a 
volume normalizer.  
With regard to calibration across test subjects the situation is more complicated. 
Whereas the disposition of many of the most potent chromophores, specifically AGEs, 
are defined by homeostasis in relation to eating, lifestyle and other habits, as well as other 
factors like test subject disease state, i.e., whether the test subject is diabetic or not. The 
AGE emission has the appropriate characteristics to account for all of the in vivo 
observations. Clearly, whatever else occurs in vivo it is occurring in addition to the 
possible sources we have described in this thesis.  
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So while we project no pretense that the experiments described in this paper are 
exhaustive for all potential NIR chromophores, we do suggest that it is possible that we 
have identified the major related cause of the observed in vivo NIR emission and its 
characteristics. Indeed the fluorescence and bleaching under UV/Vis excitation are the 
basis for new devices and protocols proposed by other researchers to screen for diabetes 
(162), and the statistics for the success of these approaches are reasonable so far. Thus it 
is clear that the effects and manifestations of AGEs must be large enough compared to all 
other contributors. 
Clearly the photobleaching issue matters in all measurements where IE is involved 
quantitatively, such as our glucose measurements as well as the newly proposed 
noninvasive in vivo Hct monitoring algorithm. Utilizing the separated IE and EE light 
that carry two independent physical and chemical properties of the irradiated tissue, we 
provided empirical calibrations for our noninvasive Hct algorithm based on a model that 
is consistent with the anatomy, function of the skin and the geometry of the probing. Our 
primary goal is simply to show that it is possible to monitor changes in the Hct by 
analyzing scattering intensities. And its feasibility has been well justified.  
The results presented in this thesis suggest an ability to monitor Hct continuously on 
a 20 ms or less measurement time scale and with apparently high sensitivity, i.e., Hct 
change of 0.02 in tens of seconds. This is encouraging but much needs to be done to 
assess the true accuracy, precision, and sensitivity of this measurement. We note that 
fluorescence based techniques are essentially zero background measurements that 
typically permit 100–1000 times smaller detection limits (196) for absolute 
concentrations and changes in concentration compared to absorption-based techniques. 
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However, so far absolute Hct values could not be offered directly from our approach. 
Nevertheless, Leypoldt et al. (99) have demonstrated that potentially useful clinical 
information is contained in monitoring relative variation from homeostasis of Hct and 
fluid volumes, which are the earliest indicators of internal hemorrhage. 
 
Figure 6-3: Correlation between standard HemoCue Hb hemoglobin measurements and 
LighTouch
TM
 Hematocrit measurements.  
 
As shown in Figure 6-3, although there is clearly a correlation between 
LighTouch
TM
 Hct measurements and HemoCue hemoglobin readings, the physiological 
implications of changes (197) in the two quantities are what determines the utility of their 
measurement to a practitioner. Total Hb relates more to the oxygen-carrying capacity of 
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the blood, whereas Hct relates more to the viscosity of the blood and may therefore 
present more unambiguous indications of impending circulatory collapse.  
Recognizing the unique and irreplaceable clinical values of Hct, other groups have 
been exploring ways to realize noninvasive Hct monitoring (99-101, 198). Leypoldt et 
al.(99) have analyzed extracorporeal blood in the ultrafiltration unit to guide dialysis 
therapy in renal patients. This approach is only “noninvasive” to a dialysis patient. Using 
a truly noninvasive transcutaneous optical approach Jeon et al. (101) reported an absolute 
mean percent error in estimating absolute Hct within ±8.3% (σ±3.67). However, to our 
knowledge, all these currently existing noninvasive optical approaches to Hct exploit the 
coupled oxy/deoxy Hb absorption spectra using at least one Hb isosbestic point(s) (e.g., 
at 569 or 805 nm). Since Hct could not be measured based only on one piece of Hb 
absorption information, empirical calibrations of Twersky’s treatment (199) is applied, in 
which it is assumed that the Hb concentration (in g/dL) is 35 times of Hct.  
Table 6-1: Erythrocytometric values for “apparently healthy” white and black subjects of 
different ages (42). 
Subjects 
Erythrocytes 
Hct 
Hb 
concentration in 
whole blood 
Mean 
corpuscular 
Hb 
concentration 
Number 
concentration 
in whole 
blood 
Mean 
corpuscular 
volume 
Mean 
95% 
range 
Mean 
95% 
range Mean 
95% 
range 
Mean 
95% 
range 
Mean 
95% 
range 
1012/L fL g/dL 
Adults 
Men 
5.1 4.3-5.9 90 80-100 0.47 0.39-0.55 15.1 13.9-16.3 34 31-37 
Adults 
Women 
4.5 3.5-5.5 88 79-98 0.42 0.36-0.48 13.5 12.0-15.0 35 30-36 
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As shown in Table 6-1, this pulse oximeter signal based approach simply makes the 
assumption that the mean corpuscular Hb concentration is constant at 35 g/dL for all 
subjects, regardless of age, gender, or even healthy conditions. Therefore, in practical 
purposes Hct calculated this way offers no different information from Hb measurement. 
Moreover, the 95% range of mean corpuscular Hb concentration (30-37 g/dL across 
gender) is wide enough to lead to significantly different Hct estimations as shown in 
Figure 6-4. This means that even if the Hb concentrations for two different healthy test 
subjects are the same, e.g., 14 g/dL, the Hct could still be very different, not to mention 
patients whose mean corpuscular Hb concentration may fall out of the 95% range. 
 
Figure 6-4: Hct estimations from measured Hb concentrations based on various 
assumptions on mean corpuscular Hb concentrations. According to Table 6-1, the 
averaged value of mean corpuscular Hb concentration is 35 g/dL with a 95% range from 
30-37 g/dL. Green shaded area: maximum Hct variation range within normal 
physiological Hb concentrations based on 30-37 g/dL corpuscular Hb assumption. 
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In fact, invasive approaches that give traditionally acceptable data  (103, 104) are 
also quite variable due mostly to sampling and handling issues (105). Nevertheless, 
devices such as oximeters (200, 201) and hemoglobinometers (198, 202) produce results 
that are apparently not sufficiently sensitive, precise, or accurate regarding blood changes 
to give unambiguous indications to clinicians for diagnosis of internal hemorrhage and 
determining the need for a transfusion. On the other hand, the Hct monitoring approach 
introduced in this thesis adopts a totally different approach which is based fundamentally 
on the photophysical and photochemical properties of RBCs and plasma. Therefore, it has 
a pragmatic potential to monitor the Hct variation. 
Finally, because the perfusion is affected by many things, experiments should 
explore the variation of the observed spectra with systematic variation in the mechanical 
coupling to the skin surface. Combining our findings in human factors control and in vivo 
skin tissue fluorescence properties, it is apparent that a standard pre-experiment 
procedure will be beneficial to follow. First of all, when necessary, such as for test 
subject with dry skin or experiments taken in dry season like winter, a thin layer of 
regular skin lotion or moisturizer could be applied to increase skin conductivity. 
Although blinking dots caused by poor contact introduce unnecessary force compensation, 
empirical experience has proved this to be an effective way to avoid such problem. 
However, be cautious of any spectral ambiguity that might be introduced by the lotion 
itself.  
Then, before the taking of any spectral data, it is suggested to measure the BP and 
heart rate from each test subject. Our research shows that for each individual both optical 
and mechanical pulses happens when the applied pressure is around the mean arterial 
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pressure (MAP), which is close to the mean of the systolic and diastolic pressure. Also, 
the force needed to apply MAP for a test subject with regular fingertip size is also in the 
range that has been proved to cause moderate blood flow modulation. Thus the pre-taken 
blood pressure could be used to guide the target pressure set-up that is optimized to each 
individual. For the best outcome from a normal noninvasive glucose measurement, it is 
optimal to set the target pressure of the unpressed part to the lowest pressure sufficient 
enough to maintain fingertip stability, and that of the pressed part to the MAP. From a 
purely engineering standpoint it would be very easy to incorporate blood pressure and 
heart rate measurements in the LighTouch
TM
 device itself using the plethysmographic 
data already collected using the PDPM. 
When the fingertip is properly positioned, the laser could be switched on after the 
test subject is informed. The pre-experimental laser exposure is made on purpose to 
prebleach the skin region under investigation. Then a PDPM set-up procedure is 
performed to take fingertip under initial pressure registration. The whole set-up step 
usually takes less than 20 sec. Thus a separate 20 sec more prebleaching step is added to 
bleach the skin even deeper. Although the total time of prebleaching is still less than what 
is needed to reach a steady state fluorescence equilibrium which could be as along as 
hundreds of seconds, the fast bleaching process should be done at this point. 
Then another ridge set-up procedure follows, during which the fingertip will be 
dragged back and forth by a motored micro actuator to take topographic scan. In our 
current version, the second detected ridge will be located to guarantee the closest vicinity 
to 53° incident angle. Once these steps are all done, either a regular single glucose 
measurement or a continuous Hct monitoring could start. The research in this thesis 
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suggests that following these steps has promise to greatly improve the experimental 
reproducibility and generate more accurate blood glucose concentration predictions. 
These ideas need to be verified in the future work. 
 
6.2 Future Work 
As mentioned in the proceeding context of this thesis, while the current research has 
led to many interesting observations and the in vivo apparatus is capable of performing 
precise and reproducible glucose and Hct measurements, there is still room for both 
technical refinements and conducting continuous study on the unsolved problems. 
From the instrumental point of view, it could be envisioned that the next generation 
of PDPM will be able to perform automatic target modulation pressure set-up. Using the 
hardware of the current PDPM to fulfill this function, the step motor and solenoid system 
could exert gradually increasing pressure under programmed pressure gradient. 
Meanwhile the mechanical pulses are monitored and the amplitudes of these pulses are 
fed into a BP measuring algorithm. Using the same principle as the oscillometric 
approach in determining BP, the MAP as well as the pulse rate could be obtained 
simultaneously. 
Although we have been logging the force, pressure, and contact area signals that 
come directly from the transducer, we have never used these sensor outputs as the criteria 
in real-time automatic active data rejection. We have shown in Chapter 2 that the 
amplitude of force variation caused by involuntary tremor is much bigger than cardiac 
pulses and normal modulation. Therefore, abnormal force fluctuation could be an 
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indicator of poor test subject compliance. Either a checkup toward the end of an 
experiment or a real-time monitoring of suspicious force variation would be beneficial 
and time-saving. 
Besides the two aforementioned refinements, there is still one obstacle that needs to 
be overcome. In our effort to modify experimental skills and improve the procedure along 
the way for making the in vivo findings presented in this thesis, we have been adapting 
most of the aforementioned steps of the proposed standard pre-experiment procedure, 
except the ridge set-up. This is simply because anatomic difficulties we encountered 
when trying to implement our current ridge set-up procedure. In this procedure, the 
transverse motored micro actuator is first positioned at a position called “center”. This is 
where the test subject originally positioned their finger. Upon starting of the ridge scan, 
the actuator, together with the finger, first backs up about 2 mm and then scans 
unidirectionally form the joint to end. While performing a topographic scan, the IE vs. 
Time curve records the position of the ridges and the actuator drags the finger back to 
where the ridge index is logged.  
Although this sounds plausible, in reality this procedure is hard to perform because 
there exists a tissue stretching issue. We noticed that moving finger together with the 
actuator always needs to overcome the initial stretching of the skin tissue that is also in 
contact with the printed circuit board surface before it actually begins to move. In other 
words, the distance travelled does not correspond to the logged actuator steps. Besides, 
upon finishing the first scan the finger is dragged in the opposite direction. This time the 
skin must restore to its original state first and then once again overcome the same 
stretching as the first time. Thus, the final position could easily be far from a ridge. 
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To solve this problem, we have to seek new approaches in locating fingertip ridges. 
Supposedly, the fingertip could be dragged to travel in only one direction in a much 
slower pace to allow short “move-measure” cycles. In other words, the actuator moves 
one step and CCD camera takes spectra to calculate IE. When this “move-measure” cycle 
is finished, the actuator drags the fingertip to the next step and repeats the cycle. Since 
our laser is not shuttered or synchronized with the actuator, at least 2 frames need to be 
allowed each step since the first frame IE may have some timing issues relating with 
CCD clearing. Both the absolute IE and the first derivatives need to be logged and 
calculated in real-time in order to stop advancing forward when a sufficient amount of 
decline in IE is observed.  
It can be foreseen that this ridge set-up procedure will be time-consuming, i.e., it 
might require as much as 20-30 seconds, but it has the potential to guarantee a ridge 
could be located accurately each time. However, how to select the parameters, such as 
thresholds and criteria needed to stop the scan, could be tricky. Each test subject’s 
fingerprints have unique widths and depths, and the fluorescence baseline could vary to 
an even bigger extent. Therefore, substantial testing will be necessary in order to realize 
this procedure in practical application. 
Concerning noninvasive Hct monitoring, as a practical matter, the spectroscopic 
experimental requirements for obtaining EE and IE measurements that are adequate for 
application of this algorithm do not seem to be very stringent. The main requirement is a 
clean separation of the EE and IE, with no need to separate the Raman contribution from 
the fluorescence; this would not require spectrographs or very narrow line width lasers or 
even particularly stable laser sources. Probably, simple filters and simple lasers may be 
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used and the measurement system can use fiber-coupled incoming laser and outgoing IE 
and EE light. Therefore, although the Hct results presented in this thesis were obtained 
using CCD detection, it would be feasible to use optical fiber, an optical filter, a low-
grade laser, or possibly only a LED and two photodiode detectors to access the same 
information. A system using these simplified optical components will greatly decrease 
the complexity and price of a real product while increasing the portability and 
convenience for clinical applications. 
As to the empirical calibrations for the in vivo noninvasive Hct algorithm, there are 
definitely more than the two approaches proposed in this thesis. Actually, the second 
assumption about the blood modulated by a typical pressure modulation is somehow 
related with the first assumption about cardiac pulses. In the process of testing the 
sensitivity of the algorithm, it is clear that we can use the tourniquet experiment as a 
separate calibration method. First of all, conventional fingerstick references can be 
compared in parallel with the spectra data. Absolute Hct change can be fed directly into 
the algorithm. Although errors do exist depending on how the tourniquet is performed 
and blood is sampled, it could be expected that this approach is at least more accurate 
than assumptions. Moreover, the tourniquet experiment by far shows the most obvious 
blood disturbance ever observed in vivo. A calibration based on this is expected to yield a 
more reliable set of parameters a-f. 
Another limitation of our in vivo Hct algorithm calibration is the narrow range of Hct 
variation. Even with the tourniquet trials, the biggest change before and after a tourniquet 
is only approximately 0.03. For one test subject, the Hct increase from 0.38 to 0.41 after 
the blood flow has been block by a tourniquet for 1 min. Although theoretically feasible, 
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we never know whether our algorithm is able to track Hct to an extreme level. To 
investigate that, an animal model needs to be employed. We have currently proposed a 
protocol for Institutional Animal Care and Use Committee (IACUC) approval to perform 
an animal study at Syracuse University.  
In this propose study, the rats will be exsanguinated while a portable Hct device will 
be used to simultaneously monitor IE and EE changes. Notice that losing blood does not 
necessarily cause an immediate change of Hct since the change will not happen until the 
compensatory phase (203, 204) is initiated. During this physiologically manifested body 
fluid compensation process, compartment-scale fluid shifts, surface fluid redistribution, 
and change in blood composition happens to compensate for blood volume loss, and thus 
result in Hct change. To actively control the rat Hct, body fluid replacements with 
Normocarb™, plasma, and whole blood are also planned. 
It is also noteworthy that, during the compensatory phase of hemorrhagic shock, 
protein and glucose concentration in the plasma are known to increase precipitously; 
measurement of the IE offers the possibility of simultaneously monitoring both Hct and 
analyte concentrations. The amide I Raman band at ≈1670 cm−1 Raman shift, is a measure 
of protein content over all three phases. The Raman features of the IE we have long used 
for glucose monitoring could also be useful in this context as an indicator of whether a 
compensatory mechanism is triggered or not in an internal hemorrhage case.  
Measuring the IE and EE simultaneously and applying the algorithm leads to a 
sensitive probe for volume changes of not only RBCs, but also plasma. Detection of Hb 
or RBCs is of course routine, but to our knowledge obtaining a plasma volume 
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simultaneously is unique. Normalizing to the internally consistent and turbidity-corrected 
plasma volume fraction calculated from our algorithm offers the possibility of calculating 
concentrations of various analytes, including but not limited to glucose. It could turn out 
to be a more accurate and straightforward volume normalizer than directly utilizing 
undifferentiated inelastic emission, but further validation needs to be planned for our 
future studies.  
Due to the importance of prebleaching, we have been thinking about solutions to 
shorten the time needed to reach the steady state fluorescence baseline. It is natural to 
propose using higher laser powers since the power dependence of photobleaching has 
been established (91). Shorter wavelength laser could also be tried. As shown in Figure 
3-11, using 805 nm laser the skin bleached about twice as much as that with 830 nm laser 
in 100 sec for two healthy test subjects, and the power used for 805 nm excitation is only 
half of 830 nm laser. However, laser safety concerns arise when trying to increase the 
power or using shorter wavelength. The American National Standards Institute (ANSI) 
allowed maximum permissible exposure is determined by laser wavelength, exposure 
length and incident spot size (205). Therefore, one possible solution is to use laser 
sources that are not tightly focused or the ones that originally have big spot sizes. By 
reducing the power density, higher allowable power is possible. Prebleaching over a 
broader area could be preferred from an engineering standpoint to implement the ridge 
set-up procedure. 
Finally, interesting chemistry between dissolved oxygen and pentosidine (possibly 
other AGEs or Maillard reaction intermediates) has been observed. However, there are 
some technical difficulties involved in this study. First of all, the TMX turns out to be 
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very efficient at depleting dissolved oxygen and extremely sensitive to light. Therefore, 
in the process of making the stock solution it is critical to keep the TMX out of any 
possible light source. Moreover, our results show that pentosidine bearing TMX has very 
similar photobleaching properties as what we observed in vivo.  Therefore, the bleaching 
behavior of pentosidine itself is conceivably useful in order to quantify the fluorescence 
and thereby assign a volume numerically to the probed volume. These are presently under 
review but we believe a better understanding of the bleaching chemistry itself is 
necessary to proceed. And this leads to our further investigation of the pure form of 
pentosidine, the synthesis of which has recently been achieved by our collaborators (206). 
To explain the pentosidine fluorescence properties under NIR excitation, ZINDO 
calculations on the singlet and triplet excitation states was performed. Although the 
results support our speculation of that interesting physical chemistry underlies the 
fluorescence and photobleaching phenomenology, such as TPE and singlet oxygen 
sensitizing, more proof is needed to be certain. Actually, the ZINDO formalism applied 
to this problem could be inappropriate since the pentosidine molecule may be charged 
under physiological conditions but ZINDO is only applicable to closed shell systems. The 
power dependence of autofluorescence production is also consistent with our proposed 
involvement with pentosidine but more work is required to obtain greater confidence in 
the hypothesis. 
In the thesis, we proposed a hypothesized pentosidine photochemical pathway in 
which it reacts with dissolved oxygen as a sensitizer and also a scavenger. The research 
presented demonstrates its potential as a sensitizer but only provides limited evidence to 
support the formation of the endoperoxide. Therefore, traditional analytical approaches, 
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such as mass spectroscopy and high-performance liquid chromatography, could be used 
to perform the product analysis. These studies will have real potential to unveil the role of 
dissolved oxygen in pentosidine photochemistry. 
Without question, there are many possibilities to use the outcomes presented in this 
thesis to explore a much broader range of possible applications, either in vivo or in vitro. 
Continued work along the lines of this project will further advance the development of 
such noninvasive blood analytes monitoring systems for final clinical availability. 
 
6.3 Conclusions 
This research is part of an ongoing project aimed at the application of combined NIR 
Raman and fluorescence spectroscopy to noninvasive in vivo blood analysis including but 
not limited to glucose monitoring. Coping with practicalities of human factors and 
exploring ways to obtain and use knowledge gained about autofluorescence to improve 
algorithms for blood and tissue analysis are the general goals of this research.  
Firstly, the study investigated the various sources of human factors pertinent to our 
concerns, such as fingerprints, turgor, skin hydration and pigmentation. We then 
introduced specialized in vivo apparatus including means for precise and reproducible 
placement of the tissues relative to the optical aperture, i.e., the PDPM. Based on solid 
instrumental performances, appropriate methodology is now provided for applying and 
maintaining pressure to keep surface tissues immobile during experiments while 
obtaining the desired blood content and flow.  
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Secondly, in vivo human fingertip skin autofluorescence photobleaching under 200 
mW 830 nm NIR irradiation is observed and it is characterized that: i) the majority of the 
photobleached fluorescence originates from static tissue not blood, ii) the bleaching (1/e 
point) occurs in 10
1
-10
2
 sec timescale, and also iii) a photobleached region remains 
bleached for at least 45 min but recovers completely within several hours. A 
corresponding extensive but not exhaustive in vitro systematic study narrowed down the 
major contributors of such fluorescence and bleaching to collagen, melanin, plasma and 
Hb: two major static tissue constituents and two major blood proteins. 
Thirdly, we established that measuring the IE and EE simultaneously leads to a 
sensitive probe for volume changes of both RBCs and plasma. An algorithm based on 
measurements obtained while performing research needed for this thesis, as well as some 
empirical calibration approaches, was presented. The calibrated algorithm showed real 
potential to track Hct variations in cardiac pulses, centrifugal loading, blood vessel 
blockage using tourniquet, and even during as subtle an occurrence as a Valsalva 
maneuver.  
Finally, NIR fluorescence and photochemistry of pentosidine, a representative of the 
AGEs which accumulate with age and hyperglycemia, was studied. The results indicate 
that oxygen plays a pivotal role in its photobleaching process. We hypothesized and 
offered proofs showing that pentosidine is a 
1
O2 sensitizer that is also subject to attack by 
the 
1
O2 resulting in the photobleaching that is observed when probing tissue using NIR. 
The photobleaching reaction is kinetically first order in pentosidine and ground state 
oxygen, and in vivo effectively first order with NIR irradiation also.  
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APPENDIX A: LOAD CELL CALIBRATION PROCEDURE 
 
In order to allow PDPM measure absolute force and pressure, the load cell (LCGC-
150G, Omega Engineering Inc., Stamford, CT, USA) needs to be properly calibrated. 
Figure A-1 shows a simplified drawing of load cell mounting and working scheme. A 
lever system is used and the aperture is positioned between the fulcrum and the tip of the 
load cell. The drawing is not to scale, but the distance between the aperture and the 
fulcrum is the same as that between the load cell and the fulcrum. According to the law of 
lever, displacement at the tip of the load cell is twice of that at the aperture. Therefore, 
the force measured by the load cell is twice of that is actually applied at the back of the 
fingertip. However, as will be shown later, the calibration procedure has naturally 
incorporate this ratio in the calibrating process. Therefore, no further scaling is necessary. 
Two screws are used to hold the spring steel board in position. While the screw close 
to the end of fulcrum (referred as “calibration screw” thereinafter) is used to fasten the 
board down, the other one between the aperture and the load cell is just loosely fitted to 
keep the board properly oriented. A rubber O-ring is used while tightening the calibration 
screw down. The fulcrum is designed to have the same height as the tip of load cell 
transducer and also the rubber O-ring, Therefore, the spring steel board is almost parallel 
to the aluminum main body. The side-view of the spring steel board shown in Figure A-1 
has a much exaggerated angle. 
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Figure A-1: Simplified drawing, not to scale, of tissue modulator. Main body is 
aluminum with load cell, thermistor shaft and stainless steel rod/fulcrum shown in gray 
tone. The angle between the spring steel modulating plate is exaggerated for clarity. Nut 
is used to adjust zero position of load cell and ensure that spring steel is always in contact 
with transducer tip. 
 
Whenever the calibration screw is adjusted, a load cell calibration is required to be 
performed. A yearly periodical calibration is also recommended and the frequency of 
calibration is determined by how extensively the PDPM is used. We perform the 
following steps for the load cell force calibration:  
i) Open the “PDPM Settings” panel as shown in Figure A-2 under “File” in the 
menu bar of the LighTouch
TM
 GUI. Make the “PDPM Feed Back” window 
visible at the same time. 
zero-force load cell 
adjustment nut 
fulcrum 
heating element 
thermistor shaft 
load cell 
aperture 
load cell-spring steel contact point 
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Figure A-2: Screenshot of the “PDPM Settings” panel on the LighTouchTM GUI. In the 
load cell calibration process, the button “Calibrate Low Pressure”, “Calibrate High 
Pressure” and “256 counts represents ___ grams” are the ones that will be used. 
 
ii) Adjust the calibration screw when a slight turn shows force variation on the low 
end of the slide bar in the “PDPM Feed Back” window of the LighTouchTM 
GUI click “Calibrate Low Pressure”. Alternatively, electronic signal from the 
load cell could be directly displayed on an oscilloscope. In this case, voltage 
variation could be referenced. 
iii) Put standard weights (100 g, 200 g or 250 g) on the aperture to saturate on the 
real-time force slide bar and click “Calibrate High Pressure”. The manufacture 
specification of the LCGC-150G load cell is to output 20 mV for 150 g force.   
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iv) Put the weight number used for the calibration in the “256 counts represents __ 
grams”. The 256 counts represent the A/D converter (up to 12-bit capacity) 
numbers that will be used to control the PDPM as shown in Figure A-3. By 
doing this, the analog voltage outputs from the load cell are converted into 
digitized numbers ranging from 0 to 255. 
 
Figure A-3: Schematic drawing of PDPM feedback cycle in set-up and experiment 
process. The load cell calibration is used in converting the inputs into digitized numbers 
using A/D converter. 
  
When the target pressure (in gf/mm
2
) is set, the following equation will be used to 
convert it into dimensionless digitized target force numbers: 
“Target Force” = “Contact Area” × “Desired Pressure”  × 256 / “??”  
  (counts)                (mm
2
)                    (gf/mm
2
)           (counts/gf) 
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The underscored part is derived from the load cell calibration. Currently, the force 
and pressure logged in the .sen and .dtl files are in dimensionless converted digital 
numbers. Therefore, the load cell calibration equation needs to be used reversely to get 
the meaningful force with proper unit.  
 
Figure A-4: Calibration curves of using different standard weights as “Calibrate High 
Pressure”. Using heavier weight extends the dynamic range, while using lighter weight 
increase the sensitivity. 
 
Usually after a load cell calibration is done, another load cell connected to a single 
channel signal conditioner-indicator (Model GM, SENSOTEC Inc., Columbus, OH, USA) 
will be used to check the linearity, sensitivity, and dynamic range of the calibration. 
Examples of typical curves are shown in Figure A-4. It is obvious that how much 
standard weights used as “Calibrate High Pressure” determines the dynamic range and 
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sensitivity of the PDPM module. Using heavier weights could extend the dynamic range, 
while using lighter weights increase the sensitivity. There is a tradeoff and the selection 
of calibration weight should be based on needs. Besides, extra attention needs to be paid 
on the drift of calibrated zero.  
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APPENDIX B: DATA STRUCTURE SPECIFICATION FOR HEMO 
MODE 
 
The LighTouch
TM
 GUI could run under two modes: “Glucose” mode and “Hemo” 
mode. To select mode, the configuration file (with a suffix of “.cfg”) needs to be loaded 
manually before the collection of any data. For the current version of LighTouch
TM
 GUI 
(v 11.06), “Glucose” and “Hemo” modes share the same configuration file but are 
different in the setting of “Experiment Length” as circled in a screenshot in Figure B-1.  
 
Figure B-1: Screenshot of LighTouch
TM
 GUI showing the “Configuration Parameters” 
panel popped up upon loading a configuration file. 
 
To take a single measurement as it is normally done under “Glucose” mode, the 
experiment length is usually set between 20 sec to 200 sec. Typically 100 or 200 sec 
acquisition should be used to collect sufficient number of frames for tissue modulated 
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Raman calculation. The maximum length of an experiment that could be performed under 
“Glucose” mode is 200 sec. 
 “Hemo” mode allows continuous data collection until quitting the mode by clicking 
“Stop Hemo”. Under this mode, the setting of “Experiment Length” means the length of a 
hemo cycle. The hemo cycle will be repeated and data will be generated for each cycle 
and automatically pooled under the designated folder specified by the initiation file, i.e., 
“LighTouch.ini”.  
Under both modes, spectral and mechanical transducer data will be logged in frame 
basis. The amount of frames generated is determined by two settings: experiment length 
and shutter time. Both of them could be set in the configuration panel shown in Figure B-
1. Frames logged in each hemo cycle could be calculated using Equation B-1 and the 
same equation could be applied to data collected under “Glucose” mode. 
frames per hemo cycle "Experiment Length"/ "Shutter Time"         Equation B-1 
At the end of a single “Glucose” experiment, .ccd and .sen files will be allowed to be 
manually saved in local hard drive. The .ccd file contains all frames of spectra captured 
by the CCD camera. The.sen file contains force, pressure, quadrants and contact area 
information detected by the mechanical transducers. Data processing procedure and 
MATLAB routines used to bulk convert these binary format files will be elaborated in 
following APPENDIX C. 
Back to the hemo data structure issue, it is important to know the number of frames 
per hemo cycle for a successful MATLAB implement. Although 40 ms shutter time has 
been occasionally used for better SNR, 20 ms is of primary preference since such setting 
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give better data density per pulse. Therefore, for every hemo cycle, typically 3 sec, 150 
CCD frames will be recorded and automatically saved as a miniature .ccd file. Usually, 
when “Hemo” mode is started, the experiment will uninterruptedly collect data and 
output the calculated RBC volumes, plasma volumes and Hct results into a consecutively 
updating graph within the GUI. Meanwhile, .ccd and .dtl files are logged sequentially in 
the designated directory every hemo cycle. The structure of the .dtl file is specified below 
in Table B-1.  
In Table B-1, the “Hemo Cycle Size” in .dtl file equals the “frames per hemo cycle” 
determined by Equation B-1, while “Hemo Cycle Instance” represents the relative 
position of a particular hemo cycle within a continuous Hct monitoring experiment. The 
Hct, plasma volumes and RBC volumes calculated from IE and EE integrals as 
elaborated in Chapter 3 are also logged in each hemo cycle. Notice that no .sen file is 
logged since the basic PDPM feedbacks, such as pressure, contact area, and quadrants, 
have been backed up in .dtl file. Force is not logged since it could be readily calculated 
based on the pressure and contact area. Pressure values are represented by dimensionless 
digitized numbers that come directly from A/D converter. Absolute real-time pressure 
with meaningful units could be got by applying the aforementioned force load cell 
transducer calibration in APPENDIX A. Finally, two more fields are included to save the 
data collected from the two channels, TP9 and TP10, of a commercial pulse oximeter 
(Nellcor
®
 N200, Nellcor Inc., Pleasanton, CA, USA) for parallel comparison with 
LighTouch
TM
 signals. 
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Table B-1: “Hemo” mode detail log file structure (.dtl) based on version 1.4 update 
Item 
Number 
Item Name 
File 
Granularity 
Logging 
Granularity 
Data 
Type 
Type Size 
(byte) 
Data Size 
(byte) 
Notes 
1 File Revision Tag Cycle Once int 4 4  
2 Hemo Cycle Size Cycle Once int 4 
8 Header 
3 Hemo Cycle Instance Cycle Once int 4 
4 Red Blood Cell Volume Cycle Frame float 4 
24 
Data 
Fields 4 - 12 are written as a set 
for each frame and consist of 24 
bytes of data 
5 Plasma Volume Cycle Frame float 4 
6 Hct Result Cycle Frame float 4 
7 Pressure Cycle Frame float 4 
8 Contact Area Cycle Frame float 4 
9 Quadrant “Down” Contact Count Cycle Frame char 1 
10 Quadrant “Up” Contact Count Cycle Frame char 1 
11 Quadrant “Out” Contact Count Cycle Frame char 1 
12 Quadrant “In” Contact Count Cycle Frame char 1 
13 Test Point 9 (TP9) Cycle Frame short 2 
4 
Fields 13 & 14 are new to 
REV2 14 Test Point 10 (TP10) Cycle Frame short 2 
File Size (bytes): 4 + 8 + (24 + 4) * (Hemo Cycle Size) 
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Thus, based on the lasted update (v1.4) on .dtl file structure, the detail file size (in 
bytes) of each hemo cycle can be calculated. For example, assuming 150 frames of data 
are generated for each cycle (3 sec hemo cycle length and 20 ms shutter time), then 4212 
bytes or 4.11 KB .dtl file will be logged. Meanwhile, 622 KB (637320 bytes) .ccd file 
will also be backed up simultaneously. Bear in mind that these just calculated storage 
spaces needed for logged data are only for a single hemo cycle, i.e., 3 sec. Thus, for a 1 
min monitoring under “Hemo” mode, about 18.34 MB of data will be logged.  
However, in order to monitor the Hct fluctuation of a test subject, one experiment 
normally takes tens of minutes, or much longer if necessary. This will eventually 
generate thousands of CCD and detail files and also take up a tremendous amount of hard 
disk spaces. While at the R&D phase raw data are favorable in optimizing parameters 
that feed into the algorithm and evaluating system performance, the redundancy of data 
logging could be significantly reduced once the testing phase ends.  
At the end of one Hct monitoring trial, a summary file with a suffix of .sum is 
logged. The .sum file only backs up the final results and the most important system 
operation parameters. Table B-2 shows the structure of a summary file. “Hemo Cycle 
Counts” records the total number of hemo cycles one continuous monitoring has taken. 
Parameters a-f are predetermined constants using the approaches elaborated in Section 
3.3 of Chapter 3. These numbers are fetched directly from .ini file where the six 
parameters are set. The “CCD Exposure Time” is another expression of the 
aforementioned “Shutter Time”. Different from the .dtl file, the Hct, plasma volumes and 
RBC volumes in the .sum file are the average for each cycle and could be plotted readily 
in the LighTouch
TM
 GUI at the end of an experiment.  
227 
 
Two Boolean fields, i.e., “Bleach” and “Stable”, are also included in the .sum, 
representing the fingertip tissue photobleaching status and compliance of the test subjects 
respectively. A “0” is false and “1” is true. The Hct related fields are only calculated 
when both of the fields are true. Therefore, no output could be shown during a 
monitoring process if one or both of the red LED lights on the GUI lit up. IE0 and EE0 
will be recalculated once a new cycle that passes the two tests starts. The .sum file takes 
much less hard drive spaces compared to the .dtl and .sum files generated along the data 
acquisition process. 
Finally, the data structures listed in Table B-1 and Table B-2 for .dtl and .sum files 
respectively should be used as references for implementing the MATLAB routines in 
hemo data processing. Changes in MATLAB codings should be made accordingly 
whenever there is a change to these structures. 
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Table B-2: “Hemo” mode summary log file structure (.sum) based on version 1.4 update 
Item 
Number 
Item Name 
File 
Granularity 
Logging 
Granularity 
Data Type 
Type Size 
(byte) 
Data Size 
(byte) 
Notes 
1 File Revision Tag Procedure Once int 4 4  
2 Hemo Cycle Count Procedure Once int 4 
40 
Header 
Laser Power in mW 
CCD Exposure in ms 
3 Hemo Cycle Size Procedure Once int 4 
4 Parameter A Procedure Once float 4 
5 Parameter B Procedure Once float 4 
6 Parameter C Procedure Once float 4 
7 Parameter D Procedure Once float 4 
8 Parameter E Procedure Once float 4 
9 Parameter F Procedure Once float 4 
10 Laser Power Procedure Once float 4 
11 CCD Exposure Time Procedure Once float 4 
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Table B-2 (Continued): “Hemo” mode summary log file structure (.sum) based on version 1.4 update 
Item 
Number 
Item Name 
File 
Granularity 
Logging 
Granularity 
Data Type 
Type Size 
(byte) 
Data Size 
(byte) 
Notes 
12 Hemo Cycle Instance Procedure Cycle int 4 
32 
Data 
Fields 12-22 are written as 
a set for each cycle and 
consist of 32 bytes of data; 
For Bleached and Stable 
fields, a value of 0 
indicates false and a value 
of 1 indicates true. 
13 Red Blood Cell Volume Procedure Cycle float 4 
14 Plasma Volume Procedure Cycle float 4 
15 Hct Result Procedure Cycle float 4 
16 CCD Exposure Temp (°C) Procedure Cycle float 4 
17 IE0 Value Procedure Cycle float 4 
18 EE0 Value Procedure Cycle float 4 
19 Bleached Procedure Cycle char 1 
20 Stable Procedure Cycle char 1 
21 Spare1 Procedure Cycle char 1 
22 Spare2 Procedure Cycle char 1 
File Size (bytes): 4 + 40 + (32 * Hemo Cycle Size) 
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APPENDIX C: IN VIVO DATA PROCESSING PROCESSURE 
 
The excessive headers in the .ccd and .sen files generated in vivo either using 
“Glucose” or “Hemo” mode could be cleaned using a C++ based command line tool 
called “ConversionTool.exe”. Either a .ccd, or .sen file, or a path to a folder which has 
these files could be specified to implement this command. More than one file or folder 
could be specified at the same time by adding them as arguments. 
The format of the .sec file, which is the converted file from .sen data, is: 
Frame Count (16 bit unsigned int) 
% Then the sensor data for each frame 
% Sensor Frame Data Format: 
Force (32 bit int) 
Pressure (32 bit int) 
Contact Area (32 bit int)  % scaled by multiplying by 1000 
Q1 Sum (32 bit int)  % scaled by multiplying by 1000 
Q2 Sum (32 bit int)  % scaled by multiplying by 1000 
Q3 Sum (32 bit int)  % scaled by multiplying by 1000 
Q4 Sum (32 bit int)  % scaled by multiplying by 1000 
 
The format of the .vec file, which is the converted file from .ccd data, is: 
Frame Count (16 bit unsigned int) 
Frame 1 Data (1024 32 bit signed values) 
... 
Frame n Data (1024 32 bit signed values) 
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Only the .vec and .sec files could be recognized by the MATLAB routines for bulk 
processing. Therefore, file type conversion is a must. To use the “ConversionTool.exe”, 
follow the following steps: 
i) Open a “Command Prompt” window. 
ii) Direct the path to where “ConversionTool.exe” is located. For example, it is 
located under the root directory of disk C:\, then input in the command line: 
iii) > C:\ConversionTool.exe "C:\2011-06-20 data" (assuming data is also saved 
under the root directory of disk C:\). 
iv) The program should then tell you it is converting the files and that they were 
successfully converted in to the original folder. 
 
The following MATLAB routines and subfunctions are used to bulk convert the 
binary formatted .dtl, .sum and the converted .vec data files into summarized Excel files. 
It is important to modify the routine according to any changes made to the data 
structures as shown in APPENDIX B. 
 
1. Main function: Hemolog.m 
 
% Save binary Hemo log files (.vec,.dtl,.sum) into .xlsx with captions; 
% Hemo Cycle Size means the number of CCD frames in a single Hemo cycle; 
% Hemo Cycle Size can be found in the Hemo.cfg settings; 
% Bin Deng 6/28/2010 
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function HemoLog() 
clc; 
clear all; 
 
% Changed the current directory for Matlab 
cd('C: \LighTouch Data\2011-06-20'); 
 
% Default Hemo Cycle Size is 3 sec, 20ms per frame, thus 150 frames 
FramesPerCycle = 150; 
 
Summary; 
Detail_LT(FramesPerCycle); 
CCD(FramesPerCycle); 
 
msgbox('Conversion is done!') 
end 
 
2. Subfunction – Summary.m 
 
% Subfunction for HemoLog.m 
% Process of .sum for each Hemo experiment 
% Based on v1.4 .sum file data structure 
% Bin Deng 6/28/2010 
 
function Summary 
 
Files = dir('*.sum'); 
 
for n=1:length(Files); 
    SumID = fopen(Files(n).name, 'r', 'ieee-le'); 
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% the equation below is determined by the .sum file structure 
% TotalHemoCycle = (SumCount-44)/32; % the number of Hemo cycles run for 
each experiment 
 
FileRevisionTag = {fread(SumID,[1,4],'*char')}; % header for each .sum is '1VER' 
HemoCycleCount = fread(SumID,1,'int32'); 
HemoCycleSize = fread(SumID,1,'int32'); % The number of CCD frames in each 
Hemo cycle 
ParaA = fread(SumID,1,'float32'); % The six parameters for the Hemocrit caculation 
algorithm 
ParaB = fread(SumID,1,'float32'); 
ParaC = fread(SumID,1,'float32'); 
ParaD = fread(SumID,1,'float32'); 
ParaE = fread(SumID,1,'float32'); 
ParaF = fread(SumID,1,'float32'); 
LaserPower = fread(SumID,1,'float32'); % in volts, can be convert to milliwatts 
using the calibration curve 
CcdExposureTime = fread(SumID,1,'float32'); % in milliseconds 
 
% define the data space for all the variables 
HemoCycleInstance = zeros(HemoCycleCount,1); 
RBCVolume = zeros(HemoCycleCount,1); 
PlasmaVolume = zeros(HemoCycleCount,1); 
HctResult = zeros(HemoCycleCount,1); 
CcdExposureTemp = zeros(HemoCycleCount,1); 
IE0 = zeros(HemoCycleCount,1); 
EE0 = zeros(HemoCycleCount,1); 
BleachStatus = zeros(HemoCycleCount,1); 
StabilityStatus = zeros(HemoCycleCount,1); 
Unused1 = zeros(HemoCycleCount,1); 
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Unused2 = zeros(HemoCycleCount,1); 
 
for i=1:HemoCycleCount; 
    HemoCycleInstance(i,1) = fread(SumID,1,'int32'); 
    RBCVolume(i,1) = fread(SumID,1,'float32'); % RBC,plasma volume & Hct is the 
average for each Hemo cycle 
    PlasmaVolume(i,1) = fread(SumID,1,'float32'); 
    HctResult(i,1) = fread(SumID,1,'float32'); 
    CcdExposureTemp(i,1) = fread(SumID,1,'float32'); % in celsius 
    IE0(i,1) = fread(SumID,1,'float32'); % IE0 & EE0 used for the Hct calculation 
    EE0(i,1) = fread(SumID,1,'float32'); 
    BleachStatus(i,1) = fread(SumID,1,'bool'); % 1 is true, 0 is false 
    StabilityStatus(i,1) = fread(SumID,1,'bool'); 
    Unused1(i,1) = fread(SumID,1,'*char'); % two unused variables for future 
expension 
    Unused2(i,1) = fread(SumID,1,'*char'); 
end 
 
Title1 = {'File Revision Tag';'HemoCycleCount';'Hemo Cycle Size';'Parameter 
A';'Parameter B';'Parameter C';'Parameter D';'Parameter E';'Parameter F';'Laser 
Power';'CCD Exposure Time'}; 
Title2 = {'Hemo Cycle Instance' 'Red Blood Cell Volume' 'Plasma Volume' 'Hct 
Result' 'CCD Exposure Temp' 'IE0 Value' 'EE0 Value' 'Bleach Status' 'Stability 
Status' 'Unused_1' 'Unused_2'}; 
xlswrite([Files(n).name,'_summary','.xls'],Title1,[Files(n).name,'_summary'],'A1'); 
xlswrite([Files(n).name,'_summary','.xls'],FileRevisionTag,[Files(n).name,'_summar
y'],'B1'); 
xlswrite([Files(n).name,'_summary','.xls'],HemoCycleCount,[Files(n).name,'_summa
ry'],'B2'); 
xlswrite([Files(n).name,'_summary','.xls'],HemoCycleSize,[Files(n).name,'_summary
'],'B3'); 
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xlswrite([Files(n).name,'_summary','.xls'],ParaA,[Files(n).name,'_summary'],'B4'); 
xlswrite([Files(n).name,'_summary','.xls'],ParaB,[Files(n).name,'_summary'],'B5'); 
xlswrite([Files(n).name,'_summary','.xls'],ParaC,[Files(n).name,'_summary'],'B6'); 
xlswrite([Files(n).name,'_summary','.xls'],ParaD,[Files(n).name,'_summary'],'B7'); 
xlswrite([Files(n).name,'_summary','.xls'],ParaE,[Files(n).name,'_summary'],'B8'); 
xlswrite([Files(n).name,'_summary','.xls'],ParaF,[Files(n).name,'_summary'],'B9'); 
xlswrite([Files(n).name,'_summary','.xls'],LaserPower,[Files(n).name,'_summary'],'B
10'); 
xlswrite([Files(n).name,'_summary','.xls'],CcdExposureTime,[Files(n).name,'_summ
ary'],'B11'); 
xlswrite([Files(n).name,'_summary','.xls'],Title2,[Files(n).name,'_summary'],'D1'); 
xlswrite([Files(n).name,'_summary','.xls'],HemoCycleInstance,[Files(n).name,'_sum
mary'],'D2'); 
xlswrite([Files(n).name,'_summary','.xls'],RBCVolume,[Files(n).name,'_summary'],'
E2'); 
xlswrite([Files(n).name,'_summary','.xls'],PlasmaVolume,[Files(n).name,'_summary'
],'F2'); 
xlswrite([Files(n).name,'_summary','.xls'],HctResult,[Files(n).name,'_summary'],'G2'
); 
xlswrite([Files(n).name,'_summary','.xls'],CcdExposureTemp,[Files(n).name,'_summ
ary'],'H2'); 
xlswrite([Files(n).name,'_summary','.xls'],IE0,[Files(n).name,'_summary'],'I2'); 
xlswrite([Files(n).name,'_summary','.xls'],EE0,[Files(n).name,'_summary'],'J2'); 
xlswrite([Files(n).name,'_summary','.xls'],BleachStatus,[Files(n).name,'_summary'],'
K2'); 
xlswrite([Files(n).name,'_summary','.xls'],StabilityStatus,[Files(n).name,'_summary']
,'L2'); 
xlswrite([Files(n).name,'_summary','.xls'],Unused1,[Files(n).name,'_summary'],'M2'); 
xlswrite([Files(n).name,'_summary','.xls'],Unused2,[Files(n).name,'_summary'],'N2'); 
warning off MATLAB:xlswrite:AddSheet 
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fclose(SumID); 
end 
end 
 
3. Subfunction – Detail.m 
 
% Subfunction for HemoLog.m 
% Process of .dtl for each Hemo Cycle 
% Based on v1.4 .dtl data structure 
% Bin Deng 12/10/2010 
 
function Detail_CL(FramesPerCycle) 
 
% define the data space for all .dtl variables 
RBCVolume = zeros(FramesPerCycle,1); 
PlasmaVolume = zeros(FramesPerCycle,1); 
HctResult = zeros(FramesPerCycle,1); 
QuadrantCount = zeros(FramesPerCycle,4); 
Pressure = zeros(FramesPerCycle,1); 
ContactArea = zeros(FramesPerCycle,1); 
TP9 = zeros(FramesPerCycle,1); 
TP10 = zeros(FramesPerCycle,1); 
 
% get all the .dtl files 
Files = dir('*.dtl'); 
TotalFrames = length(Files)* FramesPerCycle; 
 
% define the data space for all the summary variables 
HemoCycleInstanceAll = zeros(TotalFrames,1); 
RBCVolumeAll = zeros(TotalFrames,1); 
PlasmaVolumeAll = zeros(TotalFrames,1); 
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HctResultAll = zeros(TotalFrames,1); 
PressureAll = zeros(TotalFrames,1); 
ContactAreaAll = zeros(TotalFrames,1); 
QuadrantCountAll = zeros(TotalFrames,4); 
TP9All = zeros(TotalFrames,1); 
TP10All = zeros(TotalFrames,1); 
 
for n=1:length(Files); 
    DtlID = fopen(Files(n).name, 'r', 'ieee-le'); 
    [DtlData, DtlCount] = fread(DtlID); 
 
    Count = 12+28*FramesPerCycle; % calculate supposed total data bytes 
    if DtlCount ~= Count; %  
        errordlg('Wrong File Size: Please check Hemo Cycle Size','File Error'); 
    else 
        DtlID = fopen(Files(n).name,'r','ieee-le'); % relocate the pointer to the begining 
        FileRevisionTag = {fread(DtlID,[1,4],'char*1')}; % header for each .dtl is 
'1VER' 
        HemoCycleSize = fread(DtlID,1,'int32'); % HemoCycleSize should be equal to 
FramesPerCycle 
        HemoCycleInstance = fread(DtlID,1,'int32');  
        for i=1:HemoCycleSize; 
            RBCVolume(i,1) = fread(DtlID,1,'float32'); 
            PlasmaVolume(i,1) = fread(DtlID,1,'float32'); 
            HctResult(i,1) = fread(DtlID,1,'float32'); 
            Pressure(i,1) = fread(DtlID,1,'float32'); 
            ContactArea(i,1) = fread(DtlID, 1, 'float32'); 
            QuadrantCount(i,:) = fread(DtlID,[1,4],'*char'); 
            TP9(i,1) = fread(DtlID, 1, 'short'); 
            TP10(i,1) = fread(DtlID, 1, 'short'); 
 
238 
 
            k=(n-1)*HemoCycleSize+i; 
            HemoCycleInstanceAll(k,1) = HemoCycleInstance; 
            RBCVolumeAll(k,1) = RBCVolume(i,1); 
            PlasmaVolumeAll(k, 1) = PlasmaVolume(i,1); 
            HctResultAll(k,1) = HctResult(i,1); 
            PressureAll(k,1) = Pressure(i,1); 
            ContactAreaAll(k,1) = ContactArea(i,1); 
            QuadrantCountAll(k,:) = QuadrantCount(i,:); 
            TP9All(k,:) = TP9(i,1); 
            TP10All(k,:) = TP10(i,1); 
        end 
    end 
     
fclose(DtlID); 
 
% Title1 = {'File Revision Tag' 'Hemo Cycle Size' 'Hemo Cycle Instance' 'Frame 
Count' 'Red Blood Cell Volume' 'Plasma Volume' 'Hct Result' 'Pressure' 'Contact 
Area' 'Quadrant Down' 'Quadrant Up' 'Quadrant Out' 'Quadrant In'}; 
% FrameCount = transpose(1:FramesPerCycle); 
% xlswrite([Files(n).name,'.xls'],Title1,[Files(n).name],'A1'); 
% xlswrite([Files(n).name,'.xls'],FileRevisionTag,[Files(n).name],'A2'); 
% xlswrite([Files(n).name,'.xls'],HemoCycleSize,[Files(n).name],'B2'); 
% xlswrite([Files(n).name,'.xls'],HemoCycleInstance,[Files(n).name],'C2'); 
% xlswrite([Files(n).name,'.xls'],FrameCount,[Files(n).name],'D2'); 
% xlswrite([Files(n).name,'.xls'],RBCVolume,[Files(n).name],'E2'); 
% xlswrite([Files(n).name,'.xls'],PlasmaVolume,[Files(n).name],'F2'); 
% xlswrite([Files(n).name,'.xls'],HctResult,[Files(n).name],'G2'); 
% xlswrite([Files(n).name,'.xls'],Pressure,[Files(n).name],'H2'); 
% xlswrite([Files(n).name,'.xls'],ContactArea,[Files(n).name],'I2'); 
% xlswrite([Files(n).name,'.xls'],QuadrantCount,[Files(n).name],'J2'); 
warning off MATLAB:xlswrite:AddSheet 
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end 
 
Title2 = {'Hemo Cycle Instance' 'Frame' 'RBC Volume' 'Plasma Volume' 
'Hematocrit' 'BV' 'RBC' 'TP9' 'TP10'}; 
FrameCount2 = transpose(1:TotalFrames); 
xlswrite(['Frame by Frame Summary','.xlsx'],Title2,['Hct'],'A1'); 
xlswrite(['Frame by Frame Summary','.xlsx'],HemoCycleInstanceAll,['Hct'],'A2'); 
xlswrite(['Frame by Frame Summary','.xlsx'],FrameCount2,['Hct'],'B2'); 
xlswrite(['Frame by Frame Summary','.xlsx'],RBCVolumeAll,['Hct'],'C2'); 
xlswrite(['Frame by Frame Summary','.xlsx'],PlasmaVolumeAll,['Hct'],'D2'); 
xlswrite(['Frame by Frame Summary','.xlsx'],HctResultAll,['Hct'],'E2'); 
xlswrite(['Frame by Frame Summary','.xlsx'],TP9All,['Hct'],'H2'); 
xlswrite(['Frame by Frame Summary','.xlsx'],TP10All,['Hct'],'I2'); 
 
Title3 = {'Hemo Cycle Instance' 'Frame' 'Pressure' 'Contact Area' 'Quadrant Down' 
'Quadrant Up' 'Quadrant Out' 'Quadrant In'}; 
xlswrite(['Frame by Frame Summary','.xlsx'],Title3,['PDPM'],'A1'); 
xlswrite(['Frame by Frame Summary','.xlsx'],HemoCycleInstanceAll,['PDPM'],'A2'); 
xlswrite(['Frame by Frame Summary','.xlsx'],FrameCount2,['PDPM'],'B2'); 
xlswrite(['Frame by Frame Summary','.xlsx'],PressureAll,['PDPM'],'C2'); 
xlswrite(['Frame by Frame Summary','.xlsx'],ContactAreaAll,['PDPM'],'D2'); 
xlswrite(['Frame by Frame Summary','.xlsx'],QuadrantCountAll,['PDPM'],'E2'); 
 
end 
 
4. Subfunction -- CCD.m 
 
% Subfunction for HemoLog.m 
% Process of .ccd files for each Hemo Cycle 
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% .ccd needed to be converted to .vec file using the conversion tool first!! 
% Excel 2003: max rows = 65,536; max columns = 256 
% Excel 2007: max rows = over 1 million; max columns = 16,384 
% Bin Deng 6/28/2010 
 
function CCD(FramesPerCycle) 
 
% get all the .vec files 
Files = dir('*.vec'); 
TotalFrames = length(Files)* FramesPerCycle; 
 
% define BV and RBV start and end cell (.cfg number +1) 
% the following sets of params are for the old LT system 
BVStart = 401; 
BVEnd = 926; 
RBCStart = 96; 
RBCEnd = 105; 
 
% the following sets of params are for the new Hct-1 system 
% BVStart = 226; 
% BVEnd = 701; 
% RBCStart = 98; 
%RBCEnd = 104; 
 
% define the data space for all the summary variables 
BV = zeros(FramesPerCycle,1); 
RBC = zeros(FramesPerCycle,1); 
BVAll = zeros(TotalFrames,1); 
RBCAll = zeros(TotalFrames,1); 
 
for n=1:length(Files); 
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    CcdID = fopen(Files(n).name, 'r', 'ieee-le'); 
    HemoCycleSize = fread(CcdID, 1, 'uint16'); 
        if  HemoCycleSize ~= FramesPerCycle; %  
            errordlg('Wrong File Size: Please check Hemo Cycle Size','File Error'); 
        else 
            CcdData = fread(CcdID,[1024,HemoCycleSize],'int32'); 
            for i=1:HemoCycleSize; 
                BV(i,1) = sum(CcdData(BVStart:BVEnd,i)); 
                RBC(i,1) = sum(CcdData(RBCStart:RBCEnd,i)); 
             
                k=(n-1)*HemoCycleSize+i; 
             
                BVAll(k,1) = BV(i,1); 
                RBCAll(k, 1) = RBC(i,1); 
            end 
        end 
        fclose(CcdID); 
         
        %Title = {'Frame Count' 'BV' 'RBC'}; 
        %FrameCount = transpose(0:FramesPerCycle-1); 
        %xlswrite([Files(n).name,'.xls'],Title,[Files(n).name],'A1'); 
        %xlswrite([Files(n).name,'.xls'],FrameCount,[Files(n).name],'A2'); 
        %xlswrite([Files(n).name,'.xls'],BV,[Files(n).name],'B2'); 
        %xlswrite([Files(n).name,'.xls'],RBC,[Files(n).name],'C2'); 
end 
 
xlswrite(['Frame by Frame Summary','.xlsx'],BVAll,['Hct'],'F2'); 
xlswrite(['Frame by Frame Summary','.xlsx'],RBCAll,['Hct'],'G2'); 
 
% Wavelength Calibration using 5th order polynomial 
% y0,A1,A2,A3,A4,A5 can be found in .cfg file 
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% UPDATE whenever new calibration is made 
% PixelNumber = transpose(0:1023); 
% y0 = -392.516970725087; 
% A1 = 4.43554354246831; 
% A2 = -0.00710683854527714; 
% A3 = 1.91473348286739E-5; 
% A4 = -2.74128188255463E-8; 
% A5 = 1.5003258140181E-11; 
% RamanShift = 
y0+A1*PixelNumber+A2*PixelNumber.^2+A3*PixelNumber.^3+A4*PixelNumber
.^4+A5*PixelNumber.^5; 
 
% Title = {'Pixel Number' 'Raman Shift' 'Raw CCD Counts'}; 
% xlswrite([fName,'.xls'],Title,[fName,'_CCD'],'A1'); 
% xlswrite([fName,'.xls'],PixelNumber,[fName,'_CCD'],'A2'); 
% xlswrite([fName,'.xls'],RamanShift,[fName,'_CCD'],'B2'); 
% xlswrite([fName,'.xls'],CcdData,[fName,'_CCD'],'C2'); 
warning off MATLAB:xlswrite:AddSheet 
 
end 
 
These routines can also be revised in multiple ways to bulk convert the .ccd and .sen 
files generated under “Glucose” mode. Since only minimal changes are needed in order 
to do so, redundant codes will not be included in this appendix. 
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